<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">98096</article-id><article-id pub-id-type="doi">10.7554/eLife.98096</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>FGF8-mediated gene regulation affects regional identity in human cerebral organoids</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Bertacchi</surname><given-names>Michele</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4402-4974</contrib-id><email>Michele.BERTACCHI@univ-cotedazur.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Maharaux</surname><given-names>Gwendoline</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0006-7076-5887</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Loubat</surname><given-names>Agnès</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jung</surname><given-names>Matthieu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3272-7322</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Studer</surname><given-names>Michèle</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7105-2957</contrib-id><email>Michele.STUDER@univ-cotedazur.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02feahw73</institution-id><institution>Univ. Côte d’Azur (UniCA), CNRS, Inserm, Institut de Biologie Valrose (iBV)</institution></institution-wrap><addr-line><named-content content-type="city">Nice</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0015ws592</institution-id><institution>GenomEast platform, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC)</institution></institution-wrap><addr-line><named-content content-type="city">Illkirch</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Martinez-Barbera</surname><given-names>Juan Pedro</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Araújo</surname><given-names>Sofia J</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/021018s57</institution-id><institution>University of Barcelona</institution></institution-wrap><country>Spain</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>01</day><month>11</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e98096</elocation-id><history><date date-type="received" iso-8601-date="2024-03-31"><day>31</day><month>03</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-10-19"><day>19</day><month>10</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2023-12-22"><day>22</day><month>12</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.12.22.572974"/></event></pub-history><permissions><copyright-statement>© 2024, Bertacchi et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Bertacchi et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-98096-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-98096-figures-v2.pdf"/><abstract><p>The morphogen FGF8 establishes graded positional cues imparting regional cellular responses <italic>via</italic> modulation of early target genes. The roles of FGF signaling and its effector genes remain poorly characterized in human experimental models mimicking early fetal telencephalic development. We used hiPSC-derived cerebral organoids as an <italic>in vitro</italic> platform to investigate the effect of FGF8 signaling on neural identity and differentiation. We found that FGF8 treatment increases cellular heterogeneity, leading to distinct telencephalic and mesencephalic-like domains that co-develop in multi-regional organoids. Within telencephalic regions, FGF8 affects the anteroposterior and dorsoventral identity of neural progenitors and the balance between GABAergic and glutamatergic neurons, thus impacting spontaneous neuronal network activity. Moreover, FGF8 efficiently modulates key regulators responsible for several human neurodevelopmental disorders. Overall, our results show that FGF8 signaling is directly involved in both regional patterning and cellular diversity in human cerebral organoids and in modulating genes associated with normal and pathological neural development.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Healthy brain development in the human embryo relies on the precise coordination of numerous molecular signals that guide the formation of distinct brain regions in their correct locations. Molecules that diffuse through embryonic tissues, known as morphogens, serve as spatial and temporal cues that help cells determine their position within the developing brain. These positional signals are crucial for the proper formation of specific brain regions along the embryo’s principal axes.</p><p>FGF8 is a well-characterized morphogen that influences the anterior-to-posterior regional identity of brain cells in model organisms such as mice. However, studying this process in human embryos poses both technical and ethical challenges, meaning that little is known about the molecular bases of how developing brain cells determine their position along different axes. Understanding these molecular mechanisms is essential for gaining insights into human brain function and the origins of neurodevelopmental disorders.</p><p>Bertacchi et al. developed a new 'organ-in-a-dish' system – also known as an organoid – using human induced pluripotent stem cells. The research team combined 2D cell cultures on flat surfaces with 3D tissue culture techniques to create a more reproducible cerebral organoid protocol. This approach enabled the investigation of the role of FGF8 in human brain development within a controlled laboratory setting. Treatment with FGF8 enhanced brain cell diversity, as measured by gene expression analysis through single-cell RNA sequencing. Notably, distinct regions resembling the forebrain (telencephalon) and the midbrain (mesencephalon) emerged in FGF8-treated organoids. Within the telencephalic region, the cell type composition shifted, favoring neurons typically found in the ventral (lower) parts of the human brain. This altered the activity of the neural network, as evidenced by direct electrical signal measurements.</p><p>Overall, Bertacchi et al. demonstrated that a single molecular signal, FGF8, can drive the formation of distinct brain regions along multiple axes in human brain organoids. They also identified genes regulated by FGF8 that are associated with neurodevelopmental disorders. One such gene, NR2F1, is well-studied for its involvement in conditions such as intellectual disability, autism and epilepsy. This work provides a biologically accurate cell culture model, offering a valuable tool for advancing research into human brain development and associated neurological diseases.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>FGF8</kwd><kwd>hIPSC</kwd><kwd>multi-regional cerebral organoids</kwd><kwd>dorsoventral identity</kwd><kwd>LGE-derived interneurons</kwd><kwd>network activity</kwd><kwd>neurodevelopmental disease genes</kwd><kwd>NR2F1</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>IDEX UCAJedi ANR-15-IDEX-01</award-id><principal-award-recipient><name><surname>Studer</surname><given-names>Michèle</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002915</institution-id><institution>Fondation pour la Recherche Médicale</institution></institution-wrap></funding-source><award-id>EQU202003010222</award-id><principal-award-recipient><name><surname>Studer</surname><given-names>Michèle</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004431</institution-id><institution>Fondation de France</institution></institution-wrap></funding-source><award-id>00123416</award-id><principal-award-recipient><name><surname>Studer</surname><given-names>Michèle</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>ERA-NET NEURON JTC21 - Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-21-NEU2-0003-03</award-id><principal-award-recipient><name><surname>Studer</surname><given-names>Michèle</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-10-INBS-0009</award-id><principal-award-recipient><name><surname>Jung</surname><given-names>Matthieu</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001677</institution-id><institution>Institut National de la Santé et de la Recherche Médicale</institution></institution-wrap></funding-source><award-id>Dotation exceptionnelle prise de fonctions</award-id><principal-award-recipient><name><surname>Bertacchi</surname><given-names>Michele</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A novel 2D-to-3D human brain organoid protocol reveals the pivotal role of FGF8 signaling in driving regional patterning and cellular diversity, while also modulating genes crucial for both normal and pathological neural development.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The embryonic development of the mammalian brain is orchestrated by a highly coordinated cascade of cellular and molecular events. This cascade engages distinct signaling pathways activated by gradients of diffusing morphogens, including FGFs, BMPs, SHH, and WNTs (<xref ref-type="bibr" rid="bib17">Borello and Pierani, 2010</xref>; <xref ref-type="bibr" rid="bib110">Takahashi and Liu, 2006</xref>; <xref ref-type="bibr" rid="bib90">Rubenstein, 2008</xref>; <xref ref-type="bibr" rid="bib46">Hoch et al., 2009</xref>; <xref ref-type="bibr" rid="bib41">Guillemot and Zimmer, 2011</xref>). These morphogens instruct neural progenitors with spatial and temporal ‘coordinates’ along the dorsoventral (D/V) and anteroposterior (A/P) brain axes, modulating early expression gradients of key developmental genes in a dose-dependent manner. These initial stages lay the foundation for further critical processes in brain development, such as progenitor proliferation, cell migration, neuronal differentiation, and circuit formation. Disruption of any of these mechanisms can lead to multiple morphological abnormalities, and contribute to a range of neurodevelopmental disorders (NDDs).</p><p>FGF ligands and their receptors play pivotal roles in neural plate patterning (<xref ref-type="bibr" rid="bib41">Guillemot and Zimmer, 2011</xref>), and disruptions in FGF signaling pathways have been implicated in various brain malformations (<xref ref-type="bibr" rid="bib117">Turner et al., 2016</xref>) and significant cortical development defects (<xref ref-type="bibr" rid="bib109">Sun et al., 2023</xref>; <xref ref-type="bibr" rid="bib99">Shin et al., 2004</xref>; <xref ref-type="bibr" rid="bib44">Hébert et al., 2003</xref>). Notably, although some functional redundancy exists among FGF factors (<xref ref-type="bibr" rid="bib117">Turner et al., 2016</xref>), FGF8 stands out as a primary regulator of regional patterning and brain development. During early development, FGF8 is essential in establishing the midbrain-hindbrain boundary (<xref ref-type="bibr" rid="bib43">Harada et al., 2016</xref>; <xref ref-type="bibr" rid="bib58">Lee et al., 1997</xref>) - a region known as the isthmus, which acts as a brain organizer - where the FGF8 diffusing gradient controls the patterning of posterior brain regions (<xref ref-type="bibr" rid="bib58">Lee et al., 1997</xref>; <xref ref-type="bibr" rid="bib63">Mason et al., 2000</xref>; <xref ref-type="bibr" rid="bib123">Ye et al., 1998</xref>; <xref ref-type="bibr" rid="bib30">Crossley et al., 1996</xref>). During the development of telencephalic vesicles, FGF8 diffuses from the anterior neural ridge (ANR; <xref ref-type="bibr" rid="bib114">Toyoda et al., 2010</xref>; <xref ref-type="bibr" rid="bib47">Hoch et al., 2015</xref>), located at the most anterior pole, creating a gradient that regulates proliferation, apoptosis, regionalization, and identity acquisition along cortical axes (<xref ref-type="bibr" rid="bib114">Toyoda et al., 2010</xref>; <xref ref-type="bibr" rid="bib105">Storm et al., 2006</xref>; <xref ref-type="bibr" rid="bib104">Storm et al., 2003</xref>; <xref ref-type="bibr" rid="bib38">Fukuchi-Shimogori and Grove, 2001</xref>; <xref ref-type="bibr" rid="bib94">Sato et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Cholfin and Rubenstein, 2007</xref>; <xref ref-type="bibr" rid="bib28">Cholfin and Rubenstein, 2008</xref>; <xref ref-type="bibr" rid="bib39">Garel et al., 2003</xref>). Consistently, FGF8 diffusion is essential for the regulation of key telencephalic genes such as <italic>Foxg1</italic> (<xref ref-type="bibr" rid="bib98">Shimamura and Rubenstein, 1997</xref>), a transcription factor required for the regionalization and growth of telencephalic vesicles. Additionally, FGF8 promotes cortical expansion by activating the ERK signaling pathway, thereby enhancing self-renewal and increasing the pool of cortical radial glia cells (<xref ref-type="bibr" rid="bib109">Sun et al., 2023</xref>). FGFs exert their functions by binding to four highly conserved FGF receptors (FGFRs; <xref ref-type="bibr" rid="bib54">Klimaschewski and Claus, 2021</xref>); among those, FGFR3 plays a specific role in regulating brain size by influencing progenitor proliferation and apoptosis (<xref ref-type="bibr" rid="bib50">Inglis-Broadgate et al., 2005</xref>) and is essential for the correct formation and regionalization of the occipitotemporal cortex (<xref ref-type="bibr" rid="bib112">Thomson et al., 2009</xref>; <xref ref-type="bibr" rid="bib111">Thomson et al., 2007</xref>).</p><p>Given their multiple roles during embryonic (<xref ref-type="bibr" rid="bib41">Guillemot and Zimmer, 2011</xref>; <xref ref-type="bibr" rid="bib91">Rubenstein, 2011</xref>) and adult age (<xref ref-type="bibr" rid="bib117">Turner et al., 2016</xref>; <xref ref-type="bibr" rid="bib54">Klimaschewski and Claus, 2021</xref>), it is not surprising that FGF factors have been implicated in the onset of several NDDs (<xref ref-type="bibr" rid="bib5">Amaral et al., 2008</xref>), and adult psychiatric conditions, such as anxiety, depression, and schizophrenia (<xref ref-type="bibr" rid="bib54">Klimaschewski and Claus, 2021</xref>; <xref ref-type="bibr" rid="bib103">Stevens et al., 2010</xref>). FGF8 exerts its effects by modulating key developmental genes, which, in turn, directly or indirectly control critical neurogenesis processes. Dysregulation of these genes can lead to various pathological conditions. A notable example is the nuclear receptor <italic>Nr2f1</italic>, which is regulated by the FGF8 pathway and plays several roles during mouse telencephalic development (<xref ref-type="bibr" rid="bib14">Bertacchi et al., 2019</xref>; <xref ref-type="bibr" rid="bib113">Tocco et al., 2021</xref>). Mutations in the <italic>NR2F1</italic> gene lead to an emerging NDD, called Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS), a condition characterized by cognitive and visual impairments (<xref ref-type="bibr" rid="bib25">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Bosch et al., 2014</xref>; <xref ref-type="bibr" rid="bib86">Rech et al., 2020</xref>; <xref ref-type="bibr" rid="bib15">Bertacchi et al., 2022</xref>). The anterior FGF8 telencephalic gradient negatively regulates <italic>Nr2f1</italic> during early mouse development (<xref ref-type="bibr" rid="bib93">Sansom et al., 2005</xref>; <xref ref-type="bibr" rid="bib9">Assimacopoulos et al., 2012</xref>), allowing its expression to follow an anterior-low to posterior-high gradient, which is crucial for specifying areal identities in the dorsal telencephalon (<xref ref-type="bibr" rid="bib60">Liu et al., 2000</xref>; <xref ref-type="bibr" rid="bib84">Qiu et al., 1994</xref>; <xref ref-type="bibr" rid="bib115">Tripodi et al., 2004</xref>; <xref ref-type="bibr" rid="bib7">Armentano et al., 2006</xref>; <xref ref-type="bibr" rid="bib126">Zhou et al., 2001</xref>; <xref ref-type="bibr" rid="bib8">Armentano et al., 2007</xref>). Other FGF8 downstream targets promote anterior identity by inhibiting <italic>Nr2f1 (</italic><xref ref-type="bibr" rid="bib71">O’Leary et al., 2007</xref>; <xref ref-type="bibr" rid="bib72">O’Leary and Sahara, 2008</xref>), creating a cross-talk where FGFs and <italic>Nr2f1</italic> exert opposite effects on the A/P cortical axis (<xref ref-type="bibr" rid="bib14">Bertacchi et al., 2019</xref>). Interestingly, human <italic>NR2F1</italic> also exhibits a low anterior to high posterior expression gradient in the early telencephalon (<xref ref-type="bibr" rid="bib36">Foglio et al., 2021</xref>; <xref ref-type="bibr" rid="bib2">Alzu’bi et al., 2017a</xref>; <xref ref-type="bibr" rid="bib29">Clowry et al., 2018</xref>), raising the possibility that FGFs could modulate similar downstream effector genes in the human brain. However, despite significant advances in understanding FGF-related physiology and pathology, most studies have relied on animal (often murine) models, where FGF depletion results in severe phenotypes (<xref ref-type="bibr" rid="bib64">Meyers et al., 1998</xref>; <xref ref-type="bibr" rid="bib108">Sun et al., 1999</xref>; <xref ref-type="bibr" rid="bib87">Reifers et al., 1998</xref>; <xref ref-type="bibr" rid="bib96">Shanmugalingam et al., 2000</xref>). Hence, the role of FGFs, particularly FGF8, in human progenitor cells and neurons remains poorly understood, as does the contribution of FGF8 signaling and its target gene regulation in human diseases.</p><p>Self-organizing human brain organoids offer an unprecedented tool for modeling early neural development <italic>in vitro</italic>, offering an ethical and practical alternative to studying early fetal brain development (<xref ref-type="bibr" rid="bib121">Velasco et al., 2020</xref>; <xref ref-type="bibr" rid="bib82">Qian et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Chiaradia and Lancaster, 2020</xref>; <xref ref-type="bibr" rid="bib85">Quadrato et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Lancaster et al., 2013</xref>; <xref ref-type="bibr" rid="bib57">Lancaster and Knoblich, 2014</xref>; <xref ref-type="bibr" rid="bib88">Renner et al., 2017</xref>; <xref ref-type="bibr" rid="bib10">Bagley et al., 2017</xref>; <xref ref-type="bibr" rid="bib83">Qian et al., 2020</xref>). Previous studies utilizing 2D neural protocols (<xref ref-type="bibr" rid="bib24">Chambers et al., 2009</xref>; <xref ref-type="bibr" rid="bib100">Smukler et al., 2006</xref>; <xref ref-type="bibr" rid="bib40">Gaspard et al., 2009</xref>), followed by adaptations for 3D organoid protocols (<xref ref-type="bibr" rid="bib52">Kadoshima et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Qian et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Qian et al., 2016</xref>), demonstrated that pluripotent cells adopt a dorsal/anterior (<italic>i.e.</italic> telencephalic) neural fate when shielded from posteriorizing factors such as TGFβ, BMPs, retinoic acid, and WNTs. By building upon previous methods (<xref ref-type="bibr" rid="bib24">Chambers et al., 2009</xref>; <xref ref-type="bibr" rid="bib81">Qian et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Qian et al., 2016</xref>), we optimized a hybrid 2D/3D <italic>in vitro</italic> culture system that facilitates the efficient formation of telencephalic FOXG1+ tissue and allows for the assessment of FGF8-mediated effects on neural cell differentiation and identity acquisition. Our findings indicate that FGF8 treatment leads to altered regional identities in 3D organoids compared to untreated controls, resulting in the development of multi-regional organoids with distinct co-developing brain domains. FGF8 efficiently modulates <italic>NR2F1</italic> and other genes associated with brain disorders in human FOXG1+ telencephalic cells, underscoring its critical role in the fine-tuning of key neurodevelopmental and pathogenic pathways. Notably, prolonged exposure to FGF8 affects not only A/P areal identity but also D/V telencephalic cell identity. As a result, FGF8-treated brain organoids exhibit an imbalance in the production of excitatory and inhibitory neurons, which impacts the formation of electrical neural networks. Collectively, our data redefine the role of FGF8 as a crucial morphogen for regional patterning and the establishment of distinct D/V and A/P telencephalic identities in human cells, thus highlighting its significance in modulating the expression of key developmental and NDD-related genes during the organization of the human brain.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>An optimized 2D/3D organoid protocol allows a fast and reproducible generation of telencephalic cells</title><p>Based on previous methods (<xref ref-type="bibr" rid="bib24">Chambers et al., 2009</xref>; <xref ref-type="bibr" rid="bib81">Qian et al., 2018</xref>), we optimized a human brain organoid protocol to study how FGF8 signaling impacts neuronal development and differentiation (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). For fast and efficient induction of neural progenitors, we employed a dual inhibition of SMAD signaling paradigm (<xref ref-type="bibr" rid="bib24">Chambers et al., 2009</xref>) by treating confluent 2D hiPSC cultures with TGFβ and BMP inhibitors (SB-431542 and LDN-193189, respectively). As endogenous WNT factors can inhibit the acquisition of an anterior fate (<xref ref-type="bibr" rid="bib13">Bertacchi et al., 2015b</xref>; <xref ref-type="bibr" rid="bib61">Lupo et al., 2013</xref>), a chemical WNT inhibitor (XAV-939) was added for optimal induction of telencephalic regional identity. Around day5-6, clusters of radially organized neural progenitors (<italic>i.e.</italic> neural rosettes) were visible in brightfield microscopy (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Consistently with the appearance of rosettes, analysis of key markers for pluripotency and neural differentiation by real-time qRT-PCR showed efficient neural induction by day7 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), with down-regulation of stemness markers <italic>OCT4</italic> and <italic>NANOG</italic> and upregulation of a molecular signature characteristic of antero-dorsal telencephalic neural progenitors (NPs; <italic>SOX2</italic>, <italic>PAX6</italic>, <italic>SIX3</italic> and <italic>OTX2</italic>). Notably, only NPs treated with XAV-939 (WNT inhibition; WNTi hereafter) efficiently upregulated the telencephalic marker <italic>FOXG1</italic> at day10 compared to control samples (CTRL; <xref ref-type="fig" rid="fig1">Figure 1B</xref>), as further confirmed by immunostaining (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>). To obtain 3D organoids, we dissociated day7 neural rosettes and re-aggregated early NPs into spherical aggregates (embryoid bodies, EBs; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), which were included 24 hr later in Matrigel droplets. For optimal nutrient and oxygen distribution, EB-containing Matrigel droplets (named ‘cookies’; <xref ref-type="bibr" rid="bib81">Qian et al., 2018</xref>) were cultured in miniaturized spinning bioreactors (<xref ref-type="bibr" rid="bib81">Qian et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Qian et al., 2016</xref>). After a few additional days of 3D culture, NPs spontaneously re-organized as multiple radially structured rosettes (<xref ref-type="fig" rid="fig1">Figure 1E–F’</xref>), but only WNTi organoids showed a significantly higher number of FOXG1+ rosettes compared to CTRL ones (<xref ref-type="fig" rid="fig1">Figure 1E–I</xref>). After 10–15 days (day35) of culture in neural differentiation medium (NDM), SOX2+ FOXG1+ NP rosettes started to be surrounded by differentiating neurons (<xref ref-type="fig" rid="fig1">Figure 1J and J’</xref>). From this stage onwards, the culture medium was supplemented with pro-survival and anti-apoptotic elements to provide optimal conditions for long-term cultures (long-term survival medium, LTSM). At around day50, FOXG1+ NR2F1+ SOX2+ NP rosettes were surrounded by differentiated neurons (<xref ref-type="fig" rid="fig1">Figure 1K–M’</xref>), which were positive for neural-Tubulin (NTUB) staining (<xref ref-type="fig" rid="fig1">Figure 1K and K’</xref>) and expressed markers of cortical layers such as TBR1 and CTIP2 (<xref ref-type="fig" rid="fig1">Figure 1M and M’</xref>). In summary, by combining previous protocols for the induction of human brain cells, we associated the high yield and rapidity of 2D neural induction with the optimized growth of 3D neural structures in spinning bioreactors, obtaining anterior NPs in 7 days and highly organized telencephalic organoids in 1 month of culture.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Hybrid 2D/3D protocol for fast and reproducible generation of human cortical organoids.</title><p>(<bold>A</bold>) Schematic of the hybrid 2D/3D method for generating telencephalic/cortical human organoids in vitro, using a triple inhibition of TGFβ, BMP, and WNT pathways (SB-431542, 5 µM; LDN-193189, 0.25 µM; XAV-939, 2 µM). On day 7, cells are dissociated and re-aggregated in 96-well plates. One day later, embryoid bodies (EBs) are embedded in Matrigel droplets (10 µL per droplet containing 1–4 EBs). These droplets, termed ‘cookies’, are then cultured in spinning bioreactors. (<bold>B</bold>) Real-time qRT-PCR analysis quantifying pluripotency markers (<italic>NANOG</italic>, <italic>OCT4</italic>) and telencephalic neural progenitor (NP) markers (<italic>SOX2</italic>, <italic>PAX6</italic>, <italic>FOXG1</italic>, <italic>SIX3</italic>, and <italic>OTX2</italic>) in undifferentiated HMGU1 hiPSCs and in day7 and day10 control (CTRL) and WNT-inhibited (WNTi) samples, as indicated. n=2 culture wells per condition, pooled prior to RNA extraction. (<bold>C,D</bold>) Immunostaining for FOXG1 (red) and SOX2 (green) in day10 2D neural cultures under control (CTRL) conditions (<bold>C</bold>) or following WNT inhibition (WNTi) (<bold>D</bold>). (<bold>E–I</bold>) Immunostaining for FOXG1 (red) and SOX2 (green) in day14 (<bold>E-F’</bold>) and day21 (<bold>G-H’</bold>) organoids under CTRL or WNTi conditions, as indicated. White arrowheads in high-magnification images point to neural progenitor (NP) rosettes. The graph (<bold>I</bold>) shows quantification of FOXG1 pixel intensity in CTRL and WNTi samples across time points. n≥7 sections from n≥4 organoids from n=2 independent batches (except day52-69 CTRL sample, n=2 sections from 1 batch). (<bold>J,J’</bold>) FOXG1 (red) and SOX2 (green) immunostaining in day35 WNTi organoids. White arrowheads in high-magnification images indicate NP neural rosettes, while arrows highlight differentiating neurons surrounding the rosettes. (<bold>K-M’</bold>) Immunostaining for FOXG1 (red) and NTUB (green) (<bold>K, K’</bold>), NR2F1 (red) and SOX2 (green) (<bold>L, L’</bold>), and TBR1 (red) and CTIP2 (green) (<bold>M, M’</bold>) in day53 WNTi organoids. High-magnification images highlight FOXG1+ SOX2+ NR2F1+ NP rosettes/neuroepithelia (K-L’; indicated by white arrowheads) surrounded by TBR1+ CTIP2+ NR2F1+ differentiating cortical neurons (L’-M’; indicated by white arrows). Scale bars: 100 µm.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Expression level of pluripotency and telencephalic markers in 2D human progenitors.</title><p>Raw quantitative RT-PCR data showing telencephalic and pluripotency marker expression in control and WNTi cells on days 7 and 10.</p></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-98096-fig1-data1-v2.xls"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>FOXG1 staining intensity in CTRL and WNTi human organoids.</title><p>GraphPad sheet containing raw pixel intensity data measured in CTRL and WNTi organoid cryostat slices from day14 to day69 following FOXG1 immunostaining.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig1-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Hybrid 2D/3D protocol for generation of telencephalic human organoids.</title><p>Brightfield microscope images showing, from top left to bottom right: undifferentiated and confluent HMGU1 cells at the starting day of the neural differentiation protocol; day7 neural progenitors organized in groups of radially oriented cells (arrowheads) and surrounded by non-neural cells; dissociated NPs at day7, spinned at the bottom of 96-well plates; day7 dissociated NPs at the bottom of a single well; embryoid body (EB) at day8, 24 hr after dissociation; day10 EB included in Matrigel; EB at day16, with some rosettes and neural epithelia becoming visible on the borders; day65 organoid.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>FGF8 treatment modulates telencephalic target genes in brain organoids</title><p>In the developing mouse brain, distinct sources of diffusing FGF8 fine-tune the expression of several genes. In WNTi human organoids, we found that early FGF8 treatment (starting at day5; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>) reduced FOXG1 expression, in line with early FGF8 inducing posterior rather than anterior identity (<xref ref-type="bibr" rid="bib103">Stevens et al., 2010</xref>). The addition of FGF8 to the culture medium starting at day10-11 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) or later at day20 did not affect FOXG1 expression (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>), indicating preservation of telencephalic identity. However, day20 FGF8 treatment was less efficient in modulating the FGF8-target NR2F1 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C and D</xref>), suggesting that earlier treatment was more appropriate for efficient FGF8 pathway modulation. Hence, we chose day10-11 as the starting time point for FGF8 treatment (hereafter referred to as WNTi + FGF8 condition), which preserved FOXG1 expression while efficiently modulating FGF8 target genes. Real-time qRT-PCR analysis of known FGF8 target genes (<italic>SPRY4</italic>, <italic>DUSP6</italic>, <italic>ETV4</italic>, <italic>ETV1</italic>, and <italic>ETV5</italic>) confirmed that our set-up efficiently activated FGF signaling in day20 and day30 organoids (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). As a specific read-out of FGF8 treatment on the expression of telencephalic targets, we stained control (WNTi) and treated (WNTi + FGF8) organoids for NR2F1 and FOXG1 at different time points (<xref ref-type="fig" rid="fig2">Figure 2C–I</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). NR2F1 expression, still low on day19 but higher on day26, was efficiently modulated by FGF8 (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A–H</xref><bold>’</bold>). Real-time qRT-PCR confirmed FGF8-mediated inhibition of <italic>NR2F1</italic> on day20 and day30 cultures (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), while <italic>FOXG1</italic> levels were partially affected upon FGF8 treatment on day30 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Despite this, WNTi + FGF8 organoids still largely expressed FOXG1 at later stages (day35 and day53; <xref ref-type="fig" rid="fig2">Figure 2D–F</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2I–J</xref><bold>’</bold>) alongside efficient modulation of NR2F1 protein levels (<xref ref-type="fig" rid="fig2">Figure 2G–I</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2K–L</xref><bold>’</bold>). FGF8 was maintained in the culture medium until day ~60 to prevent any increase of NR2F1 expression back to normal levels (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2M–P</xref><bold>’</bold>). Thus, our FGF8 culture conditions efficiently modulate NR2F1 in telencephalic organoids starting at day19-21 and until day69-74, while maintaining FOXG1 expression at high levels (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2Q and R</xref>), validating the efficacy of FGF8 treatment <italic>in vitro</italic> and suggesting an evolutionary conservation of the NR2F1-FGF8 regulatory molecular axis from mice to humans.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>FGF8-mediated regulation of target gene expression in FOXG1+ telencephalic organoids<bold>.</bold></title><p>(<bold>A</bold>) Schematic of the hybrid 2D/3D method for applying FGF8 treatment on telencephalic/cortical human organoids <italic>in vitro</italic>. FGF8 (100 ng/mL) was added to the neural progenitor patterning medium (NPPM) beginning on day10-11 (blue bar) and maintained through subsequent culture steps until approximately day50-60. (<bold>B</bold>) Real-time qRT-PCR analysis of FGF8 target gene expression (<italic>SPRY4</italic>, <italic>DUSP6</italic>, <italic>ETV4</italic>, <italic>ETV1</italic>, and <italic>ETV5</italic>) in day20 and day30 organoids treated with WNT inhibition alone (WNTi) or in combination with FGF8 (WNTi + FGF8), as indicated. n=3 organoids per condition, pooled prior RNA extraction. (<bold>C</bold>) Real-time qRT-PCR quantification of <italic>FOXG1</italic> (telencephalic marker) and <italic>NR2F1</italic> (caudal telencephalic marker and FGF8 target) expression in day20 and day30 control (CTRL), WNT-inhibited (WNTi), and FGF8-treated (WNTi + FGF8) samples, as indicated. FGF8 treatment effectively downregulates <italic>NR2F1</italic> expression in WNTi + FGF8 organoids compared with WNTi organoids. n=3 organoids per condition, pooled prior RNA extraction. (<bold>D–F</bold>) Immunostaining for FOXG1 (red) and SOX2 (green) in day35 WNTi and WNTi + FGF8 organoids, as indicated. FGF8 treatment does not significantly alter FOXG1 expression. White arrowheads in high-magnification images indicate SOX2+ NR2 F1+ NPs within rosettes. Graph (<bold>F</bold>) shows pixel intensity quantification of FOXG1 staining in WNTi and WNTi + FGF8 organoids at different time points. n≥8 sections from n≥4 organoids from n≥2 distinct batches. (<bold>G–I</bold>) NR2F1 and NTUB (red and green, respectively, in G-H’) immunostainings on day35 WNTi and WNTi + FGF8 organoids, as indicated. FGF8 treatment efficiently modulates NR2F1 expression (compare G and H). High-magnification images (<bold>G’</bold> and <bold>H’</bold>) show neural rosettes (NTUB<sup>low</sup>, indicated by white arrowheads) and differentiating neurons (NTUB<sup>high</sup>, indicated by white arrows), both expressing NR2F1 (red) in WNTi organoids, but lacking NR2F1 in WNTi + FGF8 organoids. Graph (<bold>I</bold>) displays pixel intensity quantification of NR2F1 staining in WNTi and WNTi + FGF8 organoids over time. n≥6 sections from n≥4 organoids from n≥2 distinct batches. Scale bars: 100 µm.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Quantitative RT-PCR data for FGF target genes in human organoids.</title><p>Raw data of FGF target gene expression in day 20 and day 30 CTRL, WNTi, and WNTi +FGF8 organoids.</p></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-98096-fig2-data1-v2.xls"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Quantitative RT-PCR data for FOXG1 and NR2F1 in human organoids.</title><p>Raw data showing <italic>FOXG1</italic> and <italic>NR2F1</italic> expression levels in day 20 and day 30 CTRL, WNTi, and WNTi + FGF8 organoids.</p></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-98096-fig2-data2-v2.xls"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>FOXG1 staining intensity in WNTi and WNTi + FGF8 human organoids.</title><p>GraphPad sheet with raw pixel intensity data from day 14 to day 35, measured in WNTi and WNTi + FGF8 organoid cryostat slices following FOXG1 immunostaining.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig2-data3-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata4"><label>Figure 2—source data 4.</label><caption><title>NR2F1 staining intensity in WNTi and WNTi + FGF8 human organoids.</title><p>GraphPad sheet with raw pixel intensity data from day 14 to day 35, measured in WNTi and WNTi + FGF8 organoid cryostat slices following NR2F1 immunostaining.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig2-data4-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Effect of early or late FGF8 treatment on FOXG1 and NR2F1 expression in human organoids.</title><p>(<bold>A,B</bold>) Panel showing FOXG1 (red) and SOX2 (green) immunostaining in control (CTRL), WNT inhibited (WNTi) and FGF8 treated (WNTi + FGF8) day 30 organoids, as indicated. FGF8 was added at day5, at day10 or at day20; when added at day5, FGF8 partially inhibited FOXG1 expression, suggesting interference with induction of telencephalic identity (pixel intensity in graph B). (<bold>C,D</bold>) Panel showing NR2F1 (red) and SOX2 (green) immunostaining in WNT inhibited (WNTi) and FGF8 treated (WNTi + FGF8) day 30 organoids, as indicated. FGF8 treatment starting at day10 efficiently downregulated NR2F1, while treatment starting at a later time point (day20) failed to restrain NR2F1 expression (pixel intensity in graph D). For both graphs in B and D: n≥8 sections from n≥4 organoids from n=1 batch. Scale bars: 50 µm.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>FOXG1 staining intensity following early or late FGF8 treatment.</title><p>GraphPad sheet with raw pixel intensity data measured in CTRL, WNTi and WNTi + FGF8 organoids after FOXG1 immunostaining.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig2-figsupp1-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>NR2F1 staining intensity following early or late FGF8 treatment.</title><p>GraphPad sheet containing NR2F1 pixel intensity data for WNTi organoids and organoids treated with FGF8 at two distinct time points.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig2-figsupp1-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>FGF8-mediated control of NR2F1 level in FOXG1+ telencephalic organoids.</title><p>(<bold>A-H’</bold>) FOXG1 and NTUB (red and green, respectively, in A-B’ and in E-F’) and NR2F1 and SOX2 (red and green, respectively, in C-D’ and in G-H’) immunostainings on day19 or on day26 WNTi and WNTi + FGF8 organoids, as indicated. FGF8 treatment did not significantly interfere with FOXG1 expression (<bold>A-B’, E-F’</bold>), while NR2F1 (which started to be detectable at low levels by immunostaining at day19 in WNTi organoids) was down-regulated by FGF8 (compare C,C’ with D,D’ or G,G’ with H,H’). (<bold>I-L’</bold>) FOXG1 and NTUB (red and green, respectively, in I-J’) and NR2F1 and SOX2 (red and green, respectively, in K-L’) immunostainings on day53 WNTi and WNTi + FGF8 organoids, as indicated. (<bold>M-P’</bold>) NR2F1 (red) and SOX2 (green) immunostaining in day74 (<bold>M-N’</bold>) and in day107 (<bold>O-P’</bold>) WNTi and WNTi + FGF8 organoids, showing that NR2F1 is still efficiently modulated by FGF8 20–25 days after end of the treatment (<bold>N, N’</bold>) but is gradually upregulated back to control levels in long-term cultured organoids (day107; <bold>P-P’</bold>). (<bold>Q</bold>) Graph shows pixel intensity quantification of FOXG1 levels after immunostaining of WNTi and WNTi + FGF8 organoids at different time points, as indicated. n≥8 sections from n≥4 organoids from n≥1 batch. (<bold>R</bold>) Graph shows pixel intensity quantification of NR2F1 immunostaining in WNTi and WNTi + FGF8 organoids at different time points, as indicated. NR2F1 level was efficiently downregulated by FGF8 treatment from day26 to day74, while it raised back at later time points. n≥6 sections from n≥4 organoids from n≥1 batch. Scale bars: 100 µm.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>FOXG1 staining intensity in WNTi and WNTi + FGF8 human organoids.</title><p>GraphPad sheet with raw pixel intensity data measured in WNTi and WNTi + FGF8 organoids following FOXG1 immunostaining at different stages.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig2-figsupp2-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig2s2sdata2"><label>Figure 2—figure supplement 2—source data 2.</label><caption><title>NR2F1 staining intensity in WNTi and WNTi + FGF8 human organoids.</title><p>GraphPad sheet with raw pixel intensity data measured in WNTi and WNTi +FGF8 organoids following NR2F1 immunostaining at different stages.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig2-figsupp2-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig2-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Single-cell RNA sequencing (scRNAseq) reveals multiple progenitor and neuronal classes present in human organoids</title><p>To investigate the transcriptomic signature of cerebral organoids upon FGF8 treatment, we employed a scRNAseq approach to compare control organoids (WNTi) with FGF8-treated telencephalic organoids (WNTi + FGF8). Two distinct batches of both WNTi and WNTi + FGF8 organoids showed high reproducibility in terms of cell cluster compositions (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), allowing us to pool together individual batches to achieve a higher number of cells per cluster (n° of cells per cluster in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). Bioinformatic analysis of the whole cell population (WNTi and WNTi + FGF8 cells together) identified 15 distinct cellular clusters (shown as UMAP projections; <xref ref-type="fig" rid="fig3">Figure 3B</xref>), whose composition was determined <italic>via</italic> the expression of well-known reference markers as a read-out of cell identity (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Cell clusters comprised NPs (<italic>NESTIN</italic>+, <italic>SOX2</italic>+, and <italic>HES5</italic>+ cells in clusters 2, 5, 8, 9, 12, 13, 14, and 15), some of which were actively proliferating (<italic>KI67</italic>+ and <italic>TOP2A</italic>+), and neurons (<italic>MAPT</italic>+ cells in clusters 1, 3, 4, 6, 7, 10, and 11). Expression of neurogenic (<italic>NEUROD4</italic> and <italic>NEUROG1</italic>) and post-mitotic neuronal markers (<italic>DCX</italic>, <italic>RBFOX3</italic>, and <italic>MAPT</italic>) highlighted the existence of both differentiating and differentiated neurons (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). <italic>EOMES</italic> (also known as <italic>TBR2</italic>) expression identified intermediate progenitors, while expression of <italic>HOPX</italic>, <italic>TNC</italic>, and <italic>FAM107A</italic> indicated both apical and basal radial glia (<xref ref-type="bibr" rid="bib78">Pollen et al., 2015</xref>). Interestingly, a <italic>bona fide</italic> marker for late truncated radial glia (<italic>CRYAB</italic>; <xref ref-type="bibr" rid="bib69">Nowakowski et al., 2016</xref>), which is normally expressed in the neocortex <italic>in vivo</italic> starting at 14.5 post-conceptional weeks (PCW), was specifically expressed in NP cluster 13 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). We reasoned that multiple NP and neuronal types co-existed in telencephalic organoids, and trajectory analysis confirmed that NP clusters (clusters 2, 5, 8, 9, 12, and 15) gradually converted into post-mitotic neurons (clusters 1, 3, 4, 6, and 7; <xref ref-type="fig" rid="fig3">Figure 3D</xref>), suggesting that key steps of human brain development were recapitulated <italic>in vitro</italic>.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Single-cell RNA sequencing (scRNAseq) analysis of FGF8-induced cellular and molecular changes in human organoids.</title><p>(<bold>A</bold>) Experimental setup for scRNA-seq analysis of control (WNTi) and FGF8-treated (WNTi + FGF8) telencephalic organoids at day 69. Two independent batches of WNTi and WNTi + FGF8 organoids (each containing 2–3 organoids) were dissociated into single cells and processed using Chromium (10 X Genomics technology). Cells were clustered and visualized in 2D space using t-SNE and UMAP algorithms. (<bold>B</bold>) UMAP clustering of WNTi and WNTi + FGF8 cells, identifying 15 distinct clusters. (<bold>C</bold>) Expression levels of known markers for different cell types, including neural progenitor cells (NPs: <italic>NESTIN, SOX2, HES5</italic>), proliferating progenitors (<italic>KI67, TOP2A</italic>), intermediate progenitors (IPs: <italic>EOMES</italic>), apical and basal radial glia cells (aRGs and bRGs: <italic>HOPX, TNC, FAM107A, CRYAB</italic>), and differentiating/differentiated neurons (<italic>NEUROD4</italic> and <italic>MAPT</italic>, respectively). (<bold>D</bold>) Trajectory analysis showing the most probable developmental progression from NP clusters (2, 5, 8, 9, 12, 15) to post-mitotic cell types (notably clusters 1, 3, 4, 6, 7). (<bold>E</bold>) Expression level and cluster distribution of dorsal glutamatergic markers <italic>EMX1</italic> and <italic>SLC17A7</italic> (also called <italic>VGLUT1</italic>) and ventral GABAergic markers <italic>GSX2</italic> and <italic>SLC32A1</italic> (also called <italic>VGAT</italic>), indicating the coexistence of both glutamatergic and GABAergic NPs and neurons within FOXG1+ telencephalic organoids. (<bold>F, G</bold>) UMAP clustering of WNTi and WNTi + FGF8 cells shown separately, illustrating 15 distinct clusters and their respective proportions in each condition. Panel (<bold>G</bold>) shows the number of cells in each cluster originating from WNTi (yellow) or WNTi + FGF8 (blue) organoids. (<bold>H</bold>) UMAP projection of day69 organoid scRNA-seq data, identifying four cellular groups through sub-clustering analysis on WNTi + FGF8 clusters 8 and 9. Center and right panels display expression levels of markers for the forebrain (<italic>FOXG1</italic>), ventral telencephalon (<italic>GSX2</italic>, <italic>ASCL1</italic> and <italic>DLX2</italic>), forebrain/midbrain (<italic>OTX2</italic>), diencephalon/mesencephalon (<italic>IRX3</italic>), and mesencephalon (<italic>EN1, EN2</italic>) across the four sub-clusters. (<bold>I-I’’</bold>) Immunostaining for FOXG1 (red) and OTX2 (green) in day69 WNTi + FGF8 organoids, showing distinct FOXG1+ and FOXG1- regions. White arrows indicate FOXG1- OTX2+ non-telencephalic areas (high magnification in I’), while arrowheads denote FOXG1+ OTX2<sup>low</sup> telencephalic areas (high magnification in I’’). Ctx, cortex; MGE, medial ganglionic eminence; LGE, lateral ganglionic eminence.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Trajectory analysis for all cell clusters.</title><p>Detailed methods and data report of the developmental trajectory analysis for all cell clusters (15 clusters).</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-98096-fig3-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Cell counts per cluster by origin (control WNTi or treated WNTi + FGF8 organoids).</title><p>Summary datasheet showing WNTi or WNTi + FGF8 cell counts per cluster, extracted <italic>via</italic> 10 X Genomics Loupe Browser.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig3-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Single-cell RNA sequencing (scRNAseq) and VoxHunt similarity map analysis of 2-month-old telencephalic organoids.</title><p>(<bold>A</bold>) Number of cells per cluster after scRNAseq of day69 organoids. (<bold>B</bold>) Expression level of known markers identifying neural progenitor cells (NPs; <italic>VIMENTIN</italic> and <italic>HES1</italic>), proliferating progenitors (<italic>CCNA2</italic> and <italic>CCNB1</italic>), differentiating neurons (<italic>NEUROG1</italic>) and post-mitotic neurons (<italic>DCX</italic> and <italic>RBFOX3</italic>, also called <italic>NEUN</italic>). Additional markers are illustrated in <xref ref-type="fig" rid="fig3">Figure 3C</xref>. (<bold>C</bold>) VoxHunt similarity map showing similarity correlation index (white to violet) of each cluster to reference databases of mouse regional brain atlases. (<bold>D</bold>) VoxHunt heatmap of similarity score showing the similarity degree (blue color code) between the expression profile of clusters (lines) and distinct regions of the mouse embryonic brain (columns). Note the high similarity between clusters 1/2/3/4/5/12/14/15 and dorsal-anterior pallium (neocortex). Clusters 6 and 7, on the contrary, show high similarity to ventral subpallial regions (ganglionic eminences). Legend on the right shows the brain area associated to each color. Pall: pallium; Spall: Subpallium; POTel: Preoptic telencephalon; Hyp: hypothalamus; D: diencephalon; M: mesencephalon; PPH: Prepontine hindbrain; PH: Pontine hindbrain; MH: Medullary hindbrain. (<bold>E</bold>) Trajectory analysis evaluating the most probable developmental trajectory linking all cell progenitor clusters (left), glutamatergic NPs and neurons (center) or GABAergic NPs and neurons (right). NP clusters can either convert into one another (suggesting plasticity to switch between dorsal and ventral telencephalic identity), either differentiate into post-mitotic neurons. In all cases, progenitors can also enter in a developmental ‘bottleneck’ represented by cluster 13 (<italic>CRYAB</italic>+ truncated aRGs).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Cell count per cluster from scRNAseq analysis of day 69 organoids.</title><p>Summary datasheet showing the number of cells per cluster, extracted <italic>via</italic> 10 X Genomics Loupe Browser.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>VoxHunt analysis report.</title><p>Detailed report on the methods and data for VoxHunt visualization.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-98096-fig3-figsupp1-data2-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata3"><label>Figure 3—figure supplement 1—source data 3.</label><caption><title>Trajectory analysis of progenitor cell clusters.</title><p>Detailed methods and data report on the developmental trajectory analysis for progenitor clusters (2, 5, 8, 9, 12, 13, 14, and 15).</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-98096-fig3-figsupp1-data3-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata4"><label>Figure 3—figure supplement 1—source data 4.</label><caption><title>Trajectory analysis of glutamatergic clusters.</title><p>Detailed methods and data report for the trajectory analysis of glutamatergic progenitors and neurons (clusters 1, 2, 3, 4, 5, 12, 13, 14, and 15).</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-98096-fig3-figsupp1-data4-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata5"><label>Figure 3—figure supplement 1—source data 5.</label><caption><title>Trajectory analysis of GABAergic clusters.</title><p>Detailed methods and data report for the trajectory analysis of GABAergic progenitors and neurons (clusters 6, 7, 8, 9, and 13).</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-98096-fig3-figsupp1-data5-v2.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>FGF8-dependent induction of diencephalic and mesencephalic markers in telencephalic organoids.</title><p>(<bold>A, B</bold>) Expression level and percentages of positive cells per cluster for <italic>FOXG1</italic> in control (WNTi) and treated (WNTi + FGF8) organoids, as indicated. Despite a partial reduction of <italic>FOXG1</italic> average expression (<bold>A</bold>), most of the cells in different clusters still express <italic>FOXG1</italic> after FGF8 treatment (<bold>B</bold>). (<bold>C</bold>) Real time qRT-PCR quantification of telencephalic/diencephalic (<italic>SIX3</italic>), prosencephalic/midbrain (<italic>OTX2</italic>) and midbrain/hindbrain (<italic>EN2</italic>) markers in day20 or day30 control (CTRL), WNT inhibited (WNTi) or FGF8-treated (WNTi + FGF8) organoids, as indicated. FGF8 induces loss of <italic>SIX3</italic> expression and increase of diencephalon/midbrain markers (<italic>OTX2, EN2</italic>), suggesting that long term FGF8 treatment can induce additional -more posterior- regional identities together with <italic>FOXG1</italic>+ cells. n=3 organoids per condition, pooled before RNA extraction. (<bold>D</bold>) At the top left of the panel, an early fetal brain scheme shows FGF8 sources (blue) in the anterior telencephalon, in the diencephalon and at the midbrain/hindbrain border, and their presumable diffusing gradients (arrows). The panel illustrates expression levels of distinct brain regional markers in UMAP projections of WNTi or WNTi + FGF8 single cell RNA sequencing samples, as indicated. Mouse brain images at embryonic day (E) 13.5 obtained from the Allen Brain Atlas show the main domains where these markers are found. (<bold>E</bold>) Graph showing the percentage of cells expressing different markers (indicated on x-axis) in clusters 8 and 9 of WNTi + FGF8 organoids. Clusters 8/9 indicate high percentage of cells expressing telencephalic (<italic>FOXG1, SFRP1, GAS1, SFRP2</italic>) and diencephalic/midbrain genes (<italic>SIX3, OTX2, LEF1, IRX3, IRX2, EN2</italic>). Very few or no cells express markers for the medial ganglionic eminence (<italic>GBX2, LHX8, NKX2-1, OLIG2</italic>), for the ventral midbrain (<italic>FOXP2, ISL1, LMX1A, FOXA2</italic>) or for more posterior regions (<italic>HOXA2</italic>).</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Number of <italic>FOXG1</italic>+ cells per cluster.</title><p>Summary datasheet showing the number of <italic>FOXG1</italic>+ cells in each cluster, extracted <italic>via</italic> 10 X Genomics Loupe Browser.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig3-figsupp2-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3s2sdata2"><label>Figure 3—figure supplement 2—source data 2.</label><caption><title>Quantitative RT-PCR data for telencephalic and mesencephalic markers in human organoids.</title><p>Raw data of <italic>SIX3</italic>, <italic>OTX2</italic>, and <italic>EN2</italic> expression in day 20 and day 30 CTRL, WNTi, and WNTi + FGF8 organoids.</p></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-98096-fig3-figsupp2-data2-v2.xls"/></supplementary-material></p><p><supplementary-material id="fig3s2sdata3"><label>Figure 3—figure supplement 2—source data 3.</label><caption><title>Number of cells expressing distinct positional markers in clusters 8 and 9.</title><p>Summary datasheet of cells from clusters 8 and 9 expressing different positional identity markers, extracted <italic>via</italic> 10 X Genomics Loupe Browser.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig3-figsupp2-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>FGF8-dependent induction of OTX2+ domains in multi-regional organoids.</title><p>(<bold>A-D’</bold>) FOXG1 (red) and OTX2 (green) immunostaining in control (WNTi; <bold>A, A’, C, C’</bold>) and treated (WNTi + FGF8; <bold>B, B’, D, D’</bold>) organoids, showing the presence of FOXG1+ telencephalic domains and of OTX2+ FOXG1- diencephalic/mesencephalic domains at day52 (<bold>A-B’</bold>) and at day74 (<bold>C-D’</bold>). White arrowheads point to FOXG1- OTX2+ non-telencephalic areas in FGF8-treated organoids (high magnifications in B’ and D’). (<bold>E, F</bold>) Artificial intelligence analysis by HALO software of marker distribution in day52 and in day74 control or treated organoids, as indicated. Exemplificative images of automatically detected OTX2+ (green), FOXG1+ (red) and necrotic (black) regions are illustrated. Graph in F shows the percentages of OTX2+ surfaces in organoid sections, at different time points as indicated (quantified by HALO software; n≥8 sections from n≥3 organoids from n≥1 batch for each time point).</p><p><supplementary-material id="fig3s3sdata1"><label>Figure 3—figure supplement 3—source data 1.</label><caption><title>OTX2+ area percentages in multi-regional organoids.</title><p>GraphPad sheet with OTX2+ area percentages in WNTi and WNTi + FGF8 organoid cryostat slices from day 52 to day 74 following OTX2 immunostaining.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig3-figsupp3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig3-figsupp3-v2.tif"/></fig></fig-group><p>To assign the identities of distinct cell clusters in a more unbiased way, we used the VoxHunt spatial brain mapping and heatmap of similarity score tools (<xref ref-type="bibr" rid="bib35">Fleck et al., 2021</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref>), which evaluate the similarity between the expression profile of each cluster and those of spatial and single-cell transcriptome reference datasets. We established a high resemblance of most clusters to the dorsal telencephalon (pallium), with clusters 2, 5, 12, 14, and 15 showing high similarity scores with progenitors, while clusters 1, 3, and 4 included cortical neurons (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref>). However, some ventral telencephalic (subpallium) clusters were also present (clusters 6 and 7), consistent with previous reports showing that ventral GABAergic identity can spontaneously arise in dorsally patterned organoids (<xref ref-type="bibr" rid="bib120">Velasco et al., 2019</xref>). Notably, clusters 8, 9, 10, and 11 showed a mixed identity, as they scored high for both dorsal and ventral telencephalon characteristics and/or for more posterior brain regions (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). Analysis of known glutamatergic and GABAergic markers substantiated the D/V identity of organoid NPs and neurons, which could be subdivided into two pools of glutamatergic (<italic>EMX1</italic>+ and <italic>SLC17A7</italic>+) and GABAergic (<italic>GSX2</italic>+ and <italic>SLC32A1</italic>+) cells (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Additionally, trajectory analysis of different clusters highlighted a dynamic state of developmental trajectories (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>). Together, our 2 months-old organoid model displays a transcriptomics signature of mixed dorsal (glutamatergic) and ventral (GABAergic) cellular identities, reflecting the cellular and molecular properties of a 14.5 PCW human neocortex.</p></sec><sec id="s2-4"><title>FGF8 treatment increases brain regional heterogeneity</title><p>While widespread <italic>FOXG1</italic> expression supported the general telencephalic identity of both WNTi and WNTi + FGF8 treated organoids (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A and B</xref>)<bold>,</bold> qRT-PCR showed a partial reduction of the anterior marker <italic>SIX3</italic>, induction of <italic>OTX2</italic> a telencephalic marker at early stages (<xref ref-type="bibr" rid="bib74">Ostermann et al., 2019</xref>) before becoming restricted to more posterior regions at later stages (<xref ref-type="bibr" rid="bib79">Puelles et al., 2004</xref>), and induction of the mesencephalic marker <italic>EN2</italic> in WNTi + FGF8 organoids (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C</xref>), suggesting that long-term FGF8 treatment might induce the formation of regions other than the forebrain. Hence, we explored the expression of key markers of A/P regional identity by focusing on clusters 8 and 9, as these cellular populations were almost absent in control (WNTi) organoids and only appeared in treated (WNTi + FGF8) samples (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D and E</xref>). Although cluster 8/9 cells were largely positive for telencephalic markers such as <italic>FOXG1</italic> (50% positive cells) and <italic>SFRP1</italic> (70% positive cells) (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A–E</xref>), they also displayed expression of the diencephalic gene <italic>SIX3</italic> (&gt;40% positive cells) and mesencephalic markers <italic>OTX2</italic> (&gt;30% positive cells), <italic>IRX3</italic> (20% positive cells), and <italic>EN2</italic> (10% positive cells) upon FGF8-treatment (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D and E</xref>). These data indicate that clusters 8 and 9, which are only present in FGF8-treated organoids, are mainly composed of telencephalic progenitors (<italic>FOXG1</italic>+, <italic>SFRP1</italic>+, <italic>GAS1</italic>+, and <italic>FZD8</italic>+) but also contain some diencephalic (<italic>SIX3</italic>+) and mesencephalic (<italic>IRX3</italic>+, <italic>OTX2</italic>+, <italic>EN2</italic>+) cells (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2E</xref>), suggesting concomitant FGF8-driven induction of non-telencephalic regional identities.</p><p>To further distinguish cell types in scRNAseq clusters 8 and 9, we performed a sub-clustering analysis, which detected four main cellular groups (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). While two sub-clusters expressed <italic>FOXG1</italic> together with ventral telencephalic markers (<italic>GSX2, DLX2</italic> and <italic>ASCL1</italic>), the remaining two were negative for <italic>FOXG1</italic> but positive for <italic>OTX2, IRX3, EN1</italic> and/or <italic>EN2</italic> (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). To directly visualize the co-existence of distinct organoid domains, we performed double staining for FOXG1 (telencephalon) and OTX2 (diencephalon/mesencephalon) on treated (WNTi + FGF8) organoids (<xref ref-type="fig" rid="fig3">Figure 3I–I’’</xref>) and confirmed that FOXG1-negative domains were indeed positive for OTX2, most probably corresponding to the diencephalic/mesencephalic clusters 8 and 9 identified in scRNAseq data. Quantification of OTX2 expression revealed that a variable portion of the organoid mass (approximately 15%, reaching a maximum of ~30% in some organoids) is occupied by OTX2+ FOXG1- non-telencephalic domains in late-cultured multi-regional organoids (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). Collectively, our data suggest that while WNTi organoids develop as uniform FOXG1+ telencephalic organoids predominantly expressing cortical markers, FGF8-treated organoids form distinct and segregated regional domains. Therefore, elevated levels of FGF8 can enhance the complexity of human cultured organoids <italic>in vitro</italic> by promoting the formation of multi-regional structures, where distinct brain regions co-exist and develop concurrently within a single aggregate.</p></sec><sec id="s2-5"><title>FGF8 alters dorso/ventral cell specification of telencephalic domains</title><p>While the expression of diencephalic/mesencephalic markers was limited to clusters 8 and 9 only (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D and E</xref>), most of the remaining clusters expressed high levels of <italic>FOXG1</italic> (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A and B</xref>). Therefore, we focused on the effect of FGF8 treatment on these more abundant <italic>FOXG1</italic>-expressing telencephalic populations. Comparison of control (WNTi) and treated (WNTi + FGF8) samples in terms of cell abundance per cluster revealed an increased cell count in clusters 6 and 7 -representing cells of ventral identity- in response to FGF8 treatment (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>). In contrast, clusters associated with glutamatergic NPs (clusters 2, 5, 12, 14, and 15) and neurons (clusters 1, 3, and 4) were more abundantly populated in control organoids but less represented in FGF8-treated ones (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>). The differing abundance of cell clusters in control and treated organoids suggested a change in cellular composition following FGF8 treatment, prompting us to explore the expression of key dorsal glutamatergic and ventral GABAergic markers on WNTi and WNTi + FGF8 UMAP projections (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). Glutamatergic NP and neuronal markers such as <italic>EMX1</italic>, <italic>NEUROD6, NEUROD2, TBR1, SOX5, BCL11B, LHX2, NEUROG2, NF1A,</italic> and <italic>SLC17A7</italic> were highly reduced in FGF8-treated organoids (<xref ref-type="fig" rid="fig4">Figure 4A</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), consistent with a lower cell number in clusters 1, 3, and 4. Notably, the upper cortical layer marker <italic>SATB2</italic> was completely absent in WNTi + FGF8 cluster 1 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Conversely, ventral GABAergic markers such as <italic>ASCL1, DLX1, DLX2, PBX3, GAD1,</italic> and <italic>GAD2</italic> were increased in clusters 6, 7, 8, and 9 (<xref ref-type="fig" rid="fig4">Figure 4B</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>), supporting a ventralization of FGF8-treated samples compared to non-treated ones. An unbiased VoxHunt analysis of the correlation score with brain areas confirmed that FGF8 treatment decreased dorsal (pallial) while increasing ventral (subpallial) telencephalic properties (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C and D</xref>). Interestingly, ventral medial ganglionic eminence (MGE) transcripts (<italic>SHH, LHX8</italic>, and <italic>NKX2-1</italic>) were not induced in WNTi + FGF8 organoids, whereas lateral ganglionic eminence (LGE)-enriched ones (<italic>EBF1, GSX2</italic>, and <italic>PBX3</italic>), particularly those associated with striatal fate (<italic>MEIS2,</italic> and <italic>TLE4</italic>), were expressed at higher levels than in control samples (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>), suggesting that addition of FGF8 promotes a ventral LGE but not an MGE identity. Altogether, these data support an FGF8-mediated effect on the acquisition of a ventral LGE-like GABAergic identity at the expense of a dorsal glutamatergic one in telencephalic organoids.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Effects of FGF8 treatment on the dorso-ventral cellular composition of telencephalic organoids.</title><p>(<bold>A, B</bold>) Expression levels of markers identifying dorsal glutamatergic NPs and neurons (Panel A; <italic>EMX1, NEUROD6, SLC17A7</italic>) and ventral GABAergic NPs and neurons (Panel B; <italic>ASCL1, DLX1, GAD2</italic>). Black arrowheads highlight clusters with the most notable changes in marker and cell abundance after FGF8 treatment. (<bold>C,D</bold>) Expression levels of known markers identifying ventral GABAergic NPs and neurons in the lateral ganglionic eminence (LGE) (Panel C; <italic>EBF1, GSX2, MEIS2</italic> and <italic>TLE4</italic>) and the medial ganglionic eminence (MGE) (Panel D; <italic>NKX2-1</italic> and <italic>LHX8</italic>). Black arrowheads in C highlight clusters with the largest differences in LGE marker and cell abundance following FGF8 treatment. (<bold>E-F’</bold>) GAD1 (red) and SLC17A7 (green) immunostaining in day53 control (WNTi) and treated (WNTi + FGF8) organoids, as indicated. The distribution of these markers <italic>in vivo</italic> is shown in the brain scheme on the left. (<bold>G–I</bold>) HALO software artificial intelligence (AI) analysis of marker distribution in day53 and day74 organoids. Representative images display areas automatically identified as SLC17A7+ (green), GAD1+ (red), and necrotic (black). Graphs in H and I show the proportions of SLC17A7+ (<bold>H</bold>) and GAD1+ (<bold>I</bold>) surface areas in day 74 organoid sections, as quantified by HALO AI; n≥8 sections from n≥4 organoids from n=1 batch per time point. (<bold>J-K’</bold>) Immunostaining for SATB2 (yellow) in day74 WNTi and WNTi + FGF8 organoids, as indicated. The left schematic depicts the <italic>in vivo</italic> distribution of SATB2+ neurons, and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref> quantifies SATB2+ neuron density in these and additional samples. (<bold>L-M’</bold>) Immunostaining for ASCL1 (red) in day69 WNTi and WNTi + FGF8 organoids, as indicated. Left schematic shows the <italic>in vivo</italic> distribution of ASCL1+ ventral progenitors, with cell density detailed in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>. Scale bars: 100 µm. Ctx, cortex; MGE, medial ganglionic eminence; LGE, lateral ganglionic eminence.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>SLC17A7 (VGLUT1)-positive area in human organoids.</title><p>GraphPad sheet with SLC17A7-positive area data in WNTi and WNTi + FGF8 organoids.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig4-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>GAD1 (GAD67)-positive area in human organoids.</title><p>GraphPad sheet with GAD1-positive area data in WNTi and WNTi + FGF8 organoids.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig4-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Changes in cellular composition and glutamatergic/GABAergic identity upon FGF8 treatment.</title><p>(<bold>A,B</bold>) Expression level of known markers identifying dorsal glutamatergic NPs and neurons (panel A; <italic>NEUROD2, TBR1, SOX5, BCL11B</italic> -also called <italic>CTIP2</italic>-, <italic>SATB2, LHX2, NEUROG2</italic> and <italic>NF1A</italic>) or ventral GABAergic NPs and neurons (panel B; <italic>DLX2, PBX3, SHH</italic> and <italic>GAD1</italic>). FGF8 treatment causes an increase of ventral GABAergic cells at the expense of dorsal glutamatergic ones. Empty arrowheads indicate clusters showing the greatest differences in cell and marker abundance following FGF8 treatment. (<bold>C</bold>) VoxHunt similarity map showing correlation index (white to violet color code) of WNTi (left) or WNTi + FGF8 (right) organoids to reference databases of mouse regional brain atlases. For this analysis, all WNTi cells and all WNTi + FGF8 cells are evaluated. FGF8-treated organoids show lower similarity to dorso-lateral pallium (black arrowheads) and increased similarity to subpallial domains (blue arrowheads), compared to control samples. (<bold>D</bold>) VoxHunt heatmap illustrating the similarity score (blue color code) among the expression profile of organoid samples (WNTi -upper line- and WNTi + FGF8 -lower line-) and distinct mouse brain regions (columns). FGF8-treated organoids show lower similarity to dorsal pallium and increased similarity to subpallial regions, compared to control samples. Pall: pallium; Spall: Subpallium; POTel: Preoptic telencephalon; Hyp: hypothalamus; D: diencephalon; M: mesencephalon; PPH: Prepontine hindbrain; PH: Pontine hindbrain; MH: Medullary hindbrain.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>VoxHunt analysis report.</title><p>Detailed report on VoxHunt visualization methods and data.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-98096-fig4-figsupp1-data1-v2.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Immunostaining analysis of glutamatergic and GABAergic cellular composition of control and FGF8-treated telencephalic organoids.</title><p>(<bold>A–F</bold>) GAD1 (also called GAD67; red) and SLC17A6 (also called VGLUT2; green) immunostaining in day53 and in day74 control (WNTi) and treated (WNTi + FGF8) organoids, as indicated. The distribution of these markers <italic>in vivo</italic> is illustrated in the brain scheme on the left. Graph in C displays GAD1 pixel intensity quantification at day52-60 and at day69-74, while F shows exemplificative images of automatically detected SLC17A6 (green) and GAD1 (red) marker distribution in day74 organoids (HALO software). n≥13 sections from n≥4 organoids from n=2 batches. (<bold>G-H’</bold>) Co-staining of SLC17A6 (green) with TBR1 and CTIP2 (red and blue in G,G’) and SATB2 (red in H,H’), highlighting co-expression of SLC17A6 with neocortical markers. (<bold>I-M’</bold>) TBR1 (red) and CTIP2 (green) immunostaining in day53 (<bold>I–J</bold>) or day74 (<bold>L-M’</bold>) control (WNTi) and treated (WNTi + FGF8) organoids, as indicated. The distribution of these markers <italic>in vivo</italic> is depicted in the brain schemes on the left. Note that TBR1 and CTIP2 can be co-expressed dorsally (in cortical layers) during development; TBR1 is exclusively dorsal, whereas CTIP2 is also expressed in the ventral telencephalon. Graph in K shows the percentage of TBR1+ (red), CTIP2+ (green) or double TBR1+/CTIP2+ (yellow) cells in WNTi or WNTi + FGF8 organoids at different steps (day53 in H and day74 in I), as indicated. (<bold>N</bold>) GAD67 (red) and CTIP2 (green) immunostaining in day74 WNTi + FGF8 organoids with double CTIP2+ GAD67+ cells. (<bold>O–Q</bold>) SATB2 (yellow) immunostaining in day107 control (WNTi) and treated (WNTi + FGF8) organoids, as indicated. The distribution of SATB2+ neurons <italic>in vivo</italic> is illustrated in the brain scheme on the left, while graph in Q displays cell density at day69, day74 or day107. SATB2 cell density was measured as number of SATB2+ cells per 150X150 µm square; n≥4 sections from n≥2 organoids from n=1 batch per time point/condition. (<bold>R–T</bold>) ASCL1 (also known as MASH1; red) immunostaining in day107 control (WNTi) and treated (WNTi + FGF8) organoids, as indicated. Quantification of the cell density (number of cells per organoid section) of ASCL1+ progenitors at day69 or day107 is shown in the graph in T; n≥5 sections from n≥2 organoids from n=1 batch per time point/condition. Scale bars: 100 µm.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>GAD1 (GAD67) pixel intensity in human organoids.</title><p>GraphPad sheet with raw pixel intensity data measured in WNTi and WNTi + FGF8 organoid cryostat slices following GAD1 immunostaining.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig4-figsupp2-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata2"><label>Figure 4—figure supplement 2—source data 2.</label><caption><title>TBR1 and CTIP2 co-expression in human organoids.</title><p>Excel summary datasheet showing TBR1 and CTIP2 cell percentages in WNTi and WNTi + FGF8 organoids.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig4-figsupp2-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata3"><label>Figure 4—figure supplement 2—source data 3.</label><caption><title>SATB2 cell abundance in human organoids.</title><p>GraphPad sheet with numbers of SATB2+ cells in WNTi and WNTi + FGF8 organoid cryostat slices.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98096-fig4-figsupp2-data3-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata4"><label>Figure 4—figure supplement 2—source data 4.</label><caption><title>ASCL1 (MASH1) cell abundance in human organoids.</title><p>GraphPad sheet with ASCL1+ cell counts in WNTi and WNTi + FGF8 organoid cryostat slices.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig4-figsupp2-data4-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Regional identity-dependent effect of FGF8 treatment on D/V identity and target gene modulation.</title><p>(<bold>A-E’</bold>) Immunostaining of key neural and regional markers on day69 WNTi control organoids; FOXG1 (red in A,A’), NR2F1 (red in B,B’) and SOX2+ NPs (green in B,B’). Glutamatergic/cortical markers SLC17A6 (also called VGLUT2; green in C,C’), TBR1 (green in D,D’ or red in E,E’) and CTIP2 (green in E,E’) are abundant, indicating neocortical identity. (<bold>F-J’’</bold>) Immunostaining of the same key neural and regional markers showed in A-E’, but on sections of day69 WNTi + FGF8 treated organoids. Insets represent magnification from a FOXG1-negative non-telencephalic region (<bold>F’, G’, H’, I’, J’</bold>) or from a FOXG1+ telencephalic region (<bold>F’’, G’’, H’’, I’’, J’’</bold>). NR2F1 (red in G-G’’) show high intensity, <italic>i.e.</italic> no response to FGF8 treatment, in FOXG1-negative non-telencephalic areas. Only FOXG1+ telencephalic domains exhibit FGF8-mediated reduction of NR2F1 levels (<bold>G, G’’</bold>), associated with induction of ventral markers GAD1 (red in H,H’’) and ASCL1 (red in I,I’’) at the expense of dorsal cortical markers TBR1 (green in I-I’’). No dorsal cortical markers such as TBR1 and CTIP2 are detectable in FOXG1-negative regions (<bold>I’, J’</bold>), illustrating that efficient acquisition of anterior identity is necessary for production of cortical neurons in organoids. Insets indicated by asterisks in F (*) and G (**) are showed at high magnification in M. Scale bars: 100 µm. (<bold>K,L</bold>) Expression level and percentages of positive cells per cluster for NR2F1 in control (WNTi) and treated (WNTi + FGF8) organoids, as indicated. NR2F1 transcript levels are greatly reduced by FGF8 (<bold>K</bold>); however, clusters 8 and 9 fail to respond to FGF8 treatment by downregulating <italic>NR2F1</italic> (<bold>L</bold>) and still contain &gt;60% NR2F1+ cells. (<bold>M</bold>) Schematic representation of distinct domains in control (WNTi; left) and FGF8-treated (WNTi + FGF8; right) organoids. FOXG1+ telencephalic WNTi organoids (left) have high levels of the glutamatergic marker SLC17A6 and abundant SATB2+ and TBR1/CTIP2 double positive cortical neurons. Upon FGF8 treatment, WNTi + FGF8 organoids (right) develop co-existing FOXG1+ telencephalic domains (light red areas), in which ventral GABAergic markers GAD1 and ASCL1 are upregulated at the expense of dorsal genes, and FOXG1-/OTX2+ diencephalic/midbrain domains (light green areas). Immunostaining magnifications on the right (magnification * and ** from images in F and G, respectively) show a neural rosette located at the border between a FOXG1+ domain (upper half of the rosette; arrowheads) and an adjacent FOXG1- low expressing domain (lower half; arrows). This highlights that NR2F1 is down-regulated by FGF8 only in the telencephalic SOX2+ domain (upper half of the rosette), indicating that FGF8 target genes can respond in a different way depending on the regional identity of organoid domains. Scale bars: 100 µm.</p><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Percentage of NR2F1+ cells per cluster in WNTi and WNTi + FGF8 organoids.</title><p>Summary Excel datasheet showing NR2F1-positive cell counts per cluster for WNTi and WNTi + FGF8 samples, extracted <italic>via</italic> 10 X Genomics Loupe Browser.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig4-figsupp3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig4-figsupp3-v2.tif"/></fig></fig-group><p>To directly visualize a change in D/V identity in telencephalic organoids, we performed immunostainings for key GABAergic (GAD1 and ASCL1) and glutamatergic (SLC17A7, SLC17A6, and SATB2) markers (<xref ref-type="fig" rid="fig4">Figure 4E–M’</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Consistent with scRNAseq data, FGF8-treated organoids showed increased GAD1 levels at the expense of SLC17A7 and SLC17A6 protein expression (<xref ref-type="fig" rid="fig4">Figure 4E–I</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A–F</xref>). Notably, as SLC17A6 is also expressed in non-telencephalic brain regions (<xref ref-type="bibr" rid="bib37">Fremeau et al., 2004</xref>), we verified its dorsal glutamatergic identity by co-staining with the cortical markers TBR1, CTIP2, and SATB2 in control organoids (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2G–H</xref><bold>’</bold>). Artificial intelligence analysis using HALO software estimated a ~40% coverage of GAD1+ tissue in FGF8-treated organoids <italic>versus</italic> a 1.8% coverage in control ones (<xref ref-type="fig" rid="fig4">Figure 4G–I</xref>). Among key dorsal telencephalic proteins, double TBR1+ CTIP2+ cells (deep layer cortical neurons) decreased upon FGF8 treatment (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2I–M</xref><bold>’</bold>), whereas CTIP2+ TBR1- cells were still largely present in FGF8-treated organoids. Since these CTIP2+ cells also expressed GAD1 (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2N</xref>), we classified them as GABAergic interneurons, similar to what was previously reported in mice (<xref ref-type="bibr" rid="bib68">Nikouei et al., 2016</xref>). Furthermore, expression of the cortical marker SATB2 was highly downregulated in WNTi + FGF8 organoids at both the transcript and protein levels (<xref ref-type="fig" rid="fig4">Figure 4J–K’</xref><bold>,</bold> <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2O–Q</xref>), consistent with a partial loss of dorsal glutamatergic identity in favor of a ventral GABAergic identity. Among the ventral markers evaluated in scRNAseq, we detected an increased number of ASCL1+ ventral progenitors in WNTi + FGF8 organoids compared to WNTi organoids (<xref ref-type="fig" rid="fig4">Figure 4L–M’</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2R–T</xref>). Notably, FGF8-mediated induction of ventral GAD1 and ASCL1 markers, along with the concomitant reduction of dorsal SLC17A6, TBR1, and SATB2 ones, was observed only in FOXG1+ telencephalic and not in non-telencephalic OTX2+ regions of multi-regional organoids, as supported by comparison of sequential cryostat sections of control and treated organoids (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A–J</xref><bold>’’</bold>). Furthermore, we found that FGF8-mediated downregulation of <italic>NR2F1</italic> was present only in FOXG1+ telencephalic regions, whereas <italic>NR2F1</italic> was not modulated by FGF8 in non-telencephalic OTX2+ regions corresponding to clusters 8 and 9 (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3G–G’’, K, L</xref>). This indicates that FGF8-mediated target gene modulation follows distinct genetic rules depending on the regional identity acquired by NPs and neurons (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3M</xref>). Together, our results indicate a robust, telencephalon-specific effect of FGF8 on determining the dorsal/ventral (D/V) identity—glutamatergic <italic>versus</italic> GABAergic—of neural progenitors and neurons during human brain development <italic>in vitro</italic>.</p></sec><sec id="s2-6"><title>FGF8 treatment results in altered neural network activity</title><p>To assess whether changes in D/V neuronal composition would affect functional neuroelectric activity, we used a multi-electrode array (MEA) system on 4- and 7-month-old FGF8-treated organoids (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Striking differences in spontaneous activity were detected in WNTi + FGF8 organoids compared to non-treated ones (<xref ref-type="fig" rid="fig5">Figure 5</xref>; representative spike traces in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref>). Notably, WNTi + FGF8 organoids showed lower spike frequency (firing rate) and decreased spike amplitude, indicating reduced electrical activity compared to WNTi organoids (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). The network analysis, which assesses the synchronicity of spike events and serves as a read-out of neural network formation (<xref ref-type="bibr" rid="bib116">Trujillo et al., 2019</xref>), also highlighted differences between the two types of organoids (<xref ref-type="fig" rid="fig5">Figure 5D–F</xref>). While WNTi organoids displayed a consistent degree of network formation with a high percentage of spikes occurring within bursts (indicating a well-organized and synchronous network activity), WNTi + FGF8 organoids showed lower synchronicity, with a higher percentage of random spikes falling outside of bursts. Analysis of burst metrics also revealed a higher number of spikes per burst and peak firing rates in control organoids (<xref ref-type="fig" rid="fig5">Figure 5D and F</xref>), whereas FGF8-treated organoids displayed lower activity levels in terms of the number and frequency of spikes per burst (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>). Nevertheless, synchronous events were still detected in WNTi + FGF8 organoids, and the average burst frequency remained unchanged (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>), suggesting a good level of spontaneous circuitry organization and maturation despite lower activity levels. Furthermore, axonal tracking identified efficient signal transduction along tracts originating from WNTi organoids, which expanded across the MEA electrodes with high conduction velocity and high latency of signal propagation (<xref ref-type="fig" rid="fig5">Figure 5G–I</xref>). In contrast, FGF8-treated organoids generated lower amplitude signals at the initiation site, which struggled to propagate over long distances (<xref ref-type="fig" rid="fig5">Figure 5H and I</xref>), suggesting intrinsic inhibition that reduced the propagation of spontaneous signals. Axonal tracking analysis performed at different maturation time points also showed that most differences between control and treated organoids remained stable over time (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C–G</xref>). Given that low spike frequency, low spike amplitudes, and a high percentage of random activity outside synchronous events are consistent with the inhibitory activity of GABAergic neurons (<xref ref-type="bibr" rid="bib66">Mossink et al., 2022</xref>), we performed double immunostaining for SLC17A6 and GAD1 on organoids detached from MEA chips. This allowed us to correlate our functional recordings with the cellular and molecular identity of recorded neurons, confirming an increased number of GABAergic neurons in FGF8-treated samples (<xref ref-type="fig" rid="fig5">Figure 5J</xref>). Finally, to challenge the role of GABAergic inhibitory neurons in complex 3D organoid circuits, we tested the effects of transient GABA-A receptor inactivation on WNTi + FGF8 organoids <italic>via</italic> Bicuculline treatment (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). In the presence of 10 µM Bicuculline, WNTi + FGF8 organoids showed increased spike amplitudes (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A–C</xref>) along with a significant increase in spikes occurring within bursts (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2D–F</xref>), suggesting that GABA release contributes to the lower spike amplitude and decreased network synchronicity in 3D organoids. These data strongly indicate that prolonged FGF8 exposure affects neuronal identity and function (in terms of glutamatergic <italic>versus</italic> GABAergic balance and activity), consequently influencing the spontaneous electrical activity of neuronal circuits developing in 3D organoids.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Electrophysiological spontaneous activity of control and FGF8-treated 3D organoid networks.</title><p>(<bold>A–C</bold>) Spontaneous activity maps showing mean spike amplitude in 4-month-old (day136; upper row) and 7-month-old (day215; lower row) control (WNTi; <bold>A</bold>) and treated organoids (WNTi + FGF8; <bold>B</bold>), 2–3 weeks post-plating on high-density MEA chips. Mean activity metrics from three independent batches are summarized in (<bold>C</bold>), showing a general reduction in spike amplitude, percentage of active electrodes, and firing rate in FGF8-treated organoids. White arrowheads in electrode images indicate organoids fully or partially adhered to the MEA recording surface; note that high activity levels are observed at the organoid edges, where axonal tracts extend. (<bold>D–F</bold>) Temporal raster plots displaying firing events recorded by the 1024 most active electrodes (upper graphs) and their synchronicity indicative of network activity (lower graphs) in 7-month-old controls (WNTi; <bold>D</bold>) and FGF8-treated organoids (WNTi + FGF8; <bold>E</bold>), 3 weeks post-plating. Note that the instrument automatically sets the detection threshold (black bar) at varying levels, based on the average baseline activity specific to each sample (see Materials and methods). Graphs in (<bold>F</bold>) show network metrics (Burst frequency; Spikes within bursts) and burst metrics (number of spike per burst, burst peak firing rate, burst duration, inter-spike interval within bursts). (<bold>G–I</bold>) Overview fields of axon tracts (upper row) and representative images of individual neuronal tracts (lower rows) extending from organoids on the MEA surface, as detected using the automatic axon tracking function in WNTi (<bold>G</bold>) and WNTi + FGF8 (<bold>H</bold>) samples at day215. Graphs in (<bold>I</bold>) present axon tracking metrics (network conduction velocity, total axon or branch lengths, longest signal latency, maximum distance from initiation site, and signal amplitude), showing reduced signal amplitude and spatial propagation in FGF8-treated organoids. Additional axon tract images at different stages of differentiation are provided in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>. (<bold>J</bold>) Immunostaining for GAD1 (red) and SLC17A6 (green) in day 145 control (WNTi) and treated (WNTi + FGF8) organoids, following detachment from MEA chips post-recording. Percentages of GAD1- and SLC17A7-positive tissue in organoids are indicated. For all graphs: data represent n=3 distinct batches (each with 2–4 organoids on the MEA chip, see Materials and methods).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Analysis of spontaneous network activity in WNTi and WNTi + FGF8 organoids on MEAs.</title><p>Excel summary datasheet containing raw activity scan, network analysis, and axon tracking tool metrics for WNTi and WNTi + FGF8 organoids on MEA electrodes.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Representative spike traces and axonal maturation of WNTi and WNTi + FGF8 organoids on HD-MEA.</title><p>(<bold>A, B</bold>) Footprints of action potentials in control WNTi (A; left column) and treated WNTi + FGF8 (B; right column) organoids, as automatically detected by MaxOne software. Progressive higher magnifications of propagating spikes are displayed in red and blue boxes, while representative traces displaying the shape of action potentials are shown in the bottom row (green boxes). (<bold>C, D</bold>) Overview fields of axon tracts extending from organoids on MEA surface, as detected by the automatic axon tracking function, in WNTi (<bold>C</bold>) and WNTi + FGF8 (<bold>D</bold>) samples at day136. (<bold>E, F</bold>) Exemplificative images of single neuronal tracts extending from organoids on MEA surface, in WNTi (left) and WNTi + FGF8 (right) samples at day134 (<bold>E</bold>) and at day213 (<bold>F</bold>). Note the progressive increase in complexity and length of axons, suggesting maturation of the organoids, which is more limited after treatment with FGF8. (<bold>G</bold>) Graphs show axon tracking metrics (network conduction velocity, total axon or total branch lengths, longest signal latency, longest distance from and signal amplitude at the initiation site), in control (orange columns) and in FGF8-treated organoids (blue columns) at different developmental stages, as indicated. For graphs in G: data from n=2 distinct batches at two different differentiation times (each batch including 2–4 organoids on the MEA chip, see Materials and methods).</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Axon tracking metrics in WNTi and WNTi + FGF8 organoids on MEAs.</title><p>Excel summary datasheet with raw axon tracking measurements for control WNTi and FGF8-treated organoids on MEAs.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig5-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Bicuculline-mediated inhibition of GABA-A receptors and its effect on WNTi + FGF8 organoid spontaneous activity.</title><p>(<bold>A–C</bold>) Spontaneous activity maps showing the mean spike amplitude of 6-month-old WNTi + FGF8 organoids, before (left) or after (right) treatment with 10 µM Bicuculline, a chemical inhibitor of GABA-A receptor. Mean values of activity metrics are shown in C and highlight a slight but significant increase of spike amplitudes. White arrowheads in the electrode image on the top left point to organoids adhering totally or partially on the MEA recording surface. (<bold>D–F</bold>) Temporal raster plots showing firing events recorded by the 1024 most active electrodes (upper graphs) and their synchronicity suggestive of network activity (lower graphs), as detected from untreated (left) or Bicuculline-treated (right) WNTi + FGF8 organoids. Note that the background noise due to random activity falling outside of synchronous bursts (red dotted boxes) is decreased upon treatment with Bicuculline, as also visible in high magnification insets (* and **; before and after Bicuculline treatment, respectively). Graphs in F depict network metrics (Burst frequency and Spikes within bursts), highlighting a significant increase of percentage of spikes within synchronous network bursts. For all graphs: data from n=2 distinct batches (each including 2–4 organoids on the MEA chip, see Materials and methods).</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Activity scan and network analysis of WNTi + FGF8 organoids on MEAs with or without Bicuculline treatment.</title><p>Excel summary datasheet with raw activity and network metrics for WNTi + FGF8 organoids before and during Bicuculline treatment.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig5-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig5-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-7"><title>FGF8 alters dorso/ventral specification of glutamatergic and GABAergic populations</title><p>As the abundance of cells in specific clusters was highly impacted upon FGF8 treatment, we reasoned that the modulation of specific D/V genes (<xref ref-type="fig" rid="fig4">Figure 4</xref>) could result from two overlapping factors: (i) a varying number of cells per cluster and (ii) a differential expression level of D/V genes within a given cellular population. To disentangle these parameters, we performed an analysis of differentially expressed genes (DEGs) on specific cell populations (clusters) by comparing WNTi to WNTi + FGF8 organoids, visualizing the most strongly up- or down-regulated genes in volcano-plots (<xref ref-type="fig" rid="fig6">Figure 6</xref>). This analysis allows for normalization of gene expression levels to minimize potential bias from differences in cell abundance between control and treated organoids.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Analysis of differentially expressed genes (DEGs) in glutamatergic and GABAergic progenitors and neurons upon FGF8 treatment.</title><p>(<bold>A</bold>) DEG analysis comparing control (WNTi) and treated (WNTi + FGF8) organoids, highlighting the most strongly (x-axis, average log2 fold change) and most significantly (y-axis, adjusted p-value in -log10) differentially expressed genes (DEGs) in clusters 12/15 (proliferating glutamatergic progenitors; left volcano plot) or clusters 2/5 (non-proliferating glutamatergic progenitors; right volcano plot). Red dots indicate significantly (adjusted P-value &lt;0.05) regulated genes, with the names of the 20 most significant ones displayed (see source data material for a complete list of DEGs). (<bold>B</bold>) Expression level of <italic>ZIC1</italic> (left) and <italic>ZIC3</italic> (right) in UMAP projections of WNTi and WNTi + FGF8 samples, as indicated. Black arrowheads point to increased <italic>ZIC1</italic> and <italic>ZIC3</italic> expression in glutamatergic progenitor clusters following FGF8 treatment. (<bold>C</bold>) Expression level of <italic>GSX2</italic> (upper panel) and <italic>DLX2</italic> (lower panel) in UMAP projections of WNTi or WNTi + FGF8 samples, as indicated. Black arrowheads indicate increased <italic>GSX2</italic> and <italic>DLX2</italic> expression in proliferating glutamatergic progenitors upon FGF8 treatment. (<bold>D</bold>) DEG analysis comparing control (WNTi) and treated (WNTi + FGF8) organoids, highlighting the most significantly regulated genes in cluster 3 (early differentiating glutamatergic neurons; left volcano plot) or clusters 1/4 (differentiated glutamatergic neurons; right volcano plot). (<bold>E</bold>) DEG analysis comparing control (WNTi) and treated (WNTi + FGF8) organoids, showing the most significantly regulated genes in clusters 6/7 (volcano plot), corresponding to GABAergic neurons. The panel below shows the expression level of <italic>NR2F2</italic> in UMAP projections of WNTi and WNTi + FGF8 samples, as indicated. The black arrowhead points to decreased <italic>NR2F2</italic> expression in GABAergic cells following FGF8 treatment. Red boxes highlight FGF target genes or genes noted in OMIM as disease-related. Brain schematics with gene expression patterns are based on embryonic day 13.5 stainings from the Mouse Allen Brain Atlas.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Analysis of differentially expressed genes in cycling glutamatergic progenitors following FGF8 treatment.</title><p>Excel file listing genes with differential expression between WNTi and WNTi + FGF8 organoids in clusters 12 and 15 (glutamatergic cycling progenitors), visualized as a volcano plot in <xref ref-type="fig" rid="fig6">Figure 6A</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig6-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Analysis of differentially expressed genes in non-cycling glutamatergic progenitors following FGF8 treatment.</title><p>Excel file listing genes with differential expression between WNTi and WNTi + FGF8 organoids in clusters 2 and 5 (glutamatergic non-cycling progenitors), visualized as a volcano plot in <xref ref-type="fig" rid="fig6">Figure 6A</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig6-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Analysis of differentially expressed genes in early differentiating glutamatergic neurons following FGF8 treatment.</title><p>Excel file listing genes with differential expression between WNTi and WNTi + FGF8 organoids in cluster 3 (glutamatergic early differentiating neurons), visualized as a volcano plot in <xref ref-type="fig" rid="fig6">Figure 6D</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig6-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata4"><label>Figure 6—source data 4.</label><caption><title>Analysis of differentially expressed genes in post-mitotic glutamatergic neurons following FGF8 treatment.</title><p>Excel file listing genes with differential expression between WNTi and WNTi + FGF8 organoids in clusters 1 and 4 (glutamatergic neurons), visualized as a volcano plot in <xref ref-type="fig" rid="fig6">Figure 6D</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig6-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata5"><label>Figure 6—source data 5.</label><caption><title>Analysis of differentially expressed genes in GABAergic cells following FGF8 treatment.</title><p>Excel file listing genes with differential expression between WNTi and WNTi + FGF8 organoids in clusters 6 and 7 (GABAergic neurons), visualized as a volcano plot in <xref ref-type="fig" rid="fig6">Figure 6E</xref>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig6-data5-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Enrichment analysis of Gene Ontology (GO) terms in distinct NP or neuronal clusters.</title><p>Results of enrichment analysis of the biological process GO terms performed with the gene set enrichment analysis (GSEA) method. Each graph shows the results relative to a specific cluster or subset of clusters, as indicated. Red to blue color code corresponds to adjusted p-value, while the circle size indicates the number of genes that belong to a specific GO term listed on the left of each graph.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Gene Ontology (GO) enrichment analysis in NP and neuronal clusters.</title><p>Detailed report of enrichment analysis comparing different cell clusters in WNTi and WNTi + FGF8 organoids.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-98096-fig6-figsupp1-data1-v2.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig6-figsupp1-v2.tif"/></fig></fig-group><p>By comparing WNTi and WNTI + FGF8 samples on proliferating (clusters 12 and 15) and non-proliferating (clusters 2 and 5) glutamatergic progenitors, <italic>NR2F1</italic> emerged as the most strongly down-regulated gene upon FGF8 treatment, both in terms of fold change and p-value (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Another down-regulated gene in glutamatergic progenitors was <italic>FGFR3</italic>, which, together with <italic>NR2F1,</italic> is a primary target of FGF8 signaling and a key effector in regulating neocortical areal identity (<xref ref-type="bibr" rid="bib39">Garel et al., 2003</xref>; <xref ref-type="bibr" rid="bib50">Inglis-Broadgate et al., 2005</xref>; <xref ref-type="bibr" rid="bib67">Mott et al., 2010</xref>). Gene ontology (GO) enrichment analysis showed that many DEGs were related to cell proliferation (DNA replication) or differentiation (nervous system development; cell differentiation) categories (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Among FGF8-induced genes, <italic>ZIC1</italic> and <italic>ZIC3</italic> (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>) are known to maintain neural precursor cells in an undifferentiated state in the mouse medial telencephalon (<xref ref-type="bibr" rid="bib51">Inoue et al., 2007</xref>). Most importantly, genes typically expressed only in ventral progenitors, such as <italic>DLX2</italic> and <italic>GSX2</italic>, were significantly upregulated in dorsal glutamatergic progenitor clusters (<xref ref-type="fig" rid="fig6">Figure 6A and C</xref>), suggesting a misspecification of glutamatergic progenitors towards a ventral identity. Similarly, post-mitotic differentiating (cluster 3) and differentiated (clusters 1 and 4) glutamatergic neurons (<xref ref-type="fig" rid="fig6">Figure 6D</xref>) showed a clear imbalance in D/V gene expression, including reduced glutamatergic markers (<italic>NF1B, NEUROD6</italic> and <italic>SOX5</italic>) and induction of <italic>DLX2</italic>, confirming that FGF8 can influence the establishment of a glutamatergic molecular network by inducing ectopic GABAergic marker expression. DEGs in clusters 1, 3, and 4 were generally associated with neural differentiation GO categories (axonogenesis; neurogenesis; neuron differentiation; axon guidance; cell differentiation, among others; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), consistent with a post-mitotic neural identity of these clusters. Among FGF8-induced genes in glutamatergic neurons, we identified <italic>ETV1</italic> (<xref ref-type="bibr" rid="bib28">Cholfin and Rubenstein, 2008</xref>), a known target serving as an internal control for FGF8 efficiency, and again, <italic>NR2F1</italic> as the most significantly down-regulated gene (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Additionally, other factors modulated by FGF8 in both NPs and neurons included <italic>AUTS2, NFIB, ZIC1, ZIC3, FOXP2, CCND2, MEIS2</italic>, and <italic>SOX5</italic>, which are known to be mutated in NDDs (<xref ref-type="fig" rid="fig6">Figure 6A and D</xref>). Finally, we focused on DEG changes in ventral GABAergic cells (clusters 6 and 7; <xref ref-type="fig" rid="fig6">Figure 6E</xref>). Gene enrichment analysis revealed GO categories associated with neuronal differentiation and migration (forebrain development; CNS development; neuron migration; nervous system development, among others; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). FGF8 treatment affected the expression levels of <italic>NR2F1, NTRX2, TUBB3, ZIC1, ZIC2</italic>, and <italic>MEIS2</italic>, and notably, the <italic>NR2F1</italic> homolog <italic>NR2F2</italic> emerged as a highly modulated FGF8 target gene (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Together, our DEG analyses suggest FGF8-dependent misspecification of glutamatergic and GABAergic progenitors and neurons, along with the dysregulation of several genes related to normal and pathological brain development.</p></sec><sec id="s2-8"><title>FGF8 treatment modulates A/P neocortical identity and areal-specific factor expression</title><p>As the DEG analysis revealed downregulation of posterior factors such as <italic>NR2F1</italic> and <italic>FGFR3</italic> and upregulation of anterior genes <italic>ZIC1</italic> and <italic>ZIC3</italic> following FGF8 treatment, we hypothesized that FGF8 might also modulate the A/P identity of telencephalic cells, in addition to its effects on D/V identity. Notably, <italic>NR2F1</italic> is positioned at the top of a regulatory hierarchy controlling other region-specific factors, including <italic>EMX2, FGFR3, SP8</italic>, and <italic>PAX6 (</italic><xref ref-type="bibr" rid="bib14">Bertacchi et al., 2019</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). VoxHunt Similarity brain maps indicated that FGF8-treated organoids maintained a high similarity score with the anterior-most sections of the dorsal telencephalon, while similarity to posterior regions was nearly lost (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>). This suggests that FGF8 treatment preferentially supports the expression of anterior cortical genes. To further investigate the impact of FGF8 on A/P patterning, we quantified the percentage of cells positive for selected A/P master genes (<xref ref-type="bibr" rid="bib22">Cadwell et al., 2019</xref>; <xref ref-type="fig" rid="fig7">Figure 7A–C</xref>) in both glutamatergic NP (clusters 2/5/12/14/15) or neurons (clusters 1/3/4). Anterior genes, including <italic>PAX6, ETV1, ZIC1,</italic> and <italic>ZIC3</italic>, showed increased expression in progenitors and/or neurons following FGF8 treatment (<xref ref-type="fig" rid="fig6">Figures 6B</xref> and <xref ref-type="fig" rid="fig7">7B–D</xref>). <italic>Vice versa</italic>, and consistent with the upregulation of anterior markers, posterior ones such as <italic>NR2F1, FGFR3</italic>, and <italic>EMX1</italic> were efficiently down-regulated by FGF8 in both NPs and neurons (<xref ref-type="fig" rid="fig4">Figures 4A</xref> and <xref ref-type="fig" rid="fig7">7B–D</xref>). However, some anterior genes (e.g. <italic>ETV5</italic>) and posterior genes (e.g. <italic>CRYM, TSHZ2, EMX2,</italic> and <italic>ODZ3</italic>) displayed minimal changes (<xref ref-type="fig" rid="fig7">Figure 7B and C</xref>). These data suggest that FGF8 selectively modulates a subset of areal-specific genes within glutamatergic clusters, while other markers may be regulated <italic>via</italic> alternative mechanisms. To achieve a more comprehensive and unbiased assessment of A/P identity in telencephalic organoids, we used a SingleR approach to compare the transcriptomic profiles of control and FGF8-treated organoids against a reference dataset of distinct human fetal brain regions at 16 post-conception weeks (PCWs), including parietal, motor, prefrontal, somatosensory, temporal, and visual cortices (<xref ref-type="bibr" rid="bib16">Bhaduri et al., 2020</xref>; <xref ref-type="bibr" rid="bib33">Eze et al., 2021</xref>; <xref ref-type="bibr" rid="bib70">Nowakowski et al., 2017</xref>; <xref ref-type="bibr" rid="bib102">Speir et al., 2021</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>). Notably, WNTi and WNTi + FGF8 organoid samples (each subdivided into NP clusters or differentiated neuron clusters) showed high similarity to 16 PCW pre-frontal and somatosensory cortices (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>, <italic>left graph</italic>). Specifically, by visualizing the SingleR annotation scores between organoid samples and fetal brain areas (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>, <italic>right graph</italic>), we found that neural progenitors, regardless of FGF8 treatment, predominantly resembled the fetal somatosensory cortex, while differentiated neurons exhibited greater similarity to either the prefrontal cortex or somatosensory cortex. Despite these findings, FGF8 treatment had a detectable effect on A/P identity, marked by a slight increase in the similarity of WNTi + FGF8 NPs to the transcriptional profile of the prefrontal cortex. Conversely, WNTi + FGF8 NPs and neurons showed reduced similarity to the fetal visual cortex and temporal areas (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>, <italic>right graph</italic>). Collectively, our data suggest that FGF8 modulates areal patterning by promoting the expression of genes associated with an anterior (prefrontal) cortical identity while reducing markers of a posterior (visual) identity.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>FGF8-dependent acquisition of distinct antero-posterior areal identities in human telencephalic organoids.</title><p>(<bold>A</bold>) Glutamatergic neural progenitor (NPs; clusters 2/5/12/14/15) and glutamatergic neurons (clusters 1/3/4) are highlighted on the UMAP projection of day69 organoid scRNAseq data. (<bold>B,C</bold>) Images on the right display the clusters selected for analysis, as described in A. The graphs show the percentages of cells expressing anterior-posterior (A/P) cortical markers within the two highlighted cluster groups: NPs (top graph) and neurons (bottom graph). The percentage of cells positive for anterior markers (<italic>PAX6, ER81, ETV5</italic>) and posterior markers (<italic>WNT7B, EMX2, NR2F1, FGFR3, CRYM, TSHZ2, ODZ3</italic>) is shown in yellow for control (WNTi) organoids and in blue for FGF8-treated (WNTi + FGF8) organoids. (<bold>D</bold>) Expression level of key posterior (<italic>NR2F1, FGFR3, WNT7B, EMX2</italic>) and anterior (<italic>ETV1, PAX6</italic>) genes in UMAP projections of WNTi or WNTi + FGF8 day69 organoid samples, as indicated. Black arrowheads in the <italic>NR2F1</italic> and <italic>FGFR3</italic> UMAP projections point to decreased expression in proliferating glutamatergic progenitors upon FGF8 treatment, while arrowheads in the <italic>ETV1</italic> UMAP projection indicate increased expression in FGF8-treated glutamatergic neurons. Brain schematics with gene expression patterns are based on embryonic day 13.5 staining data from the Mouse Allen Brain Atlas.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Percentage of cells expressing antero-posterior cortical markers in WNTi and WNTi + FGF8 organoids.</title><p>Summary Excel datasheet with counts of cells expressing A/P markers (<italic>PAX6, ER81, ETV5, WNT7B, EMX2, NR2F1, FGFR3, CRYM, TSHZ2</italic>, and <italic>ODZ3</italic>) within glutamatergic progenitor (clusters 2, 5, 12, 14, 15) and neuron (clusters 1, 3, 4) groups for both WNTi and WNTi + FGF8 samples, extracted <italic>via</italic> 10 X Genomics Loupe Browser.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98096-fig7-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>FGF8-dependent acquisition of different antero-posterior areal identities in human telencephalic organoids.</title><p>(<bold>A</bold>) Schematic drawing of the mammalian developing brain showing FGF8 sources (blue) in the anterior telencephalon and at the midbrain/hindbrain border, and their presumable diffusing gradients (arrows). The red inset illustrates a sagittal section of the telencephalon with the two opposite FGF8 (blue) and NR2F1 (orange) gradients. (<bold>B</bold>) VoxHunt Similarity Map showing similarity correlation index (white to violet color code) of control (WNTi) and treated (WNTi + FGF8) organoids on virtual brain coronal sections. The color code in the first left column of brain virtual sections identifies different brain regions, listed in the legend at the bottom. Blue arrowheads point to the dorsal-most region of the pallium. (<bold>C</bold>) Cell-level (left) and cluster-level (right) heatmaps of the SingleR assignment scores (<italic>i.e.</italic> the confidence of the predicted labels across the dataset; dark blue to yellow color code) as well as the corresponding inferred annotation for the clusters/cells in the ‘Labels’ top bar. Cell/cluster annotation was obtained by using SingleR to evaluate the similarity between control (WNTi) or FGF8-treated (WNTi + FGF8) samples against a 16 post conceptional week (PCW) fetal brain dataset. Glutamatergic progenitors correspond to clusters 2/5/12/14/15, while neurons corresponded to clusters 1/3/4. The reference dataset corresponds to primary cells dataset published by <xref ref-type="bibr" rid="bib102">Speir et al., 2021</xref> and where only cells belonging to 16 PCW and not to the hippocampus were kept. In the left graph, the ‘Cls’ top bar identifies the organoid cells. Note that most of the organoid cells (columns) are annotated as pre-fontal cortex (PFC; light blue) or somatosensory cortex (green), based on transcriptional similarity. In the graph on the right, the average annotation score per sample is depicted; control and treated progenitors show high annotation score to somatosensory cortex, while control and treated neurons resemble the PFC. Despite this, note that FGF8 treatment decreases the annotation score to caudal V1 (visual) and temporal areas, while slightly increasing the annotation score to the rostral PFC, indicating anteriorization of cell identity.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>SingleR cluster annotation analysis of human organoid areal identity.</title><p>Detailed report on methods and data for annotating clusters/cells using SingleR, comparing <italic>in vitro</italic> organoids with <italic>in vivo</italic> fetal cortical regions, specifically assessing glutamatergic neuron (clusters 1, 3, 4) and progenitor (clusters 2, 5, 12, 14, 15) clusters.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-98096-fig7-figsupp1-data1-v2.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-fig7-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><sec id="s3-1"><title>A hybrid 2D/3D cerebral organoid protocol enables rapid and reproducible generation of telencephalic progenitors and neurons</title><p>Over the last decade, 3D human organoids have emerged as a powerful tool for modeling both normal and pathological embryonic brain development. In this study, we adapted previous protocols to introduce a novel experimental approach that combines efficient 2D NP induction (<xref ref-type="bibr" rid="bib24">Chambers et al., 2009</xref>) with 3D culture in spinning bioreactors (<xref ref-type="bibr" rid="bib81">Qian et al., 2018</xref>). While dual SMAD inhibition in 2D allows rapid neural induction in just 7 days, subsequent steps in 3D culture promote the formation of reproducible brain-like cellular architectures, including rosettes and neural epithelia, which gradually mature into neurons organized in a cortical plate-like structure. As early NPs are dissociated and re-aggregated to form 3D embryoid bodies, this hybrid 2D/3D method could be particularly beneficial for experimental approaches that aim to mix different NP types or cells with distinct genetic backgrounds. It is important to note that the use of a ROCK inhibitor was necessary during early NP dissociation, as significant cell death occurred within 24 hr in its absence, indicating that early human progenitor cells are susceptible to apoptosis when cell contacts are lost, similar to undifferentiated hiPSCs. In late culture samples, our scRNAseq data revealed the presence of distinct types of human NPs, including <italic>HOPX</italic>+ outer radial glia (RG) cells (<xref ref-type="bibr" rid="bib78">Pollen et al., 2015</xref>) and, notably, <italic>CRYAB</italic>+ apical truncated RG cells, which, to our knowledge, have only been identified in a few protocols (<xref ref-type="bibr" rid="bib69">Nowakowski et al., 2016</xref>). This high cellular heterogeneity is likely promoted by the dual SMAD inhibition approach combined with WNT inhibition, a condition known to enhance NP amplification and diversity (<xref ref-type="bibr" rid="bib89">Rosebrock et al., 2022</xref>).</p></sec><sec id="s3-2"><title>FGF8-induced cellular heterogeneity leads to the formation of segregated co-developing domains in multi-regional organoids</title><p>The regionalization of the embryonic brain is a multi-step process that operates both sequentially and simultaneously, primarily regulated by localized sources of various signaling molecules that function as organizing centers to pattern neighboring regions and create distinct molecular domains (<xref ref-type="bibr" rid="bib17">Borello and Pierani, 2010</xref>; <xref ref-type="bibr" rid="bib110">Takahashi and Liu, 2006</xref>). From E8.5 in the mouse, FGF8 is expressed at the boundary between the midbrain and hindbrain, playing a crucial role in posterior brain patterning and strongly promoting midbrain identity (<xref ref-type="bibr" rid="bib43">Harada et al., 2016</xref>; <xref ref-type="bibr" rid="bib59">Liu et al., 1999</xref>; <xref ref-type="bibr" rid="bib62">Martinez et al., 1999</xref>). This is why protocols designed to generate midbrain neurons <italic>in vitro</italic> employ early FGF8 treatment (<xref ref-type="bibr" rid="bib24">Chambers et al., 2009</xref>; <xref ref-type="bibr" rid="bib77">Perrier et al., 2004</xref>). Consistently, our findings revealed that the early addition of FGF8 to the culture media resulted in the abolition of <italic>FOXG1</italic> expression, thereby preventing telencephalic induction. Importantly, our data indicate that in human brain organoids, day10-11 represents the optimal window for FGF8 application, allowing for the preservation of <italic>FOXG1</italic> expression and telencephalic identity while effectively modulating FGF8 target genes such as <italic>NR2F1</italic>. In contrast, initiating FGF8 treatment from day20 maintained <italic>FOXG1</italic> expression but was less effective in regulating <italic>NR2F1</italic>. Consequently, we only treated organoids with FGF8 after a minimum of 10 days of neural induction to avoid early interference with telencephalic development. Despite this precaution, some regions resembling diencephalic and mesencephalic structures still formed in our organoids, likely due to the presence of unspecified NPs at day10, which might remain responsive to the mesencephalon-inducing effects of FGF8. We propose that FGF8 can play multiple roles in human cells <italic>in vitro</italic>, depending on the competence, developmental state, and regional identity of NPs exposed to it. Early in development, when acting on unspecified progenitors, FGF8 serves as a potent inducer of posteriorized identity, capable of specifying discrete diencephalic/mesencephalic-like domains in brain organoids. However, as development progresses and <italic>FOXG1</italic> expression becomes established, consolidating a telencephalic fate, FGF8 acts as a regulator of A/P and D/V identities in forebrain cells. Interestingly, the ability of FGF8 to modulate target genes can also vary based on the regional identity of the FGF8-exposed cells.</p><p>The co-presence of various regional domains in FGF8-treated organoids - specifically dorsal and ventral telencephalon, as well as diencephalic and mesencephalic regions - represents a significant outcome. One of the major challenges in the field of <italic>in vitro</italic> models of human brain development is successfully reproducing the interactions between distinct brain regions. Unguided organoids tend to spontaneously develop multiple brain regions (<xref ref-type="bibr" rid="bib56">Lancaster et al., 2013</xref>; <xref ref-type="bibr" rid="bib57">Lancaster and Knoblich, 2014</xref>; <xref ref-type="bibr" rid="bib88">Renner et al., 2017</xref>), but this occurs in a stochastic manner, resulting in weak reproducibility across different batches (<xref ref-type="bibr" rid="bib120">Velasco et al., 2019</xref>). A more reliable strategy involves utilizing signaling molecules, such as morphogens and chemical drugs in the culture medium, to control the patterning of organoids into specific structures, like the cortex, ventral telencephalon, hypothalamus, and thalamus. However, organoids specified to distinct identities often require further manipulation, such as the fusion of different structures in multiwell plates and/or embedding them together in Matrigel to create ‘assembloids’ (<xref ref-type="bibr" rid="bib76">Paşca, 2019</xref>). This additional step can be time-consuming and may introduce further variability, even though it is essential for studying neuronal migration and facilitating the formation of inter-regional neuronal connections.</p><p>In this study, we demonstrate that the addition of patterning cues (FGF8 in this case) to the culture medium - even when applied in a non-polarized manner - is sufficient to instruct the development of additional regional fates that co-exist and co-develop within the same organoid while maintaining spatial segregation. Notably, we identified FOXG1+ telencephalic areas containing both TBR1+ dorsal cortical neurons and ventral GABAergic cells, alongside more posterior OTX2+ FOXG1- diencephalic/mesencephalic-like domains. By enhancing organoid complexity, FGF8 signaling enables the formation of more biologically realistic models of human brain assembly <italic>in vitro</italic>. Multi-regional organoids present an opportunity to investigate how different brain regions self-organize and interact, thus eliminating the need for manual assembly of pre-patterned organoids into assembloids. We propose that the simple addition of instructing cues (morphogens) to the culture medium can enhance the complexity of brain organoids, providing a compromise between maintaining a certain degree of spontaneous self-organization while inducing multiple brain regions in a reproducible manner.</p></sec><sec id="s3-3"><title>FGF8 signaling as a key driver of lateral ganglionic eminence specification in D/V telencephalic patterning</title><p>Within the telencephalon, FGF8 forms a gradient from its anterior source, the ANR, acting as a morphogen that triggers distinct cellular responses relative to its concentration. In mice, reduced Fgf8 levels cause progressive telencephalic hypoplasia (<xref ref-type="bibr" rid="bib105">Storm et al., 2006</xref>), as described in <italic>Fgf8</italic> hypomorphic and conditional mutants, which show smaller telencephalons due to decreased proliferation, increased apoptosis, and altered expression of areal patterning genes such as <italic>Nr2f1</italic>, <italic>Pax6</italic>, <italic>Emx2,</italic> and <italic>Sp8</italic> (<xref ref-type="bibr" rid="bib105">Storm et al., 2006</xref>; <xref ref-type="bibr" rid="bib104">Storm et al., 2003</xref>; <xref ref-type="bibr" rid="bib39">Garel et al., 2003</xref>). Notably, severe <italic>Fgf8null</italic> mutants exhibit a marked reduction of antero-ventral structures, likely impacting adjacent signaling centers expressing <italic>Bmp4</italic>, <italic>Wnt8b</italic>, and/or <italic>Shh</italic>. Conversely, conditional <italic>Fgf8</italic> mutants, where <italic>Fgf8</italic> is inactivated at a later stage, display a milder phenotype, with reduced frontal cortex and ventral structures and an expanded dorso-posterior molecular profile (<xref ref-type="bibr" rid="bib105">Storm et al., 2006</xref>; <xref ref-type="bibr" rid="bib39">Garel et al., 2003</xref>). Severe phenotypic alterations and cross-regulation between anterior (FGF), dorsal (BMP, WNT), and/or ventral (SHH) patterning centers in genetic loss-of-function (LOF) animal models obscure the specific role of FGF8 signaling in telencephalic development. Therefore, a system with controlled FGF8 signaling modulation is preferable.</p><p>In this study, we investigated the exclusive, long-term effects of FGF8 signaling on human cerebral organoids by enabling proper differentiation of FOXG1+ telencephalic cells and assessing molecular and cellular changes across developmental stages. Transcriptomic analysis of FGF8-treated <italic>versus</italic> untreated cerebral organoids revealed a clear FGF8-mediated induction of ventral telencephalic genes, suggesting that one of the primary roles of FGF8 signaling within telencephalic territories may be the promotion of ventral identity. Consistently, we observed upregulation of ventral genes such as <italic>ASCL1</italic>, <italic>DLX2</italic>, and <italic>PBX3</italic> and simultaneous downregulation of dorsal genes like <italic>EMX1</italic>, <italic>NEUROG2</italic>, <italic>SOX5</italic>, and <italic>LHX2</italic>. As a result, FGF8-treated organoids showed an altered balance between glutamatergic neurons (expressing <italic>NEUROD6</italic>, <italic>NEUROD2</italic>, <italic>CTIP2</italic>, <italic>TBR1</italic>, <italic>SATB2</italic>, <italic>NF1A</italic>, and <italic>SLC17A7</italic>) and GABAergic neurons (expressing <italic>EBF1</italic>, <italic>GSX2</italic>, <italic>PBX3</italic>, and <italic>GAD1</italic>). Supporting these findings, functional assays using multi-electrode arrays (MEA) indicated reduced spontaneous network activity and decreased electrical signal propagation in FGF8-treated organoids compared to controls. This electrophysiological profile, with lower firing and network burst rates, aligns with a reduction in excitatory glutamatergic neurons and an increase in inhibitory GABAergic neurons (<xref ref-type="bibr" rid="bib66">Mossink et al., 2022</xref>) and supports an FGF8-induced shift toward ventral GABAergic identity at the expense of a dorsal glutamatergic identity in telencephalic organoids. Acute FGF8 modulation in mice, achieved by implanting FGF8-soaked beads into E9.5 telencephalic explants, was shown to induce the expression of ventral markers like <italic>Ascl1</italic> and <italic>Dlx2</italic> while repressing the dorsal cortical marker <italic>Emx1</italic> (<xref ref-type="bibr" rid="bib55">Kuschel et al., 2003</xref>). Our data in human organoids align with these mouse findings and suggest that the absence of FGF8 may hinder the induction of ventral markers <italic>in vitro</italic> as well as the formation of ganglionic eminence structures <italic>in vivo</italic> (<xref ref-type="bibr" rid="bib105">Storm et al., 2006</xref>).</p><p>Interestingly, we observed that certain genes upregulated by FGF8, such as <italic>MESI2</italic>, <italic>TLE4</italic>, and <italic>PBX3</italic>, are specific to the ventral lateral ganglionic eminence (LGE), a region ventral to the lateral pallium, and, particularly, are characteristic of striatal precursors (<xref ref-type="bibr" rid="bib97">Shi et al., 2021</xref>). This FGF8-induced effect does not extend to medial ganglionic eminence (MGE) markers such as <italic>SHH</italic>, <italic>LHX8</italic>, and <italic>NKX2-1</italic>. To our knowledge, the striatal-promoting effect of FGF8 has been little documented before; it could be interesting to test the combined influence of FGF8 with SHH, known to promote medium spiny neuron production <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib32">Delli Carri et al., 2013</xref>). Notably, the ‘ventral’ marker ASCL1, which is upregulated by FGF8 treatment in our organoids, is also expressed in a subset of glutamatergic progenitors in rodents (<xref ref-type="bibr" rid="bib20">Britz et al., 2006</xref>) and humans (<xref ref-type="bibr" rid="bib4">Alzu’bi and Clowry, 2019</xref>). This suggests that ASCL1 is not exclusively a marker of cells of ventral origin, particularly within the human telencephalon (<xref ref-type="bibr" rid="bib31">Delgado et al., 2022</xref>; <xref ref-type="bibr" rid="bib53">Kim et al., 2023</xref>), where lineage-tracing studies reveal that dorsal progenitors expressing LGE-like markers can also differentiate into GABAergic neurons (<xref ref-type="bibr" rid="bib31">Delgado et al., 2022</xref>; <xref ref-type="bibr" rid="bib3">Alzu’bi et al., 2017b</xref>). In this context, FGF8 may enhance an inherent GABAergic-producing capacity in human telencephalic progenitors by promoting the expression of LGE markers. Thus, FGF8-induced ventral LGE identity in human organoids may reflect a species-specific feature: the intrinsic potential of human glutamatergic progenitors to produce GABAergic neurons with an LGE-like molecular profile.</p></sec><sec id="s3-4"><title>FGF8-mediated control of A/P areal identity and unified role of FGF8 as an ‘antero-ventral’ inducer</title><p>FGF8 is a well-established key regulator of anterior <italic>versus</italic> posterior identity, directing cortical area specification in the mouse neocortex (<xref ref-type="bibr" rid="bib1">Alfano and Studer, 2013</xref>). Its gradient diffuses from anterior to posterior along the neocortical epithelium, promoting prefrontal while inhibiting more occipital cortical areas, like the visual cortex. Although human cerebral organoids do not develop segregated functional areas as in the developing neocortex (<xref ref-type="bibr" rid="bib22">Cadwell et al., 2019</xref>; <xref ref-type="bibr" rid="bib16">Bhaduri et al., 2020</xref>), we observed that FGF8 can downregulate the expression of posterior cortical genes, like <italic>FGFR3</italic> and <italic>NR2F1</italic>, while inducing anterior ones, such as <italic>ETV1</italic>. This suggests that beyond controlling D/V cell identity, FGF8 may also influence A/P areal-specific gene expression in human cerebral organoids. However, the global identity of both FGF8-treated and untreated organoids, based on transcriptional similarity to human fetal brain areas, remained aligned with somatosensory and pre-frontal cortical regions, indicating only a limited effect on full A/P areal specification. Optimizing FGF8 doses or timing could enhance A/P areal identity control in telencephalic organoids. A promising approach may involve introducing a polarized FGF8 source to better mimic physiological gradients, as done with SHH-expressing organoids (<xref ref-type="bibr" rid="bib23">Cederquist et al., 2019</xref>), where an endogenous signaling center generates distinct D/V identities in a dose-dependent manner. Establishing a localized FGF8 source adjacent to polarized forebrain organoids could expose telencephalic cells to varying concentrations of FGF8, potentially improving <italic>in vitro</italic> modeling of areal patterning by inducing distinct A/P areal identities and ultimately establishing neocortical axes. The introduction of discrete morphogen sources in polarized organoids has been explored in recent reports (<xref ref-type="bibr" rid="bib19">Bosone et al., 2024</xref>; <xref ref-type="bibr" rid="bib122">Xue et al., 2024</xref>).</p><p>In summary, our study shows that FGF8 influences both D/V and A/P regional identity in telencephalic organoids. Although we analyzed the A/P and D/V axes separately, these induction and patterning processes are likely interconnected. For instance, specific neocortical areas along the A/P axis have varying populations of ventrally-generated GABAergic interneurons (<xref ref-type="bibr" rid="bib65">Molnár et al., 2019</xref>). Interestingly, the anterior-most prefrontal cortex has a higher relative proportion of GABAergic neurons (<xref ref-type="bibr" rid="bib65">Molnár et al., 2019</xref>; <xref ref-type="bibr" rid="bib125">Zhong et al., 2018</xref>), although the mechanisms originating this property remain unclear. Given the antero-ventral position of the ANR in the early telencephalon, FGF8 could be considered an ‘antero-ventral’ inducer. This might explain the dual role of FGF8 in cerebral organoids, promoting both ventral (LGE-like) and anterior brain identities, generating new hypotheses about the role of FGF8 in linking cortical areal identity with the abundance and subtype of GABAergic interneurons. It is tempting to speculate that, rather than relying solely on migration from ventral regions, these interneurons could be locally generated by cortical progenitors exposed to distinct, areal-specific doses of FGF8.</p></sec><sec id="s3-5"><title>FGF8 signaling impacts NDD-related developmental trajectories</title><p>Through long-term treatment of human organoids, we identified a correlation between FGF signaling activation and the modulation of several developmental and/or neurodevelopmental disorder (NDD)-related genes. Among the FGF8-regulated genes, <italic>NR2F1</italic> was the most significantly affected, suggesting that it may be a primary effector of FGF8 signaling in telencephalic development. In addition to <italic>NR2F1</italic>, other FGF8-responsive genes detected in the DEG analysis are implicated in human brain malformations and/or NDDs. For example, dysregulation of <italic>FGFR3</italic> leads to Thanatophoric dysplasia, a fatal form of chondrodysplastic dwarfism, characterized by temporal lobe enlargement, abnormal sulci, and hippocampal dysplasia, resulting in cognitive impairments and reduced synaptic plasticity in both patients and mouse models (<xref ref-type="bibr" rid="bib45">Hevner, 2005</xref>). <italic>ZIC1</italic>, which was significantly up-regulated in FGF8-treated organoids, is implicated in complex syndromes involving cortical, callosal, and cerebellar malformations associated with intellectual disability (<xref ref-type="bibr" rid="bib118">Twigg et al., 2015</xref>; <xref ref-type="bibr" rid="bib119">Vandervore et al., 2018</xref>). Moreover, haploinsufficiency of <italic>NFIB</italic> results in macrocephaly and impaired intellectual development, similar to what has been described in <italic>Nfib</italic> mutant mice (<xref ref-type="bibr" rid="bib95">Schanze et al., 2018</xref>). We also identified other disease genes, including <italic>AUTS2</italic> (linked to autism; <xref ref-type="bibr" rid="bib48">Hori et al., 2021</xref>), <italic>FOXP2</italic> (associated with speech and language disorders; <xref ref-type="bibr" rid="bib34">Fisher and Scharff, 2009</xref>), and <italic>SOX5</italic> (linked to developmental delay or intellectual disability; <xref ref-type="bibr" rid="bib124">Zawerton et al., 2020</xref>). Finally, <italic>FOXG1</italic>, normally induced by FGF8, is implicated in a range of brain disorders, including the congenital variant of Rett syndrome, infantile spasms, microcephaly, autism spectrum disorder, and schizophrenia (<xref ref-type="bibr" rid="bib49">Hou et al., 2020</xref>). In our organoid model, however, early FGF8 treatment led to a decrease in <italic>FOXG1</italic> levels rather than an increase, suggesting that FGF8-mediated regulation of <italic>FOXG1</italic> in NPs and neurons could be time- and region-dependent. In summary, our findings highlight an FGF8-dependent effect on regional identity, along with the modulation of several NDD-related targets, including an evolutionarily conserved <italic>FGF8-NR2F1</italic> molecular axis.</p><p>In conclusion, we propose that FGF8-mediated modulation of key developmental genes guides the developmental trajectories of human brain cells along the D/V and A/P telencephalic axes. Diverse genes and signaling pathways may converge to orchestrate shared cellular and molecular processes, resulting in similar or overlapping phenotypes in neurodevelopmental pathologies (<xref ref-type="bibr" rid="bib75">Parenti et al., 2020</xref>). We speculate that a disruption in an FGF8-dependent molecular framework could lead to NDD phenotypes by altering the expression of NDD-related genes and/or interfering with the fundamental processes of A/P and D/V neuronal specification during early brain development.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HMGU1; Human induced pluripotent stem cells</td><td align="left" valign="bottom">kind gift of<break/>Dr. Drukker</td><td align="left" valign="bottom">HMGU1; source cells: BJ (ATCC CRL-2522)</td><td align="left" valign="bottom">MTA approval was obtained from the Helmholtz Zentrum München (HMGU), Germany</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Recombinant Human/Mouse FGF-8b Protein</td><td align="left" valign="bottom">R&amp;D</td><td align="left" valign="bottom">423-F8-025/CF</td><td align="left" valign="bottom">(100 ng/ML)</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">BDNF</td><td align="left" valign="bottom">PeproTech</td><td align="left" valign="bottom">#450–02</td><td align="left" valign="bottom">10 ng/mL</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">hPSC genetic Analysis kit</td><td align="left" valign="bottom">Stem Cell Technologies</td><td align="left" valign="bottom">#07550</td><td align="left" valign="bottom">hiPSCs culture</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NucleoSpin RNA II columns</td><td align="left" valign="bottom">Macherey-Nagel</td><td align="left" valign="bottom">740902.50</td><td align="left" valign="bottom">hiPSCs culture</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Reverse Transcriptase Core Kit</td><td align="left" valign="bottom">Eurogentec</td><td align="left" valign="bottom">RT-RTCK-03</td><td align="left" valign="bottom">hiPSCs culture</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Matrigel</td><td align="left" valign="bottom">Corning</td><td align="left" valign="bottom">354234</td><td align="left" valign="bottom">5–10 µl matrigel dissolved in 1 ml cold DMEM-F12 for each well of a 6-well culture plate</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">mTeSR1 medium</td><td align="left" valign="bottom">STEMCELL Technologies</td><td align="left" valign="bottom">#85850</td><td align="left" valign="bottom">hiPSCs culture</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ROCK inhibitor Y-27632</td><td align="left" valign="bottom">MedChemExpress; or Stem Cell Technologies</td><td align="left" valign="bottom">MedChemExpress HY-10583; or Stem Cell Technologies #72304</td><td align="left" valign="bottom">10 µM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMEM/F12</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">#31331028</td><td align="left" valign="bottom">hiPSCs culture</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">N-2 Supplement 100X</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">17502–048</td><td align="left" valign="bottom">hiPSCs culture</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">B-27 Supplement 50X, minus vitamin A</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">12587–010</td><td align="left" valign="bottom">hiPSCs culture</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">LDN-193189</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">SML0559-5MG</td><td align="left" valign="bottom">0.25 µM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SB-431542</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">S4317-5MG</td><td align="left" valign="bottom">5 µM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">XAV-939</td><td align="left" valign="bottom">Stem cell technologies</td><td align="left" valign="bottom">72674</td><td align="left" valign="bottom">2 µM</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CTIP2, FOXG1, GAD1, OTX2, MAP2, ASCL1, NR2F1, NTUB (ACETILATED TUBULIN), OCT-3/4, PAX6, SATB2, SOX2, TBR1, TUJ1, SLC17A6, SLC17A7 antibodies</td><td align="left" valign="bottom">See <xref ref-type="table" rid="table2">Table 2</xref> for supplier information and antibody host species</td><td align="left" valign="bottom">See <xref ref-type="table" rid="table2">Table 2</xref> for reference codes</td><td align="left" valign="bottom">See <xref ref-type="table" rid="table2">Table 2</xref> for antibody dilution</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">DUSP6, EN2, ETV1, ETV4, ETV5, FOXG1, GAPDH, NANOG, NR2F1, OCT4, OTX2, PAX6, SIX3, SOX2, SPRY4, B-ACTIN primers</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">See <xref ref-type="table" rid="table1">Table 1</xref> for sequence of forward and reverse primers</td></tr></tbody></table></table-wrap><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Primer sequences used.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">gene</th><th align="left" valign="bottom">forward sequence</th><th align="left" valign="bottom">reverse sequence</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold><italic>DUSP6</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">AACCTGTCCCAGTTTTTCCCT</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">GCCAAGCAATGTACCAAGACAC</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>EN2</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">TCTACTGTACGCGCTACTCG</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">CGCTTGTCCTCTTTGTTCGG</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>ETV1</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">CCAATAGTCAGCGTGGGAGAA</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">TTCTGCAAGCCATGTTTCCTGT</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>ETV4</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">TCAAACAGGAACAGACGGACTT</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">AGGTTTCTCATAGCCATAGCCCA</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>ETV5</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">ACACGGGTTCCAGTCACCAA</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">GCTGCTGGAGAAATAACCCCC</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>FOXG1</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">GCCAAGTTTTACGACGGGAC</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">AAGGGTTGGAAGAAGACCCC</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>GAPDH</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">CGTGGAAGGACTCATGACCA</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">CAGTCTTCTGGGTGGCAGTGA</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>NANOG</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">CAAAGGCAAACAACCCACTT</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">TCTGCTGGAGGCTGAGGTAT</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>NR2F1</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">TGGCAATGGTAGTTAGCAGCT</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">TTGAGGCACTTCTTGAGGCG</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>OCT4</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">GTGGAGGAAGCTGACAACAA</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">ATTCTCCAGGTTGCCTCTCA</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>OTX2</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">CCTCACTCGCCACATCTACT</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">CTTGGTGGGTGGGTTTGGAG</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>PAX6</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">AGTGAATCAGCTCGGTGGTGTCTT</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">TGCAGAATTCGGGAAATGTCGCAC</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>SIX3</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">CAGCAAGAAACGCGAACTGG</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">AATGGCCTGGTGCTGGA</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>SOX2</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">AGGATAAGTACACGCTGCCC</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">TAACTGTCCATGCGCTGGTT</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>SPRY4</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">CGGCTTCAGGATTTACACAGAC</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">CTGCAAACCGCTCAATACAGG</named-content></td></tr><tr><td align="left" valign="bottom"><bold><italic>β-Actin</italic></bold></td><td align="left" valign="bottom"><named-content content-type="sequence">CTTCGCGGGCGACGAT</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">ACATAGGAATCCTCCTGACCC</named-content></td></tr></tbody></table></table-wrap><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Primary antibodies used.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Primary antibody</th><th align="left" valign="bottom">species</th><th align="left" valign="bottom">Concentration used</th><th align="left" valign="bottom">Brand</th><th align="left" valign="bottom">ref</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>CTIP2</bold></td><td align="left" valign="bottom">Rat monoclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab18465</td></tr><tr><td align="left" valign="bottom"><bold>FOXG1</bold></td><td align="left" valign="bottom">Rabbit polyclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab18259</td></tr><tr><td align="left" valign="bottom"><bold>GAD1</bold></td><td align="left" valign="bottom">Mouse monoclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">MAB5406</td></tr><tr><td align="left" valign="bottom"><bold>OTX2</bold></td><td align="left" valign="bottom">Goat polyclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">R&amp;D</td><td align="left" valign="bottom">AF1979</td></tr><tr><td align="left" valign="bottom"><bold>MAP2</bold></td><td align="left" valign="bottom">Mouse monoclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">M4403</td></tr><tr><td align="left" valign="bottom"><bold>ASCL1 (MASH1)</bold></td><td align="left" valign="bottom">Mouse monoclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">BD Biosciences</td><td align="char" char="." valign="bottom">556604</td></tr><tr><td align="left" valign="bottom"><bold>NR2F1 (COUP TF1)</bold></td><td align="left" valign="bottom">Rabbit monoclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab181137</td></tr><tr><td align="left" valign="bottom"><bold>NTUB</bold></td><td align="left" valign="bottom">Mouse monoclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">T6793</td></tr><tr><td align="left" valign="bottom"><bold>OCT-3/4</bold></td><td align="left" valign="bottom">Mouse monoclonal</td><td align="char" char="." valign="bottom">(1:500)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">sc-5279</td></tr><tr><td align="left" valign="bottom"><bold>PAX6</bold></td><td align="left" valign="bottom">Rabbit polyclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">AB2237</td></tr><tr><td align="left" valign="bottom"><bold>SATB2</bold></td><td align="left" valign="bottom">Mouse monoclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab51502</td></tr><tr><td align="left" valign="bottom"><bold>SOX2</bold></td><td align="left" valign="bottom">Mouse monoclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">R&amp;D</td><td align="left" valign="bottom">MAB2018</td></tr><tr><td align="left" valign="bottom"><bold>TBR1</bold></td><td align="left" valign="bottom">Rabbit polyclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab31940</td></tr><tr><td align="left" valign="bottom"><bold>TUJ1 (TUBB3)</bold></td><td align="left" valign="bottom">Rabbit polyclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">BioLegend</td><td align="char" char="." valign="bottom">802001</td></tr><tr><td align="left" valign="bottom"><bold>SLC17A6 (VGLUT2)</bold></td><td align="left" valign="bottom">Guinea Pig polyclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">AB2251</td></tr><tr><td align="left" valign="bottom"><bold>SLC17A7</bold></td><td align="left" valign="bottom">Rabbit polyclonal</td><td align="char" char="." valign="bottom">(1:1000)</td><td align="left" valign="bottom">Invitrogen</td><td align="char" char="ndash" valign="bottom">48–2400</td></tr></tbody></table></table-wrap><p>Human induced pluripotent stem cells (hiPSCs) used in this study are the HMGU1 cell line, derived from fibroblasts established from skin taken from normal foreskin from a neonatal male (ATCC number CRL-2522, designation BJ), mycoplasma-free and a kind gift of Dr. Drukker. MTA approval was obtained from the Helmholtz Zentrum München (HMGU), Germany. HMGU1 hiPSCs were cultured on Matrigel-coated plates (Corning, 354234; 5–10 µl matrigel dissolved in 1 ml cold DMEM-F12 for each well of a six-well culture plate) in mTeSR1 medium (STEMCELL Technologies; #85850). Medium was changed daily. HMGU1 cells were passaged with Versene (Thermo Fisher Scientific; 15040066) as previously described <xref ref-type="bibr" rid="bib11">Beers et al., 2012</xref>; briefly, cells were washed with 1 ml PBS1x (Thermo Fisher Scientific 14190169; or Sigma D8537), treated with Versene for up to 5 min, then detached by gently pipetting with 1 ml mTeSR1 medium. Alternatively, when single cell dissociation and cell counting were needed, HMGU1 cells were passaged with Accutase (Sigma; A6964). Single cells passaging required addition of 10 µM dihydrochloride ROCK inhibitor Y-27632 (MedChemExpress HY-10583; or Stem Cell Technologies #72304) to prevent apoptosis. ROCK inhibitor was removed 24 hr after dissociation. For immunostaining, cells were grown on glass coverslips (Epredia X1000 Round Coverslip dia. 13 mm, Product Code: 10513234) with the same medium and coating treatment.</p><sec id="s4-1"><title>hiPSCs quality controls</title><p>HMGU1 cells were checked for mycoplasma contamination once per year, while amplifying and preparing multiple cryovial aliquots that were used during the following months. Genetic/chromosomic analysis was performed by using the hPSC genetic Analysis kit (Stem Cell Technologies; #07550) by following the manufacturer’s instructions. Two different hiPSC lines (WT-T12, kind gift of Dr. Magdalena Laugsch, and PGP1, purchased from Synthego) were used as controls to be compared with HMGU1 cells. Briefly, hiPSC cell pellets were lysed with lysis buffer (1 M TRIS HCL pH8, 5 M NaCL, 0.5 M EDTA, 10% SDS in milli-Q H<sub>2</sub>O) supplemented with 10 mg/mL Proteinase K (Sigma, 0311580); lysis incubation was performed at 58 °C for 30 min. Genomic DNA was obtained by Isopropanol precipitation and 70% Ethanol cleaning. We detected frequent mutations in the HMGU1 cell line, and found that extended culture of hiPSCs caused chromosomal abnormalities to further accumulate in sensitive regions. To prevent this, we did not use HMGU1 cells after passage 26. Finally, pluripotency was checked by OCT4 immunostaining.</p></sec><sec id="s4-2"><title>Neural differentiation into telencephalic organoids</title><p>HMGU1 cells were seeded in Matrigel-coated 24 well-plates at a density of 25,000–50,000 cells per well and cultured in mTeSR1 medium till high confluency, which is key for efficient neural induction in this protocol (<xref ref-type="bibr" rid="bib24">Chambers et al., 2009</xref>). When highly confluent (90–95% surface covered), hiPSCs were washed with pre-warmed DMEM/F12 (Thermo Fisher Scientific; #31331028) then medium was switched to neural progenitor patterning medium (NPPM). NPPM consisted of DMEM/F12 supplemented with N2 (N-2 Supplement 100X; Thermo Fisher Scientific 17502–048), B27 (B-27 Supplement 50X, minus vitamin A; Thermo Fisher Scientific 12587–010), GlutaMAX (Thermo Fisher Scientific 35050038), Non-Essential Amino-Acid (NEAA; Thermo Fisher Scientific 11140–035), Sodium Pyruvate (NaPyr; Thermo Fisher Scientific #11360070), 50 µM 2-mercaptoethanol (Thermo Fisher Scientific 31350–010), 2 µg/mL Heparin (Sigma H3149) and Penicillin/Streptomycin (Biozol ECL-EC3001D). The latter could be substituted by Antibiotic/Antimycotic solution (Sigma A5955). Neural induction was boosted by adding a BMP inhibitor (0.25 µM LDN-193189; Sigma SML0559-5MG) and a TGFβ inhibitor (5 µM SB-431542; Sigma S4317-5MG) for the control condition (‘CTRL’ in figures); telencephalic induction also required use of a WNT inhibitor (2 µM XAV-939; Stem cell technologies 72674; ‘WNTi’ in figures). On day 7 (max on day 8) of the protocol, cells were dissociated by Accutase (Sigma; A6964) and seeded in 96 U-bottom well plates (Corning #7007; or Sarstedt 83.3925500) at a concentration of 60,000 cells/well, in NPPM medium containing ROCK inhibitor. A gentle centrifugation of the 96-well plate (1 min at 1000 rpm) allowed quick accumulation of the cells at the bottom of the wells. The day after, the embryoid bodies (EBs) were collected and transferred in Matrigel droplets (Corning 354234; 70 µl Matrigel for 16 EBs) to generate ‘cookies’, distributed on parafilm and incubated 30 min at 37 °C for Matrigel to solidify, then transferred in SpinΩ mini-rotors (<xref ref-type="bibr" rid="bib81">Qian et al., 2018</xref>) in NPPM medium (still supplemented with SB + LDN ± XAV; 2.5 ml per well in a 12-well plate). On day9 (max on day10), most of the medium was removed and replaced with NPPM without SB-431542 and LDN-193189, but still containing WNT-inhibitor. Starting on day10, FGF8 (100 ng/ML; Recombinant Human/Mouse FGF-8b Protein; R&amp;D 423-F8-025/CF) could be added to NPPM medium, that was then changed every 2–3 days, to create the treated condition (referred to in the text and figures as ‘WNTi + FGF8’). If medium showed excessively yellow color indicating pH acidification, cookies were diluted by redistributing in multiple wells to have a maximum of five cookies per well. At day 20, medium was switched for Neural Differentiation Medium (NDM) containing 50% DMEM-F-12 medium and 50% Neurobasal medium (ThermoFisher scientific 21103049) supplemented with N2, Glutamax, NEAA, NaPyr, 50 µM Beta-mercaptoethanol, 2 µg/mL Heparin and Insulin (25 µl per 100 ML medium; Sigma #19278). At day30 (max at day35), NDM was substituted with Long-term pro-Survival Medium (LTSM) consisting in Neurobasal medium supplemented with N2, B27 without Vitamin A, Glutamax, NEAA, NaPyr, 50 µM Beta-mercaptoethanol, 2 µg/mL Heparin, 1% Serum (Fetal Bovine Serum, ThermoFisher scientific 10270–106; inactivated for 30 min at 56 °C then aliquoted and stored at –20 °C), 10 ng/mL BDNF (PeproTech #450–02) and dissolved Matrigel (final concentration in the medium: 0.1%). Medium was changed every 3–4 days, until the desired differentiation stage. Starting at day50-60, bigger organoids were sliced with a sterile blade under the stereomicroscope (typically once per month), which allows for better survival and reduces the formation of an inner necrotic core (<xref ref-type="bibr" rid="bib83">Qian et al., 2020</xref>). Organoids were cultured up to 110 days.</p></sec><sec id="s4-3"><title>Real time qRT-PCR</title><p>Cell pellets or organoids (typically cell pellets from two independent wells or three organoids) were pooled and spun in 1.5 ml Eppendorf tubes, then frozen at –80 °C. Total RNA was extracted with NucleoSpin RNA II columns (Macherey-Nagel; 740902.50). RNA quantity and quality were assessed with Nanodrop and gel electrophoresis. For each sample, 200/500 ng of total RNA were reverse transcribed using random nonamers (Reverse Transcriptase Core Kit, Eurogentec, qRT-RTCK-03); qRT-PCR was performed using GoTaq SYBR Green qPCR Mix (Promega A6001) or KAPA SYBR<sup>R</sup> FAST (KAPA Biosystems; KK4610) on LightCycler (Roche). cDNA (stored at –20 °C) was diluted so that each reaction contained 2 ng. Amplification take-off values were evaluated using the built-in LightCycler relative quantification analysis function, and relative expression was calculated with the 2<sup>-ΔΔCt</sup> method as previously described (<xref ref-type="bibr" rid="bib12">Bertacchi et al., 2015a</xref>), normalizing to the housekeeping genes <italic>GAPDH</italic> or <italic>β-Actin</italic>. Standard errors for error bars were obtained from the error propagation formula (<xref ref-type="bibr" rid="bib12">Bertacchi et al., 2015a</xref>). For each genotype/time point, 2–3 organoids/cell pellets (biological replicates) were pooled together before RNA extraction, while at least two reactions were assembled per sample/gene analyzed during qRT-PCR amplification (technical replicates).</p></sec><sec id="s4-4"><title>Immunostaining on cryostat sections</title><p>Organoids were collected in 2 ml Eppendorf tubes and fixed in 2 ml of 4% PFA at 4 °C for 3–4 hr in gentle agitation, then washed twice with PBS 1 X and dehydrated in 10% sucrose (Sigma-Aldrich, S9378-1KG; dissolved in PBS1x; minimum 4 hr to maximum over-night) followed by 25% sucrose (dissolved in PBS1x; overnight at 4 °C). Most of the sucrose was removed and substituted with OCT resin (Leica Tissue Freezing Medium, 14020108926; or Cryomatrix, 6769006) with a 10 min wash with gentle rotation, then organoids were transferred in embedding molds in clean OCT and stored at –80 °C. Cryostat 12 µm sections (Leica cryostat, model: CM3050S) were collected on glass slides (Thermo Fisher Scientific, Superfrost Plus, J1800AMNZ, or VWR SuperFrost Plus, 631–0108) and stored at –80 °C. Prior starting immunostaining, sections were dried at RT for 10–15 min, then washed two times with PBS1x (10 min each) to remove traces of OCT resin. All antibodies required antigen retrieval prior to incubation (unmasking: 10 min at 95 °C in pH = 6 0.1 M sodium citrate solution). After a 5-min PBS1x wash to remove unmasking solution, pre-blocking solution was added on the slides for 1 hr, containing PBS1x with 5% serum (Sheep serum, Sigma, S2263-100ML; in case of primary antibodies raised in sheep or goat: Newborn Calf Serum, Thermo Fisher Scientific, 16010–167) and 0.3% Triton (Sigma-Aldrich, T8787-250ML). For primary antibody incubation (from a minimum of 4 hr at RT to a maximum of over-night at 4 °C), blocking solution consisted in PBS1x supplemented with 1% serum and 0.1% Triton. Primary antibodies used in this study are listed in <xref ref-type="table" rid="table2">Table 2</xref>. Alexa Fluor 488, 555, 594, and 647 anti-mouse, anti-rabbit, anti-rat, anti-goat, anti-guinea pig or anti-sheep IgG conjugates (Thermo Fisher Scientific, all diluted at 1:500) were used as secondary antibodies (incubation time: from a minimum of 2 hr at RT to a maximum of over-night at 4 °C). Secondary antibody solution also contained 1:1.000 Hoechst 33342 for nuclei staining (Invitrogen, H3570). After final washes (3 times, 10 min each, in PBS 1 x), organoid sections were covered with mounting solution (80% glycerol, 2% N-propyl gallate in PBS1x) and glass coverslips, which were sealed with nail polish on the edges. Stained sections were stored at –20 °C. Images were acquired at an Apotome Zeiss, using the AxioVision software, and exported as TIF files. Alternatively, images were collected using a Vectra Polaris slide scanner (Akoya Biosciences) and then underwent artificial intelligence-driven analysis by HALO software (Indica Labs).</p></sec><sec id="s4-5"><title>Immunostaining of cultured cells</title><p>For immunostaining, cells were cultured on Matrigel coated round glass coverslip. The immunostaining protocol is the same used for cryostat sections, except fixation with 4% paraformaldehyde lasted only 15 min at room temperature, no antigen retrieval was performed, and PBS1x for washes always contained 1% serum to limit cell detachment.</p></sec><sec id="s4-6"><title>Statistical analysis</title><p>All data were statistically analyzed and graphically represented using Microsoft Office Excel software or GraphPad Prism (Version 7.00). Quantitative data are shown as the mean ± SEM. For cell percentage/number quantification after immunostaining, measurements were performed on at least five sections coming from two to three different organoids, unless otherwise stated. Organoid sections with damaged histology were excluded from any further analysis/processing; the inner necrotic core of the organoid, when present, was excluded from counting. Microscope images were processed with Photoshop or ImageJ software, by randomly overlapping fixed-width (100 µm) square boxes on the area of interest [<italic>e.g.</italic> organoid surface], then quantifying positive cells inside the boxes. When calculating percentages over the total cell number, the latter was quantified by counting Hoechst+ nuclei, unless otherwise specified. Data were analyzed using the Mann–Whitney U-test or two-tailed Student’s t-test (when comparing two data groups), or by two-way ANOVA for comparison of three or more groups. Statistical significance was set as follows: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p></sec><sec id="s4-7"><title>MEA recordings</title><p>For MEA recordings, we used the high-density MEA system (HD-MEA) from MaxWell (Model: MaxOne; Chips: MaxOne single-well chips). Prior recordings, organoids were plated on electrodes by following the MaxWell ‘Brain organoid plating protocol, version 1’, with few modifications. Briefly, MEA chips were cleaned with 1% Terg-a-zyme solution for minimum 2 hr at RT, washed in distilled water and sterilized with 70% Ethanol. A first coating with Poly-L-ornithine hydrobromide (20 µg/ml in distilled water for 5 hr at 37 °C, Sigma P3655) was followed by a second one with Laminin (25 µg/ml in PBS1x, Santa Cruz, sc-29012). After a pre-incubation with LTSM medium (minimum 2 hr, maximum O/N at 37 °C; pre-conditioning medium was prepared as detailed in <italic>Neural differentiation into telencephalic organoids</italic> and supplemented with additional 5 µl Matrigel per 1 ml of medium) to pre-condition the chip surface, organoids were transferred on MEA chips (n=3/5 organoids per chip) and let deposit by gravity in the incubator, while avoiding any vibration for the next 24 hr. Medium was delicately changed every 3 days during a 2 week incubation on chip; during the second week, medium was gradually switched to LTSM that was prepared using BrainPhys (Stem Cell Technologies, #05790) as a base medium where to dilute the supplements. The organoids underwent complete adhesion within 1–2 weeks and interconnected with bundles of axons, a condition known to promote complex and oscillatory activity (<xref ref-type="bibr" rid="bib73">Osaki et al., 2024</xref>). Medium was always changed 1 day before the recording to promote electric activity. Recordings were performed with the MaxOne software, by using in-built protocol ‘Activity Scan Assay’ to detect active areas and to measure mean firing rate and mean spike amplitude, followed by the ‘Network Assay’ to evaluate firing synchronicity and by the ‘Axon Tracking Assay’ to detect signal propagation along axonal tracts. Average data were obtained by recording from the whole chip surface, hence pooling active electrodes from 3/4 organoids per condition. For statistical analysis (GraphPad; 2-way ANOVA), recording data were pooled from control (WNTi) and treated (WNTi + FGF8) samples from three distinct batches (each including 2–4 organoids on the MEA chip active surface), including three different developmental stages <italic>in vitro</italic> (Batch1: days 131–143; Batch2: days 202–215; Batch3: days 153–187). For the detection of synchronous events (bursts) in the ‘Network Assay’, the threshold was automatically determined by the MEA system. This threshold depended on a fixed multiplying factor that was consistent across both control and treated samples; the factor was then multiplied by the basal average activity of each individual sample. This method allowed for the detection of bursts as synchronized activity emerging from the basal noise, which varies in every sample. For the ‘Axon Tracking Assay’, a total of 170 WNTi and 165 WNTi + FGF8 axonal tracts were detected and analyzed from the three batches (see <xref ref-type="fig" rid="fig5">Figure 5</xref>). An ‘Axon Tracking Assay’ analysis was also performed separately at different developmental stages to investigate axonal maturation (see <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). For Bicuculline treatment on WNTi + FGF8 organoids (10 µM Bicuculline; Abcam, ab120107), 200 µl of medium were collected from the electrode, mixed with Bicuculline, added back to the MEA chip and gently mixed by pipetting. Recordings were conducted before (control condition) and after (treatment condition) the addition of Bicuculline, with a minimum drug incubation period of 15 minutes before starting the treatment condition recording.</p></sec><sec id="s4-8"><title>Cell dissociation for single-cell RNA sequencing and flow cytometry analysis</title><p>Day69 control (WNTi) and treated (WNTi + FGF8) organoids were dissociated using an enzymatic Papain Dissociation System (Serlabo technologies LK003150 or Worthington, #LK003150), by following manufacturer’s instructions. Low-bind Eppendorf tubes were used to limit material loss. Two to three organoids per batch were isolated in Eppendorf tubes containing 1 ml of pre-warmed Papain solution supplemented with DNase. Total incubation lasted 70 min, with manipulations every ten minutes that consisted in gentle mixing by tube inversion (first 2 rounds) then gentle pipetting (following rounds), ending up with addition of Ovomucoid solution for Papain inactivation. Samples were filtered (Cell Strainer 40 µm Nylon, FALCON, 352340) to remove undissociated cells, spinned down (1200 rpm, corresponding to 170 <italic>g</italic>, for 5 minutes) and resuspended in PBS1x supplemented with 0.1% BSA (Jackson, 001-000-161). Cell viability upon dissociation was checked by Propidium Iodide (PI) staining in flow cytometry in an independent experiment, where Papain was compared with Accutase and with ReLeSR (Stem Cell Technologies, #100–0483). For flow cytometry, cells were stained with Propidium Iodide (40 µg/ML, Sigma, P4170) in PBS1x for 15 min at RT, washed twice with PBS1x supplemented with 1% Serum, then analysed with BD LSRFortessa and FACSDiva software (Becton Dickinson) to measure dying cells which incorporated PI. Cells were analysed on the basis of 10,000 total events (debris excluded). Cell viability was tested again by Trypan blue staining just prior cell counting for library preparation, and samples were considered suitable for single cell RNA sequencing only when damaged cells detected by Trypan blue or by PI staining were ≤10% of the total population.</p></sec><sec id="s4-9"><title>Single-cell RNA sequencing: library preparation and sequencing</title><p>Single-cell RNA sequencing experiment was performed by using 10 X Genomics technology. Dissociated cells were processed following the manufactures’ instruction of Chromium Next GEM Single Cell 3ʹ Reagent Kits v3.1 (Dual Index). Briefly, they were resuspended in ice-cold PBS containing 0.1% BSA at a concentration of 1000 cells/μl, and approximately 17,400 cells per channel (corresponding to an estimated recovery of 10,000 cells per channel) were loaded onto a Chromium Single Cell 3′ Chip (10 x Genomics, PN 2000177) and processed through the Chromium controller to generate single-cell gel beads in emulsion (GEMs). scRNA-seq libraries were prepared with the Chromium Single Cell 3′ Library &amp; Gel Bead Kit v.2 (10x Genomics, PN-120237). Final cDNA libraries were checked for quality and quantified using 2100 Bioanalyzer (High Sensitivity DNA Assay; Agilent Technologies). Libraries were sequenced using Illumina HiSeq 4000 system in Paired-End mode with 100 or 28 bases for read 1 and 100 bases for read 2, following Illumina’s instructions. Image analysis and base calling were performed using RTA version 2.7.2 and Cell Ranger version 3.0.2.</p></sec><sec id="s4-10"><title>Single-cell RNA sequencing: analysis</title><sec id="s4-10-1"><title>Primary analysis</title><p>FastQ files of each sample were processed with Cell Ranger count pipeline (10 X Genomics) version 6.1.1, that performs alignment, filtering, barcode counting, and UMI counting, using the pre-processed <italic>Homo sapiens</italic> reference GRCh38-2020-A (GENCODE v32/Ensembl 98) from 10 X Genomics. Data were then aggregated using Cell Ranger aggr tool which normalizes counts to the same sequencing depth and then recomputing the feature-barcode matrices and analysis (dimensionality reduction, <italic>i.e</italic>. UMAP, and clustering) on the combined data (24,651 cells).A subset of cells expressing endoderm or mesoderm markers (1662 cells, corresponding to 6.7% of the total population) and a subset of cells expressing high levels of stress markers (4399 cells, corresponding to 17.8% of the total population) were excluded, and analysis (dimensionality reduction and clustering) was performed again after exclusion of these non-neural and/or sub-optimally differentiated cell populations using Cell Ranger reanalyse tool, resulting a set of 18,590 cells regrouped in 15 clusters. More information about Cell ranger software can be found on the manufacturer website (<ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/software/overview/welcome">https://support.10xgenomics.com/single-cell-gene-expression/software/overview/welcome</ext-link>).</p></sec><sec id="s4-10-2"><title>Trajectory analysis</title><p>Count data were normalized with the log normalize method using Seurat R package version 4.0.5 then filtered by keeping only genes with more than 5 UMI counts detected in at least 10 cells. Four analyses were performed: one with all cells (clusters 1–15), final data used in the analysis contained 18,590 cells and 7133 genes; one for ventral progenitors (only WNTi + FGF8 cells belonging to clusters 6, 7, 8, 9, and 13) with 4608 cells and 5382 genes; one for dorsal progenitors (only WNTi cells belonging to clusters 1, 2, 3, 4, 5, 12, 13, 14, and 15) with 8246 cells and 5827 genes; and the last one for all progenitors (dorsal + ventral; cells belonging to clusters 2, 5, 8, 9, 12, 13, 14, and 15) with 8876 cells and 6452 genes. Trajectory inference analyses were performed using slingshot method (<xref ref-type="bibr" rid="bib106">Street et al., 2018</xref>) implemented in the dyno package (<xref ref-type="bibr" rid="bib92">Saelens et al., 2019</xref>).</p></sec><sec id="s4-10-3"><title>VoxHunt analysis</title><p>Similarity maps between single-cell data and the public Allen Developing Mouse Brain Atlas expression data, stage E13, were computed using the VoxHunt R package version 1.0.1 (<xref ref-type="bibr" rid="bib35">Fleck et al., 2021</xref>).</p></sec><sec id="s4-10-4"><title>Analyses of differentially expressed genes (DEGs) and Gene enrichment</title><p>Count data were normalized with the log normalize method using Seurat R package version 4.0.5 before performing the analysis (<xref ref-type="bibr" rid="bib21">Butler et al., 2018</xref>). Differential gene expression analyses, realized with Seurat, between clusters of interest are performed using a Wilcoxon test whose performance for single-cell differential expression analysis has been evaluated in a previous report (<xref ref-type="bibr" rid="bib101">Soneson and Robinson, 2018</xref>) and resulting p-values were adjusted for multiple testing using a Bonferroni correction. Enrichment analyses were performed on differentially expressed genes previously identified using cluster Profiler R package version 4.2.0 with Gene Set Enrichment Analysis (GSEA) method (<xref ref-type="bibr" rid="bib107">Subramanian et al., 2005</xref>). Genes were ranked by their log2 Fold-Change. Enrichment analyses are performed on the three domains of GO (Gene Ontology) terms: biological process; molecular function; and cellular component.</p></sec><sec id="s4-10-5"><title>Cluster annotation with SingleR</title><p>Annotation of Neurones_CTRL (clusters 1, 3, and 4 of WNTi cells), Neurones_FGF8 (clusters 1, 3, and 4 of WNTi + FGF8 cells), Progeniteurs_CTRL (clusters 2, 5, 12, 14, and 15 of WNTi cells) and Progeniteurs_FGF8 (clusters 2, 5, 12, 14, and 15 of WNTi + FGF8 cells) cells at the cluster and cell levels were performed with SingleR version 2.0.0 R package (<xref ref-type="bibr" rid="bib6">Aran et al., 2019</xref>) using a previously published primary cell dataset (<xref ref-type="bibr" rid="bib102">Speir et al., 2021</xref>). In this reference dataset, only cells corresponding to 16 PCW age and not to hippocampus area were kept. Before performing the annotation both datasets were normalized using the LogNormalize method implemented in the Seurat R package version 4.3.0 (<xref ref-type="bibr" rid="bib42">Hao et al., 2021</xref>). <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref> shows a heatmap of the SingleR assignment scores as well as the corresponding inferred annotation for the clusters/cells. Scores allows users to inspect the confidence of the predicted labels across the dataset. Ideally, each cell/cluster (<italic>i.e.</italic> column of the heatmap) should have one score that is obviously larger than the rest, indicating that it is unambiguously assigned to a single label. A spread of similar scores for a given cell/cluster indicates that the assignment is uncertain, although this may be acceptable if the uncertainty is distributed across similar cell/cluster types that cannot be easily resolved.</p></sec></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Data curation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Validation, Investigation, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-98096-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The raw data from the single-cell RNA sequencing (scRNA-seq) experiments have been deposited in the NCBI Gene Expression Omnibus (GEO) and are publicly available under the accession number GSE276558. Further details can be accessed at the linked repository. Additional data for the graphs of immunostaining pixel intensity, cell counting, or real-time qRT-PCR are provided as Source data linked to the images.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Bertacchi</surname><given-names>M</given-names></name><name><surname>Jung</surname><given-names>M</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>FGF8-mediated gene regulation affects regional identity in human cerebral organoids</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276558">GSE276558</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr Micha Drukker for the kind gift of HMGU1 human iPS cells, and the GenomEast platform in Strasbourg, France, for the Illumina HiSeq 4000 Sequencing. We are grateful to Samah Rekima for the technical help with the iBV histology facility, and we also thank the iBV PRISM Microscopy facility for their regular support. This work was funded by the French Government (National Research Agency, ANR) through the ‘Investments for the Future’ programs IDEX UCAJedi ANR-15-IDEX-01, by the “Fondation pour la Recherche Médicale (Equipe FRM2020)” (#EQU202003010222), “Fondation de France” (#00123416), ERA-NET NEURON JTC21(ANR-21-NEU2-0003-03) grants to MS, by the “France Génomique” consortium (#ANR-10-INBS-0009) to MJ and by INSERM funding (“Dotation exceptionnelle prise de fonctions”) to MB.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfano</surname><given-names>C</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neocortical arealization: Evolution, mechanisms, and open questions: Evolution and Development of Neocortical Areas</article-title><source>Developmental Neurobiology</source><volume>73</volume><fpage>411</fpage><lpage>447</lpage></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alzu’bi</surname><given-names>A</given-names></name><name><surname>Lindsay</surname><given-names>SJ</given-names></name><name><surname>Harkin</surname><given-names>LF</given-names></name><name><surname>McIntyre</surname><given-names>J</given-names></name><name><surname>Lisgo</surname><given-names>SN</given-names></name><name><surname>Clowry</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>The transcription factors COUP-TFI and COUP-TFII have distinct roles in arealisation and GABAergic interneuron specification in the early human fetal telencephalon</article-title><source>Cerebral Cortex</source><volume>27</volume><fpage>4971</fpage><lpage>4987</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhx185</pub-id><pub-id pub-id-type="pmid">28922831</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alzu’bi</surname><given-names>A</given-names></name><name><surname>Lindsay</surname><given-names>S</given-names></name><name><surname>Kerwin</surname><given-names>J</given-names></name><name><surname>Looi</surname><given-names>SJ</given-names></name><name><surname>Khalil</surname><given-names>F</given-names></name><name><surname>Clowry</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Distinct cortical and sub-cortical neurogenic domains for GABAergic interneuron precursor transcription factors NKX2.1, OLIG2 and COUP-TFII in early fetal human telencephalon</article-title><source>Brain Structure &amp; Function</source><volume>222</volume><fpage>2309</fpage><lpage>2328</lpage><pub-id pub-id-type="doi">10.1007/s00429-016-1343-5</pub-id><pub-id pub-id-type="pmid">27905023</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alzu’bi</surname><given-names>A</given-names></name><name><surname>Clowry</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Expression of ventral telencephalon transcription factors ASCL1 and DLX2 in the early fetal human cerebral cortex</article-title><source>Journal of Anatomy</source><volume>235</volume><fpage>555</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1111/joa.12971</pub-id><pub-id pub-id-type="pmid">30861584</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amaral</surname><given-names>DG</given-names></name><name><surname>Schumann</surname><given-names>CM</given-names></name><name><surname>Nordahl</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Neuroanatomy of autism</article-title><source>Trends in Neurosciences</source><volume>31</volume><fpage>137</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2007.12.005</pub-id><pub-id pub-id-type="pmid">18258309</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aran</surname><given-names>D</given-names></name><name><surname>Looney</surname><given-names>AP</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>E</given-names></name><name><surname>Fong</surname><given-names>V</given-names></name><name><surname>Hsu</surname><given-names>A</given-names></name><name><surname>Chak</surname><given-names>S</given-names></name><name><surname>Naikawadi</surname><given-names>RP</given-names></name><name><surname>Wolters</surname><given-names>PJ</given-names></name><name><surname>Abate</surname><given-names>AR</given-names></name><name><surname>Butte</surname><given-names>AJ</given-names></name><name><surname>Bhattacharya</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage</article-title><source>Nature Immunology</source><volume>20</volume><fpage>163</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0276-y</pub-id><pub-id pub-id-type="pmid">30643263</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armentano</surname><given-names>M</given-names></name><name><surname>Filosa</surname><given-names>A</given-names></name><name><surname>Andolfi</surname><given-names>G</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>COUP-TFI is required for the formation of commissural projections in the forebrain by regulating axonal growth</article-title><source>Development</source><volume>133</volume><fpage>4151</fpage><lpage>4162</lpage><pub-id pub-id-type="doi">10.1242/dev.02600</pub-id><pub-id pub-id-type="pmid">17021036</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armentano</surname><given-names>M</given-names></name><name><surname>Chou</surname><given-names>SJ</given-names></name><name><surname>Tomassy</surname><given-names>GS</given-names></name><name><surname>Leingärtner</surname><given-names>A</given-names></name><name><surname>O’Leary</surname><given-names>DDM</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>COUP-TFI regulates the balance of cortical patterning between frontal/motor and sensory areas</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>1277</fpage><lpage>1286</lpage><pub-id pub-id-type="doi">10.1038/nn1958</pub-id><pub-id pub-id-type="pmid">17828260</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assimacopoulos</surname><given-names>S</given-names></name><name><surname>Kao</surname><given-names>T</given-names></name><name><surname>Issa</surname><given-names>NP</given-names></name><name><surname>Grove</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fibroblast growth factor 8 organizes the neocortical area map and regulates sensory map topography</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>7191</fpage><lpage>7201</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0071-12.2012</pub-id><pub-id pub-id-type="pmid">22623663</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagley</surname><given-names>JA</given-names></name><name><surname>Reumann</surname><given-names>D</given-names></name><name><surname>Bian</surname><given-names>S</given-names></name><name><surname>Lévi-Strauss</surname><given-names>J</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Fused cerebral organoids model interactions between brain regions</article-title><source>Nature Methods</source><volume>14</volume><fpage>743</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4304</pub-id><pub-id pub-id-type="pmid">28504681</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beers</surname><given-names>J</given-names></name><name><surname>Gulbranson</surname><given-names>DR</given-names></name><name><surname>George</surname><given-names>N</given-names></name><name><surname>Siniscalchi</surname><given-names>LI</given-names></name><name><surname>Jones</surname><given-names>J</given-names></name><name><surname>Thomson</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions</article-title><source>Nature Protocols</source><volume>7</volume><fpage>2029</fpage><lpage>2040</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.130</pub-id><pub-id pub-id-type="pmid">23099485</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertacchi</surname><given-names>M</given-names></name><name><surname>Lupo</surname><given-names>G</given-names></name><name><surname>Pandolfini</surname><given-names>L</given-names></name><name><surname>Casarosa</surname><given-names>S</given-names></name><name><surname>D’Onofrio</surname><given-names>M</given-names></name><name><surname>Pedersen</surname><given-names>RA</given-names></name><name><surname>Harris</surname><given-names>WA</given-names></name><name><surname>Cremisi</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Activin/Nodal signaling supports retinal progenitor specification in a narrow time window during pluripotent stem cell neuralization</article-title><source>Stem Cell Reports</source><volume>5</volume><fpage>532</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2015.08.011</pub-id><pub-id pub-id-type="pmid">26388287</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertacchi</surname><given-names>M</given-names></name><name><surname>Pandolfini</surname><given-names>L</given-names></name><name><surname>D’Onofrio</surname><given-names>M</given-names></name><name><surname>Brandi</surname><given-names>R</given-names></name><name><surname>Cremisi</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>The double inhibition of endogenously produced BMP and Wnt factors synergistically triggers dorsal telencephalic differentiation of mouse ES cells</article-title><source>Developmental Neurobiology</source><volume>75</volume><fpage>66</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1002/dneu.22209</pub-id><pub-id pub-id-type="pmid">25044881</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertacchi</surname><given-names>M</given-names></name><name><surname>Parisot</surname><given-names>J</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The pleiotropic transcriptional regulator COUP-TFI plays multiple roles in neural development and disease</article-title><source>Brain Research</source><volume>1705</volume><fpage>75</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2018.04.024</pub-id><pub-id pub-id-type="pmid">29709504</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertacchi</surname><given-names>M</given-names></name><name><surname>Tocco</surname><given-names>C</given-names></name><name><surname>Schaaf</surname><given-names>CP</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pathophysiological heterogeneity of the BBSOA neurodevelopmental syndrome</article-title><source>Cells</source><volume>11</volume><elocation-id>1260</elocation-id><pub-id pub-id-type="doi">10.3390/cells11081260</pub-id><pub-id pub-id-type="pmid">35455940</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaduri</surname><given-names>A</given-names></name><name><surname>Andrews</surname><given-names>MG</given-names></name><name><surname>Mancia Leon</surname><given-names>W</given-names></name><name><surname>Jung</surname><given-names>D</given-names></name><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Allen</surname><given-names>D</given-names></name><name><surname>Jung</surname><given-names>D</given-names></name><name><surname>Schmunk</surname><given-names>G</given-names></name><name><surname>Haeussler</surname><given-names>M</given-names></name><name><surname>Salma</surname><given-names>J</given-names></name><name><surname>Pollen</surname><given-names>AA</given-names></name><name><surname>Nowakowski</surname><given-names>TJ</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cell stress in cortical organoids impairs molecular subtype specification</article-title><source>Nature</source><volume>578</volume><fpage>142</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-1962-0</pub-id><pub-id pub-id-type="pmid">31996853</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borello</surname><given-names>U</given-names></name><name><surname>Pierani</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Patterning the cerebral cortex: traveling with morphogens</article-title><source>Current Opinion in Genetics &amp; Development</source><volume>20</volume><fpage>408</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2010.05.003</pub-id><pub-id pub-id-type="pmid">20542680</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>DGM</given-names></name><name><surname>Boonstra</surname><given-names>FN</given-names></name><name><surname>Gonzaga-Jauregui</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>de Ligt</surname><given-names>J</given-names></name><name><surname>Jhangiani</surname><given-names>S</given-names></name><name><surname>Wiszniewski</surname><given-names>W</given-names></name><name><surname>Muzny</surname><given-names>DM</given-names></name><name><surname>Yntema</surname><given-names>HG</given-names></name><name><surname>Pfundt</surname><given-names>R</given-names></name><name><surname>Vissers</surname><given-names>L</given-names></name><name><surname>Spruijt</surname><given-names>L</given-names></name><name><surname>Blokland</surname><given-names>EAW</given-names></name><name><surname>Chen</surname><given-names>CA</given-names></name><collab>Baylor-Hopkins Center for Mendelian Genomics</collab><name><surname>Lewis</surname><given-names>RA</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>Lupski</surname><given-names>JR</given-names></name><name><surname>Zoghbi</surname><given-names>HY</given-names></name><name><surname>Cremers</surname><given-names>FPM</given-names></name><name><surname>de Vries</surname><given-names>BBA</given-names></name><name><surname>Schaaf</surname><given-names>CP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>NR2F1 mutations cause optic atrophy with intellectual disability</article-title><source>American Journal of Human Genetics</source><volume>94</volume><fpage>303</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2014.01.002</pub-id><pub-id pub-id-type="pmid">24462372</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosone</surname><given-names>C</given-names></name><name><surname>Elisabetta Barilà</surname><given-names>S</given-names></name><name><surname>Krenn</surname><given-names>V</given-names></name><name><surname>A. Knoblich</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Detailed Culture Protocol for the Generation of Human Polarized Cortical Assembloids (polCA) V1</article-title><source>Protocol Exchange</source><volume>1</volume><elocation-id>4r3l2qyz4l1y/v1</elocation-id><pub-id pub-id-type="doi">10.17504/protocols.io.4r3l2qyz4l1y/v1</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britz</surname><given-names>O</given-names></name><name><surname>Mattar</surname><given-names>P</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name><name><surname>Langevin</surname><given-names>LM</given-names></name><name><surname>Zimmer</surname><given-names>C</given-names></name><name><surname>Alam</surname><given-names>S</given-names></name><name><surname>Guillemot</surname><given-names>F</given-names></name><name><surname>Schuurmans</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A role for proneural genes in the maturation of cortical progenitor cells</article-title><source>Cerebral Cortex</source><volume>16 Suppl 1</volume><fpage>i138</fpage><lpage>i151</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhj168</pub-id><pub-id pub-id-type="pmid">16766700</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><pub-id pub-id-type="pmid">29608179</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadwell</surname><given-names>CR</given-names></name><name><surname>Bhaduri</surname><given-names>A</given-names></name><name><surname>Mostajo-Radji</surname><given-names>MA</given-names></name><name><surname>Keefe</surname><given-names>MG</given-names></name><name><surname>Nowakowski</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Development and arealization of the cerebral cortex</article-title><source>Neuron</source><volume>103</volume><fpage>980</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.07.009</pub-id><pub-id pub-id-type="pmid">31557462</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cederquist</surname><given-names>GY</given-names></name><name><surname>Asciolla</surname><given-names>JJ</given-names></name><name><surname>Tchieu</surname><given-names>J</given-names></name><name><surname>Walsh</surname><given-names>RM</given-names></name><name><surname>Cornacchia</surname><given-names>D</given-names></name><name><surname>Resh</surname><given-names>MD</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Specification of positional identity in forebrain organoids</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>436</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0085-3</pub-id><pub-id pub-id-type="pmid">30936566</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>SM</given-names></name><name><surname>Fasano</surname><given-names>CA</given-names></name><name><surname>Papapetrou</surname><given-names>EP</given-names></name><name><surname>Tomishima</surname><given-names>M</given-names></name><name><surname>Sadelain</surname><given-names>M</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling</article-title><source>Nature Biotechnology</source><volume>27</volume><fpage>275</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/nbt.1529</pub-id><pub-id pub-id-type="pmid">19252484</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CA</given-names></name><name><surname>Bosch</surname><given-names>DGM</given-names></name><name><surname>Cho</surname><given-names>MT</given-names></name><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><name><surname>Shinawi</surname><given-names>M</given-names></name><name><surname>Lewis</surname><given-names>RA</given-names></name><name><surname>Mann</surname><given-names>J</given-names></name><name><surname>Jayakar</surname><given-names>P</given-names></name><name><surname>Payne</surname><given-names>K</given-names></name><name><surname>Walsh</surname><given-names>L</given-names></name><name><surname>Moss</surname><given-names>T</given-names></name><name><surname>Schreiber</surname><given-names>A</given-names></name><name><surname>Schoonveld</surname><given-names>C</given-names></name><name><surname>Monaghan</surname><given-names>KG</given-names></name><name><surname>Elmslie</surname><given-names>F</given-names></name><name><surname>Douglas</surname><given-names>G</given-names></name><name><surname>Boonstra</surname><given-names>FN</given-names></name><name><surname>Millan</surname><given-names>F</given-names></name><name><surname>Cremers</surname><given-names>FPM</given-names></name><name><surname>McKnight</surname><given-names>D</given-names></name><name><surname>Richard</surname><given-names>G</given-names></name><name><surname>Juusola</surname><given-names>J</given-names></name><name><surname>Kendall</surname><given-names>F</given-names></name><name><surname>Ramsey</surname><given-names>K</given-names></name><name><surname>Anyane-Yeboa</surname><given-names>K</given-names></name><name><surname>Malkin</surname><given-names>E</given-names></name><name><surname>Chung</surname><given-names>WK</given-names></name><name><surname>Niyazov</surname><given-names>D</given-names></name><name><surname>Pascual</surname><given-names>JM</given-names></name><name><surname>Walkiewicz</surname><given-names>M</given-names></name><name><surname>Veluchamy</surname><given-names>V</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Hisama</surname><given-names>FM</given-names></name><name><surname>de Vries</surname><given-names>BBA</given-names></name><name><surname>Schaaf</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The expanding clinical phenotype of Bosch-Boonstra-Schaaf optic atrophy syndrome: 20 new cases and possible genotype-phenotype correlations</article-title><source>Genetics in Medicine</source><volume>18</volume><fpage>1143</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1038/gim.2016.18</pub-id><pub-id pub-id-type="pmid">26986877</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiaradia</surname><given-names>I</given-names></name><name><surname>Lancaster</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>1496</fpage><lpage>1508</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-00730-3</pub-id><pub-id pub-id-type="pmid">33139941</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cholfin</surname><given-names>JA</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Patterning of frontal cortex subdivisions by Fgf17</article-title><source>PNAS</source><volume>104</volume><fpage>7652</fpage><lpage>7657</lpage><pub-id pub-id-type="doi">10.1073/pnas.0702225104</pub-id><pub-id pub-id-type="pmid">17442747</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cholfin</surname><given-names>JA</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Frontal cortex subdivision patterning is coordinately regulated by Fgf8, Fgf17, and Emx2</article-title><source>The Journal of Comparative Neurology</source><volume>509</volume><fpage>144</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1002/cne.21709</pub-id><pub-id pub-id-type="pmid">18459137</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clowry</surname><given-names>GJ</given-names></name><name><surname>Alzu’bi</surname><given-names>A</given-names></name><name><surname>Harkin</surname><given-names>LF</given-names></name><name><surname>Sarma</surname><given-names>S</given-names></name><name><surname>Kerwin</surname><given-names>J</given-names></name><name><surname>Lindsay</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Charting the protomap of the human telencephalon</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>76</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.08.033</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crossley</surname><given-names>PH</given-names></name><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Midbrain development induced by FGF8 in the chick embryo</article-title><source>Nature</source><volume>380</volume><fpage>66</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/380066a0</pub-id><pub-id pub-id-type="pmid">8598907</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>RN</given-names></name><name><surname>Allen</surname><given-names>DE</given-names></name><name><surname>Keefe</surname><given-names>MG</given-names></name><name><surname>Mancia Leon</surname><given-names>WR</given-names></name><name><surname>Ziffra</surname><given-names>RS</given-names></name><name><surname>Crouch</surname><given-names>EE</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A</given-names></name><name><surname>Nowakowski</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Individual human cortical progenitors can produce excitatory and inhibitory neurons</article-title><source>Nature</source><volume>601</volume><fpage>397</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-04230-7</pub-id><pub-id pub-id-type="pmid">34912114</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delli Carri</surname><given-names>A</given-names></name><name><surname>Onorati</surname><given-names>M</given-names></name><name><surname>Castiglioni</surname><given-names>V</given-names></name><name><surname>Faedo</surname><given-names>A</given-names></name><name><surname>Camnasio</surname><given-names>S</given-names></name><name><surname>Toselli</surname><given-names>M</given-names></name><name><surname>Biella</surname><given-names>G</given-names></name><name><surname>Cattaneo</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Human pluripotent stem cell differentiation into authentic striatal projection neurons</article-title><source>Stem Cell Reviews and Reports</source><volume>9</volume><fpage>461</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1007/s12015-013-9441-8</pub-id><pub-id pub-id-type="pmid">23625190</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eze</surname><given-names>UC</given-names></name><name><surname>Bhaduri</surname><given-names>A</given-names></name><name><surname>Haeussler</surname><given-names>M</given-names></name><name><surname>Nowakowski</surname><given-names>TJ</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell atlas of early human brain development highlights heterogeneity of human neuroepithelial cells and early radial glia</article-title><source>Nature Neuroscience</source><volume>24</volume><fpage>584</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-00794-1</pub-id><pub-id pub-id-type="pmid">33723434</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>SE</given-names></name><name><surname>Scharff</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>FOXP2 as a molecular window into speech and language</article-title><source>Trends in Genetics</source><volume>25</volume><fpage>166</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2009.03.002</pub-id><pub-id pub-id-type="pmid">19304338</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleck</surname><given-names>JS</given-names></name><name><surname>Sanchís-Calleja</surname><given-names>F</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Santel</surname><given-names>M</given-names></name><name><surname>Boyle</surname><given-names>MJ</given-names></name><name><surname>Camp</surname><given-names>JG</given-names></name><name><surname>Treutlein</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Resolving organoid brain region identities by mapping single-cell genomic data to reference atlases</article-title><source>Cell Stem Cell</source><volume>28</volume><fpage>1148</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2021.02.015</pub-id><pub-id pub-id-type="pmid">33711282</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foglio</surname><given-names>B</given-names></name><name><surname>Rossini</surname><given-names>L</given-names></name><name><surname>Garbelli</surname><given-names>R</given-names></name><name><surname>Regondi</surname><given-names>MC</given-names></name><name><surname>Mercurio</surname><given-names>S</given-names></name><name><surname>Bertacchi</surname><given-names>M</given-names></name><name><surname>Avagliano</surname><given-names>L</given-names></name><name><surname>Bulfamante</surname><given-names>G</given-names></name><name><surname>Coras</surname><given-names>R</given-names></name><name><surname>Maiorana</surname><given-names>A</given-names></name><name><surname>Nicolis</surname><given-names>S</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name><name><surname>Frassoni</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Dynamic expression of NR2F1 and SOX2 in developing and adult human cortex: comparison with cortical malformations</article-title><source>Brain Structure &amp; Function</source><volume>226</volume><fpage>1303</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1007/s00429-021-02242-7</pub-id><pub-id pub-id-type="pmid">33661352</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fremeau</surname><given-names>RT</given-names><suffix>Jr</suffix></name><name><surname>Voglmaier</surname><given-names>S</given-names></name><name><surname>Seal</surname><given-names>RP</given-names></name><name><surname>Edwards</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate</article-title><source>Trends in Neurosciences</source><volume>27</volume><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2003.11.005</pub-id><pub-id pub-id-type="pmid">15102489</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuchi-Shimogori</surname><given-names>T</given-names></name><name><surname>Grove</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Neocortex patterning by the secreted signaling molecule FGF8</article-title><source>Science</source><volume>294</volume><fpage>1071</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1126/science.1064252</pub-id><pub-id pub-id-type="pmid">11567107</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garel</surname><given-names>S</given-names></name><name><surname>Huffman</surname><given-names>KJ</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Molecular regionalization of the neocortex is disrupted in Fgf8 hypomorphic mutants</article-title><source>Development</source><volume>130</volume><fpage>1903</fpage><lpage>1914</lpage><pub-id pub-id-type="doi">10.1242/dev.00416</pub-id><pub-id pub-id-type="pmid">12642494</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaspard</surname><given-names>N</given-names></name><name><surname>Bouschet</surname><given-names>T</given-names></name><name><surname>Herpoel</surname><given-names>A</given-names></name><name><surname>Naeije</surname><given-names>G</given-names></name><name><surname>van den Ameele</surname><given-names>J</given-names></name><name><surname>Vanderhaeghen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Generation of cortical neurons from mouse embryonic stem cells</article-title><source>Nature Protocols</source><volume>4</volume><fpage>1454</fpage><lpage>1463</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.157</pub-id><pub-id pub-id-type="pmid">19798080</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillemot</surname><given-names>F</given-names></name><name><surname>Zimmer</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>From cradle to grave: the multiple roles of fibroblast growth factors in neural development</article-title><source>Neuron</source><volume>71</volume><fpage>574</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.08.002</pub-id><pub-id pub-id-type="pmid">21867876</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id><pub-id pub-id-type="pmid">34062119</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fgf8 signaling for development of the midbrain and hindbrain</article-title><source>Development, Growth &amp; Differentiation</source><volume>58</volume><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1111/dgd.12293</pub-id><pub-id pub-id-type="pmid">27273073</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hébert</surname><given-names>JM</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Partanen</surname><given-names>J</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>McConnell</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>FGF signaling through FGFR1 is required for olfactory bulb morphogenesis</article-title><source>Development</source><volume>130</volume><fpage>1101</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1242/dev.00334</pub-id><pub-id pub-id-type="pmid">12571102</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hevner</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The cerebral cortex malformation in thanatophoric dysplasia: neuropathology and pathogenesis</article-title><source>Acta Neuropathologica</source><volume>110</volume><fpage>208</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1007/s00401-005-1059-8</pub-id><pub-id pub-id-type="pmid">16133544</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoch</surname><given-names>RV</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name><name><surname>Pleasure</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genes and signaling events that establish regional patterning of the mammalian forebrain</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>20</volume><fpage>378</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2009.02.005</pub-id><pub-id pub-id-type="pmid">19560042</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoch</surname><given-names>RV</given-names></name><name><surname>Clarke</surname><given-names>JA</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fgf signaling controls the telencephalic distribution of Fgf-expressing progenitors generated in the rostral patterning center</article-title><source>Neural Development</source><volume>10</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.1186/s13064-015-0037-7</pub-id><pub-id pub-id-type="pmid">25889070</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hori</surname><given-names>K</given-names></name><name><surname>Shimaoka</surname><given-names>K</given-names></name><name><surname>Hoshino</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title><italic>AUTS2</italic> gene: keys to understanding the pathogenesis of neurodevelopmental disorders</article-title><source>Cells</source><volume>11</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.3390/cells11010011</pub-id><pub-id pub-id-type="pmid">35011572</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>PS</given-names></name><name><surname>hAilín</surname><given-names>DÓ</given-names></name><name><surname>Vogel</surname><given-names>T</given-names></name><name><surname>Hanashima</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transcription and beyond: delineating FOXG1 function in cortical development and disorders</article-title><source>Frontiers in Cellular Neuroscience</source><volume>14</volume><elocation-id>35</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2020.00035</pub-id><pub-id pub-id-type="pmid">32158381</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inglis-Broadgate</surname><given-names>SL</given-names></name><name><surname>Thomson</surname><given-names>RE</given-names></name><name><surname>Pellicano</surname><given-names>F</given-names></name><name><surname>Tartaglia</surname><given-names>MA</given-names></name><name><surname>Pontikis</surname><given-names>CC</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic development</article-title><source>Developmental Biology</source><volume>279</volume><fpage>73</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2004.11.035</pub-id><pub-id pub-id-type="pmid">15708559</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>M</given-names></name><name><surname>Mikoshiba</surname><given-names>K</given-names></name><name><surname>Aruga</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Zic1 and Zic3 regulate medial forebrain development through expansion of neuronal progenitors</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>5461</fpage><lpage>5473</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4046-06.2007</pub-id><pub-id pub-id-type="pmid">17507568</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadoshima</surname><given-names>T</given-names></name><name><surname>Sakaguchi</surname><given-names>H</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Soen</surname><given-names>M</given-names></name><name><surname>Ando</surname><given-names>S</given-names></name><name><surname>Eiraku</surname><given-names>M</given-names></name><name><surname>Sasai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell-derived neocortex</article-title><source>PNAS</source><volume>110</volume><fpage>20284</fpage><lpage>20289</lpage><pub-id pub-id-type="doi">10.1073/pnas.1315710110</pub-id><pub-id pub-id-type="pmid">24277810</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SN</given-names></name><name><surname>Viswanadham</surname><given-names>VV</given-names></name><name><surname>Doan</surname><given-names>RN</given-names></name><name><surname>Dou</surname><given-names>Y</given-names></name><name><surname>Bizzotto</surname><given-names>S</given-names></name><name><surname>Khoshkhoo</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>AY</given-names></name><name><surname>Yeh</surname><given-names>R</given-names></name><name><surname>Chhouk</surname><given-names>B</given-names></name><name><surname>Truong</surname><given-names>A</given-names></name><name><surname>Chappell</surname><given-names>KM</given-names></name><name><surname>Beaudin</surname><given-names>M</given-names></name><name><surname>Barton</surname><given-names>A</given-names></name><name><surname>Akula</surname><given-names>SK</given-names></name><name><surname>Rento</surname><given-names>L</given-names></name><name><surname>Lodato</surname><given-names>M</given-names></name><name><surname>Ganz</surname><given-names>J</given-names></name><name><surname>Szeto</surname><given-names>RA</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Tsai</surname><given-names>JW</given-names></name><name><surname>Hill</surname><given-names>RS</given-names></name><name><surname>Park</surname><given-names>PJ</given-names></name><name><surname>Walsh</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cell Lineage Analysis with Somatic Mutations Reveals Late Divergence of Neuronal Cell Types and Cortical Areas in Human Cerebral Cortex</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.11.06.565899</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klimaschewski</surname><given-names>L</given-names></name><name><surname>Claus</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fibroblast growth factor signalling in the diseased nervous system</article-title><source>Molecular Neurobiology</source><volume>58</volume><fpage>3884</fpage><lpage>3902</lpage><pub-id pub-id-type="doi">10.1007/s12035-021-02367-0</pub-id><pub-id pub-id-type="pmid">33860438</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuschel</surname><given-names>S</given-names></name><name><surname>Rüther</surname><given-names>U</given-names></name><name><surname>Theil</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A disrupted balance between Bmp/Wnt and Fgf signaling underlies the ventralization of the Gli3 mutant telencephalon</article-title><source>Developmental Biology</source><volume>260</volume><fpage>484</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1016/s0012-1606(03)00252-5</pub-id><pub-id pub-id-type="pmid">12921747</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancaster</surname><given-names>MA</given-names></name><name><surname>Renner</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>CA</given-names></name><name><surname>Wenzel</surname><given-names>D</given-names></name><name><surname>Bicknell</surname><given-names>LS</given-names></name><name><surname>Hurles</surname><given-names>ME</given-names></name><name><surname>Homfray</surname><given-names>T</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Jackson</surname><given-names>AP</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cerebral organoids model human brain development and microcephaly</article-title><source>Nature</source><volume>501</volume><fpage>373</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1038/nature12517</pub-id><pub-id pub-id-type="pmid">23995685</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancaster</surname><given-names>MA</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Generation of cerebral organoids from human pluripotent stem cells</article-title><source>Nature Protocols</source><volume>9</volume><fpage>2329</fpage><lpage>2340</lpage><pub-id pub-id-type="doi">10.1038/nprot.2014.158</pub-id><pub-id pub-id-type="pmid">25188634</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SMK</given-names></name><name><surname>Danielian</surname><given-names>PS</given-names></name><name><surname>Fritzsch</surname><given-names>B</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Evidence that FGF8 signalling from the midbrain-hindbrain junction regulates growth and polarity in the developing midbrain</article-title><source>Development</source><volume>124</volume><fpage>959</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1242/dev.124.5.959</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Losos</surname><given-names>K</given-names></name><name><surname>Joyner</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>FGF8 can activate Gbx2 and transform regions of the rostral mouse brain into a hindbrain fate</article-title><source>Development</source><volume>126</volume><fpage>4827</fpage><lpage>4838</lpage><pub-id pub-id-type="doi">10.1242/dev.126.21.4827</pub-id><pub-id pub-id-type="pmid">10518499</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Dwyer</surname><given-names>ND</given-names></name><name><surname>O’Leary</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Differential expression of COUP-TFI, CHL1, and two novel genes in developing neocortex identified by differential display PCR</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>7682</fpage><lpage>7690</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-20-07682.2000</pub-id><pub-id pub-id-type="pmid">11027229</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lupo</surname><given-names>G</given-names></name><name><surname>Novorol</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>JR</given-names></name><name><surname>Vallier</surname><given-names>L</given-names></name><name><surname>Miranda</surname><given-names>E</given-names></name><name><surname>Alexander</surname><given-names>M</given-names></name><name><surname>Biagioni</surname><given-names>S</given-names></name><name><surname>Pedersen</surname><given-names>RA</given-names></name><name><surname>Harris</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Multiple roles of Activin/Nodal, bone morphogenetic protein, fibroblast growth factor and Wnt/β-catenin signalling in the anterior neural patterning of adherent human embryonic stem cell cultures</article-title><source>Open Biology</source><volume>3</volume><elocation-id>120167</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.120167</pub-id><pub-id pub-id-type="pmid">23576785</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>Crossley</surname><given-names>PH</given-names></name><name><surname>Cobos</surname><given-names>I</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>FGF8 induces formation of an ectopic isthmic organizer and isthmocerebellar development via a repressive effect on Otx2 expression</article-title><source>Development</source><volume>126</volume><fpage>1189</fpage><lpage>1200</lpage><pub-id pub-id-type="doi">10.1242/dev.126.6.1189</pub-id><pub-id pub-id-type="pmid">10021338</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>I</given-names></name><name><surname>Chambers</surname><given-names>D</given-names></name><name><surname>Shamim</surname><given-names>H</given-names></name><name><surname>Walshe</surname><given-names>J</given-names></name><name><surname>Irving</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Regulation and function of FGF8 in patterning of midbrain and anterior hindbrain</article-title><source>Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire</source><volume>78</volume><fpage>577</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1139/o00-073</pub-id><pub-id pub-id-type="pmid">11103948</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyers</surname><given-names>EN</given-names></name><name><surname>Lewandoski</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination</article-title><source>Nature Genetics</source><volume>18</volume><fpage>136</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1038/ng0298-136</pub-id><pub-id pub-id-type="pmid">9462741</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molnár</surname><given-names>Z</given-names></name><name><surname>Clowry</surname><given-names>GJ</given-names></name><name><surname>Šestan</surname><given-names>N</given-names></name><name><surname>Alzu’bi</surname><given-names>A</given-names></name><name><surname>Bakken</surname><given-names>T</given-names></name><name><surname>Hevner</surname><given-names>RF</given-names></name><name><surname>Hüppi</surname><given-names>PS</given-names></name><name><surname>Kostović</surname><given-names>I</given-names></name><name><surname>Rakic</surname><given-names>P</given-names></name><name><surname>Anton</surname><given-names>ES</given-names></name><name><surname>Edwards</surname><given-names>D</given-names></name><name><surname>Garcez</surname><given-names>P</given-names></name><name><surname>Hoerder-Suabedissen</surname><given-names>A</given-names></name><name><surname>Kriegstein</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>New insights into the development of the human cerebral cortex</article-title><source>Journal of Anatomy</source><volume>235</volume><fpage>432</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1111/joa.13055</pub-id><pub-id pub-id-type="pmid">31373394</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossink</surname><given-names>B</given-names></name><name><surname>van Rhijn</surname><given-names>JR</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Linda</surname><given-names>K</given-names></name><name><surname>Vitale</surname><given-names>MR</given-names></name><name><surname>Zöller</surname><given-names>JEM</given-names></name><name><surname>van Hugte</surname><given-names>EJH</given-names></name><name><surname>Bak</surname><given-names>J</given-names></name><name><surname>Verboven</surname><given-names>AHA</given-names></name><name><surname>Selten</surname><given-names>M</given-names></name><name><surname>Negwer</surname><given-names>M</given-names></name><name><surname>Latour</surname><given-names>BL</given-names></name><name><surname>van der Werf</surname><given-names>I</given-names></name><name><surname>Keller</surname><given-names>JM</given-names></name><name><surname>Klein Gunnewiek</surname><given-names>TM</given-names></name><name><surname>Schoenmaker</surname><given-names>C</given-names></name><name><surname>Oudakker</surname><given-names>A</given-names></name><name><surname>Anania</surname><given-names>A</given-names></name><name><surname>Jansen</surname><given-names>S</given-names></name><name><surname>Lesch</surname><given-names>KP</given-names></name><name><surname>Frega</surname><given-names>M</given-names></name><name><surname>van Bokhoven</surname><given-names>H</given-names></name><name><surname>Schubert</surname><given-names>D</given-names></name><name><surname>Nadif Kasri</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Cadherin-13 is a critical regulator of GABAergic modulation in human stem-cell-derived neuronal networks</article-title><source>Molecular Psychiatry</source><volume>27</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1038/s41380-021-01117-x</pub-id><pub-id pub-id-type="pmid">33972691</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mott</surname><given-names>NN</given-names></name><name><surname>Chung</surname><given-names>WCJ</given-names></name><name><surname>Tsai</surname><given-names>PS</given-names></name><name><surname>Pak</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Differential fibroblast growth factor 8 (FGF8)-mediated autoregulation of its cognate receptors, Fgfr1 and Fgfr3, in neuronal cell lines</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e10143</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0010143</pub-id><pub-id pub-id-type="pmid">20405041</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikouei</surname><given-names>K</given-names></name><name><surname>Muñoz-Manchado</surname><given-names>AB</given-names></name><name><surname>Hjerling-Leffler</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>BCL11B/CTIP2 is highly expressed in GABAergic interneurons of the mouse somatosensory cortex</article-title><source>Journal of Chemical Neuroanatomy</source><volume>71</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.jchemneu.2015.12.004</pub-id><pub-id pub-id-type="pmid">26698402</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowakowski</surname><given-names>TJ</given-names></name><name><surname>Pollen</surname><given-names>AA</given-names></name><name><surname>Sandoval-Espinosa</surname><given-names>C</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transformation of the radial glia scaffold demarcates two stages of human cerebral cortex development</article-title><source>Neuron</source><volume>91</volume><fpage>1219</fpage><lpage>1227</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.09.005</pub-id><pub-id pub-id-type="pmid">27657449</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowakowski</surname><given-names>TJ</given-names></name><name><surname>Bhaduri</surname><given-names>A</given-names></name><name><surname>Pollen</surname><given-names>AA</given-names></name><name><surname>Alvarado</surname><given-names>B</given-names></name><name><surname>Mostajo-Radji</surname><given-names>MA</given-names></name><name><surname>Di Lullo</surname><given-names>E</given-names></name><name><surname>Haeussler</surname><given-names>M</given-names></name><name><surname>Sandoval-Espinosa</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>SJ</given-names></name><name><surname>Velmeshev</surname><given-names>D</given-names></name><name><surname>Ounadjela</surname><given-names>JR</given-names></name><name><surname>Shuga</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lim</surname><given-names>DA</given-names></name><name><surname>West</surname><given-names>JA</given-names></name><name><surname>Leyrat</surname><given-names>AA</given-names></name><name><surname>Kent</surname><given-names>WJ</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex</article-title><source>Science</source><volume>358</volume><fpage>1318</fpage><lpage>1323</lpage><pub-id pub-id-type="doi">10.1126/science.aap8809</pub-id><pub-id pub-id-type="pmid">29217575</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Leary</surname><given-names>DDM</given-names></name><name><surname>Chou</surname><given-names>S-J</given-names></name><name><surname>Sahara</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Area patterning of the mammalian cortex</article-title><source>Neuron</source><volume>56</volume><fpage>252</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.010</pub-id><pub-id pub-id-type="pmid">17964244</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Leary</surname><given-names>DD</given-names></name><name><surname>Sahara</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Genetic regulation of arealization of the neocortex</article-title><source>Current Opinion in Neurobiology</source><volume>18</volume><fpage>90</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2008.05.011</pub-id><pub-id pub-id-type="pmid">18524571</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osaki</surname><given-names>T</given-names></name><name><surname>Duenki</surname><given-names>T</given-names></name><name><surname>Chow</surname><given-names>SYA</given-names></name><name><surname>Ikegami</surname><given-names>Y</given-names></name><name><surname>Beaubois</surname><given-names>R</given-names></name><name><surname>Levi</surname><given-names>T</given-names></name><name><surname>Nakagawa-Tamagawa</surname><given-names>N</given-names></name><name><surname>Hirano</surname><given-names>Y</given-names></name><name><surname>Ikeuchi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Complex activity and short-term plasticity of human cerebral organoids reciprocally connected with axons</article-title><source>Nature Communications</source><volume>15</volume><elocation-id>2945</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-024-46787-7</pub-id><pub-id pub-id-type="pmid">38600094</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostermann</surname><given-names>L</given-names></name><name><surname>Ladewig</surname><given-names>J</given-names></name><name><surname>Müller</surname><given-names>FJ</given-names></name><name><surname>Kesavan</surname><given-names>J</given-names></name><name><surname>Tailor</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Brüstle</surname><given-names>O</given-names></name><name><surname>Koch</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>In vitro recapitulation of developmental transitions in human neural stem cells</article-title><source>Stem Cells</source><volume>37</volume><fpage>1429</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1002/stem.3065</pub-id><pub-id pub-id-type="pmid">31339593</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parenti</surname><given-names>I</given-names></name><name><surname>Rabaneda</surname><given-names>LG</given-names></name><name><surname>Schoen</surname><given-names>H</given-names></name><name><surname>Novarino</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neurodevelopmental disorders: from genetics to functional pathways</article-title><source>Trends in Neurosciences</source><volume>43</volume><fpage>608</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2020.05.004</pub-id><pub-id pub-id-type="pmid">32507511</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paşca</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Assembling human brain organoids</article-title><source>Science</source><volume>363</volume><fpage>126</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1126/science.aau5729</pub-id><pub-id pub-id-type="pmid">30630918</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrier</surname><given-names>AL</given-names></name><name><surname>Tabar</surname><given-names>V</given-names></name><name><surname>Barberi</surname><given-names>T</given-names></name><name><surname>Rubio</surname><given-names>ME</given-names></name><name><surname>Bruses</surname><given-names>J</given-names></name><name><surname>Topf</surname><given-names>N</given-names></name><name><surname>Harrison</surname><given-names>NL</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Derivation of midbrain dopamine neurons from human embryonic stem cells</article-title><source>PNAS</source><volume>101</volume><fpage>12543</fpage><lpage>12548</lpage><pub-id pub-id-type="doi">10.1073/pnas.0404700101</pub-id><pub-id pub-id-type="pmid">15310843</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollen</surname><given-names>AA</given-names></name><name><surname>Nowakowski</surname><given-names>TJ</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Retallack</surname><given-names>H</given-names></name><name><surname>Sandoval-Espinosa</surname><given-names>C</given-names></name><name><surname>Nicholas</surname><given-names>CR</given-names></name><name><surname>Shuga</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>SJ</given-names></name><name><surname>Oldham</surname><given-names>MC</given-names></name><name><surname>Diaz</surname><given-names>A</given-names></name><name><surname>Lim</surname><given-names>DA</given-names></name><name><surname>Leyrat</surname><given-names>AA</given-names></name><name><surname>West</surname><given-names>JA</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Molecular identity of human outer radial glia during cortical development</article-title><source>Cell</source><volume>163</volume><fpage>55</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.09.004</pub-id><pub-id pub-id-type="pmid">26406371</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puelles</surname><given-names>E</given-names></name><name><surname>Annino</surname><given-names>A</given-names></name><name><surname>Tuorto</surname><given-names>F</given-names></name><name><surname>Usiello</surname><given-names>A</given-names></name><name><surname>Acampora</surname><given-names>D</given-names></name><name><surname>Czerny</surname><given-names>T</given-names></name><name><surname>Brodski</surname><given-names>C</given-names></name><name><surname>Ang</surname><given-names>SL</given-names></name><name><surname>Wurst</surname><given-names>W</given-names></name><name><surname>Simeone</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Otx2 regulates the extent, identity and fate of neuronal progenitor domains in the ventral midbrain</article-title><source>Development</source><volume>131</volume><fpage>2037</fpage><lpage>2048</lpage><pub-id pub-id-type="doi">10.1242/dev.01107</pub-id><pub-id pub-id-type="pmid">15105370</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Nguyen</surname><given-names>HN</given-names></name><name><surname>Song</surname><given-names>MM</given-names></name><name><surname>Hadiono</surname><given-names>C</given-names></name><name><surname>Ogden</surname><given-names>SC</given-names></name><name><surname>Hammack</surname><given-names>C</given-names></name><name><surname>Yao</surname><given-names>B</given-names></name><name><surname>Hamersky</surname><given-names>GR</given-names></name><name><surname>Jacob</surname><given-names>F</given-names></name><name><surname>Zhong</surname><given-names>C</given-names></name><name><surname>Yoon</surname><given-names>KJ</given-names></name><name><surname>Jeang</surname><given-names>W</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Thakor</surname><given-names>J</given-names></name><name><surname>Berg</surname><given-names>DA</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Kang</surname><given-names>E</given-names></name><name><surname>Chickering</surname><given-names>M</given-names></name><name><surname>Nauen</surname><given-names>D</given-names></name><name><surname>Ho</surname><given-names>CY</given-names></name><name><surname>Wen</surname><given-names>Z</given-names></name><name><surname>Christian</surname><given-names>KM</given-names></name><name><surname>Shi</surname><given-names>PY</given-names></name><name><surname>Maher</surname><given-names>BJ</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>P</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Ming</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Brain-region-specific organoids using mini-bioreactors for modeling zikv exposure</article-title><source>Cell</source><volume>165</volume><fpage>1238</fpage><lpage>1254</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.032</pub-id><pub-id pub-id-type="pmid">27118425</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Jacob</surname><given-names>F</given-names></name><name><surname>Song</surname><given-names>MM</given-names></name><name><surname>Nguyen</surname><given-names>HN</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Ming</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Generation of human brain region-specific organoids using a miniaturized spinning bioreactor</article-title><source>Nature Protocols</source><volume>13</volume><fpage>565</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1038/nprot.2017.152</pub-id><pub-id pub-id-type="pmid">29470464</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Ming</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Brain organoids: advances, applications and challenges</article-title><source>Development</source><volume>146</volume><elocation-id>dev166074</elocation-id><pub-id pub-id-type="doi">10.1242/dev.166074</pub-id><pub-id pub-id-type="pmid">30992274</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Adam</surname><given-names>CD</given-names></name><name><surname>Deutschmann</surname><given-names>AU</given-names></name><name><surname>Pather</surname><given-names>SR</given-names></name><name><surname>Goldberg</surname><given-names>EM</given-names></name><name><surname>Su</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Jacob</surname><given-names>F</given-names></name><name><surname>Nguyen</surname><given-names>PTT</given-names></name><name><surname>Huh</surname><given-names>S</given-names></name><name><surname>Hoke</surname><given-names>A</given-names></name><name><surname>Swinford-Jackson</surname><given-names>SE</given-names></name><name><surname>Wen</surname><given-names>Z</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Pierce</surname><given-names>RC</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Briand</surname><given-names>LA</given-names></name><name><surname>Chen</surname><given-names>HI</given-names></name><name><surname>Wolf</surname><given-names>JA</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Ming</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Sliced human cortical organoids for modeling distinct cortical layer formation</article-title><source>Cell Stem Cell</source><volume>26</volume><fpage>766</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.02.002</pub-id><pub-id pub-id-type="pmid">32142682</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Cooney</surname><given-names>AJ</given-names></name><name><surname>Kuratani</surname><given-names>S</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Spatiotemporal expression patterns of chicken ovalbumin upstream promoter-transcription factors in the developing mouse central nervous system: evidence for a role in segmental patterning of the diencephalon</article-title><source>PNAS</source><volume>91</volume><fpage>4451</fpage><lpage>4455</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.10.4451</pub-id><pub-id pub-id-type="pmid">8183930</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quadrato</surname><given-names>G</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Macosko</surname><given-names>EZ</given-names></name><name><surname>Sherwood</surname><given-names>JL</given-names></name><name><surname>Min Yang</surname><given-names>S</given-names></name><name><surname>Berger</surname><given-names>DR</given-names></name><name><surname>Maria</surname><given-names>N</given-names></name><name><surname>Scholvin</surname><given-names>J</given-names></name><name><surname>Goldman</surname><given-names>M</given-names></name><name><surname>Kinney</surname><given-names>JP</given-names></name><name><surname>Boyden</surname><given-names>ES</given-names></name><name><surname>Lichtman</surname><given-names>JW</given-names></name><name><surname>Williams</surname><given-names>ZM</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cell diversity and network dynamics in photosensitive human brain organoids</article-title><source>Nature</source><volume>545</volume><fpage>48</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/nature22047</pub-id><pub-id pub-id-type="pmid">28445462</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rech</surname><given-names>ME</given-names></name><name><surname>McCarthy</surname><given-names>JM</given-names></name><name><surname>Chen</surname><given-names>CA</given-names></name><name><surname>Edmond</surname><given-names>JC</given-names></name><name><surname>Shah</surname><given-names>VS</given-names></name><name><surname>Bosch</surname><given-names>DGM</given-names></name><name><surname>Berry</surname><given-names>GT</given-names></name><name><surname>Williams</surname><given-names>L</given-names></name><name><surname>Madan-Khetarpal</surname><given-names>S</given-names></name><name><surname>Niyazov</surname><given-names>D</given-names></name><name><surname>Shaw-Smith</surname><given-names>C</given-names></name><name><surname>Kovar</surname><given-names>EM</given-names></name><name><surname>Lupo</surname><given-names>PJ</given-names></name><name><surname>Schaaf</surname><given-names>CP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Phenotypic expansion of Bosch-Boonstra-Schaaf optic atrophy syndrome and further evidence for genotype-phenotype correlations</article-title><source>American Journal of Medical Genetics. Part A</source><volume>182</volume><fpage>1426</fpage><lpage>1437</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.61580</pub-id><pub-id pub-id-type="pmid">32275123</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reifers</surname><given-names>F</given-names></name><name><surname>Böhli</surname><given-names>H</given-names></name><name><surname>Walsh</surname><given-names>EC</given-names></name><name><surname>Crossley</surname><given-names>PH</given-names></name><name><surname>Stainier</surname><given-names>DY</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Fgf8 is mutated in zebrafish acerebellar (ace) mutants and is required for maintenance of midbrain-hindbrain boundary development and somitogenesis</article-title><source>Development</source><volume>125</volume><fpage>2381</fpage><lpage>2395</lpage><pub-id pub-id-type="doi">10.1242/dev.125.13.2381</pub-id><pub-id pub-id-type="pmid">9609821</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renner</surname><given-names>M</given-names></name><name><surname>Lancaster</surname><given-names>MA</given-names></name><name><surname>Bian</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>H</given-names></name><name><surname>Ku</surname><given-names>T</given-names></name><name><surname>Peer</surname><given-names>A</given-names></name><name><surname>Chung</surname><given-names>K</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Self-organized developmental patterning and differentiation in cerebral organoids</article-title><source>The EMBO Journal</source><volume>36</volume><fpage>1316</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.15252/embj.201694700</pub-id><pub-id pub-id-type="pmid">28283582</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosebrock</surname><given-names>D</given-names></name><name><surname>Arora</surname><given-names>S</given-names></name><name><surname>Mutukula</surname><given-names>N</given-names></name><name><surname>Volkman</surname><given-names>R</given-names></name><name><surname>Gralinska</surname><given-names>E</given-names></name><name><surname>Balaskas</surname><given-names>A</given-names></name><name><surname>Aragonés Hernández</surname><given-names>A</given-names></name><name><surname>Buschow</surname><given-names>R</given-names></name><name><surname>Brändl</surname><given-names>B</given-names></name><name><surname>Müller</surname><given-names>FJ</given-names></name><name><surname>Arndt</surname><given-names>PF</given-names></name><name><surname>Vingron</surname><given-names>M</given-names></name><name><surname>Elkabetz</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Enhanced cortical neural stem cell identity through short SMAD and WNT inhibition in human cerebral organoids facilitates emergence of outer radial glial cells</article-title><source>Nature Cell Biology</source><volume>24</volume><fpage>981</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1038/s41556-022-00929-5</pub-id><pub-id pub-id-type="pmid">35697781</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>JLR</given-names></name></person-group><year iso-8601-date="2008">2008</year><chapter-title>Intrinsic and extrinsic control of cortical development</chapter-title><person-group person-group-type="editor"><name><surname>Bock</surname><given-names>GR</given-names></name><name><surname>Cardew</surname><given-names>G</given-names></name></person-group><source>In Novartis Foundation Symposia</source><publisher-name>John Wiley &amp; Sons, Ltd</publisher-name><fpage>67</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1002/0470846631</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>JLR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Annual Research Review: Development of the cerebral cortex: implications for neurodevelopmental disorders</article-title><source>Journal of Child Psychology and Psychiatry, and Allied Disciplines</source><volume>52</volume><fpage>339</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7610.2010.02307.x</pub-id><pub-id pub-id-type="pmid">20735793</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saelens</surname><given-names>W</given-names></name><name><surname>Cannoodt</surname><given-names>R</given-names></name><name><surname>Todorov</surname><given-names>H</given-names></name><name><surname>Saeys</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A comparison of single-cell trajectory inference methods</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>547</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0071-9</pub-id><pub-id pub-id-type="pmid">30936559</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sansom</surname><given-names>SN</given-names></name><name><surname>Hébert</surname><given-names>JM</given-names></name><name><surname>Thammongkol</surname><given-names>U</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Nisbet</surname><given-names>G</given-names></name><name><surname>Surani</surname><given-names>MA</given-names></name><name><surname>McConnell</surname><given-names>SK</given-names></name><name><surname>Livesey</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Genomic characterisation of a Fgf-regulated gradient-based neocortical protomap</article-title><source>Development</source><volume>132</volume><fpage>3947</fpage><lpage>3961</lpage><pub-id pub-id-type="doi">10.1242/dev.01968</pub-id><pub-id pub-id-type="pmid">16079153</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Kikkawa</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Itoi</surname><given-names>K</given-names></name><name><surname>Osumi</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Organizing activity of Fgf8 on the anterior telencephalon</article-title><source>Development, Growth &amp; Differentiation</source><volume>59</volume><fpage>701</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1111/dgd.12411</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schanze</surname><given-names>I</given-names></name><name><surname>Bunt</surname><given-names>J</given-names></name><name><surname>Lim</surname><given-names>JWC</given-names></name><name><surname>Schanze</surname><given-names>D</given-names></name><name><surname>Dean</surname><given-names>RJ</given-names></name><name><surname>Alders</surname><given-names>M</given-names></name><name><surname>Blanchet</surname><given-names>P</given-names></name><name><surname>Attié-Bitach</surname><given-names>T</given-names></name><name><surname>Berland</surname><given-names>S</given-names></name><name><surname>Boogert</surname><given-names>S</given-names></name><name><surname>Boppudi</surname><given-names>S</given-names></name><name><surname>Bridges</surname><given-names>CJ</given-names></name><name><surname>Cho</surname><given-names>MT</given-names></name><name><surname>Dobyns</surname><given-names>WB</given-names></name><name><surname>Donnai</surname><given-names>D</given-names></name><name><surname>Douglas</surname><given-names>J</given-names></name><name><surname>Earl</surname><given-names>DL</given-names></name><name><surname>Edwards</surname><given-names>TJ</given-names></name><name><surname>Faivre</surname><given-names>L</given-names></name><name><surname>Fregeau</surname><given-names>B</given-names></name><name><surname>Genevieve</surname><given-names>D</given-names></name><name><surname>Gérard</surname><given-names>M</given-names></name><name><surname>Gatinois</surname><given-names>V</given-names></name><name><surname>Holder-Espinasse</surname><given-names>M</given-names></name><name><surname>Huth</surname><given-names>SF</given-names></name><name><surname>Izumi</surname><given-names>K</given-names></name><name><surname>Kerr</surname><given-names>B</given-names></name><name><surname>Lacaze</surname><given-names>E</given-names></name><name><surname>Lakeman</surname><given-names>P</given-names></name><name><surname>Mahida</surname><given-names>S</given-names></name><name><surname>Mirzaa</surname><given-names>GM</given-names></name><name><surname>Morgan</surname><given-names>SM</given-names></name><name><surname>Nowak</surname><given-names>C</given-names></name><name><surname>Peeters</surname><given-names>H</given-names></name><name><surname>Petit</surname><given-names>F</given-names></name><name><surname>Pilz</surname><given-names>DT</given-names></name><name><surname>Puechberty</surname><given-names>J</given-names></name><name><surname>Reinstein</surname><given-names>E</given-names></name><name><surname>Rivière</surname><given-names>JB</given-names></name><name><surname>Santani</surname><given-names>AB</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Sherr</surname><given-names>EH</given-names></name><name><surname>Smith-Hicks</surname><given-names>C</given-names></name><name><surname>Wieland</surname><given-names>I</given-names></name><name><surname>Zackai</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Gronostajski</surname><given-names>RM</given-names></name><name><surname>Zenker</surname><given-names>M</given-names></name><name><surname>Richards</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>NFIB haploinsufficiency is associated with intellectual disability and macrocephaly</article-title><source>American Journal of Human Genetics</source><volume>103</volume><fpage>752</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2018.10.006</pub-id><pub-id pub-id-type="pmid">30388402</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanmugalingam</surname><given-names>S</given-names></name><name><surname>Houart</surname><given-names>C</given-names></name><name><surname>Picker</surname><given-names>A</given-names></name><name><surname>Reifers</surname><given-names>F</given-names></name><name><surname>Macdonald</surname><given-names>R</given-names></name><name><surname>Barth</surname><given-names>A</given-names></name><name><surname>Griffin</surname><given-names>K</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Ace/Fgf8 is required for forebrain commissure formation and patterning of the telencephalon</article-title><source>Development</source><volume>127</volume><fpage>2549</fpage><lpage>2561</lpage><pub-id pub-id-type="doi">10.1242/dev.127.12.2549</pub-id><pub-id pub-id-type="pmid">10821754</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Mi</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Marín</surname><given-names>O</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mouse and human share conserved transcriptional programs for interneuron development</article-title><source>Science</source><volume>374</volume><elocation-id>eabj6641</elocation-id><pub-id pub-id-type="doi">10.1126/science.abj6641</pub-id><pub-id pub-id-type="pmid">34882453</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimamura</surname><given-names>K</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Inductive interactions direct early regionalization of the mouse forebrain</article-title><source>Development</source><volume>124</volume><fpage>2709</fpage><lpage>2718</lpage><pub-id pub-id-type="doi">10.1242/dev.124.14.2709</pub-id><pub-id pub-id-type="pmid">9226442</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>DM</given-names></name><name><surname>Korada</surname><given-names>S</given-names></name><name><surname>Raballo</surname><given-names>R</given-names></name><name><surname>Shashikant</surname><given-names>CS</given-names></name><name><surname>Simeone</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>JR</given-names></name><name><surname>Vaccarino</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>2247</fpage><lpage>2258</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5285-03.2004</pub-id><pub-id pub-id-type="pmid">14999075</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smukler</surname><given-names>SR</given-names></name><name><surname>Runciman</surname><given-names>SB</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>van der Kooy</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences</article-title><source>The Journal of Cell Biology</source><volume>172</volume><fpage>79</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1083/jcb.200508085</pub-id><pub-id pub-id-type="pmid">16390999</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soneson</surname><given-names>C</given-names></name><name><surname>Robinson</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Bias, robustness and scalability in single-cell differential expression analysis</article-title><source>Nature Methods</source><volume>15</volume><fpage>255</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4612</pub-id><pub-id pub-id-type="pmid">29481549</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speir</surname><given-names>ML</given-names></name><name><surname>Bhaduri</surname><given-names>A</given-names></name><name><surname>Markov</surname><given-names>NS</given-names></name><name><surname>Moreno</surname><given-names>P</given-names></name><name><surname>Nowakowski</surname><given-names>TJ</given-names></name><name><surname>Papatheodorou</surname><given-names>I</given-names></name><name><surname>Pollen</surname><given-names>AA</given-names></name><name><surname>Raney</surname><given-names>BJ</given-names></name><name><surname>Seninge</surname><given-names>L</given-names></name><name><surname>Kent</surname><given-names>WJ</given-names></name><name><surname>Haeussler</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>UCSC cell browser: visualize your single-cell data</article-title><source>Bioinformatics</source><volume>37</volume><fpage>4578</fpage><lpage>4580</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btab503</pub-id><pub-id pub-id-type="pmid">34244710</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>HE</given-names></name><name><surname>Smith</surname><given-names>KM</given-names></name><name><surname>Rash</surname><given-names>BG</given-names></name><name><surname>Vaccarino</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders</article-title><source>Frontiers in Neuroscience</source><volume>4</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2010.00059</pub-id><pub-id pub-id-type="pmid">20877431</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storm</surname><given-names>EE</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Dosage of Fgf8 determines whether cell survival is positively or negatively regulated in the developing forebrain</article-title><source>PNAS</source><volume>100</volume><fpage>1757</fpage><lpage>1762</lpage><pub-id pub-id-type="doi">10.1073/pnas.0337736100</pub-id><pub-id pub-id-type="pmid">12574514</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storm</surname><given-names>EE</given-names></name><name><surname>Garel</surname><given-names>S</given-names></name><name><surname>Borello</surname><given-names>U</given-names></name><name><surname>Hebert</surname><given-names>JM</given-names></name><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>McConnell</surname><given-names>SK</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dose-dependent functions of Fgf8 in regulating telencephalic patterning centers</article-title><source>Development</source><volume>133</volume><fpage>1831</fpage><lpage>1844</lpage><pub-id pub-id-type="doi">10.1242/dev.02324</pub-id><pub-id pub-id-type="pmid">16613831</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Street</surname><given-names>K</given-names></name><name><surname>Risso</surname><given-names>D</given-names></name><name><surname>Fletcher</surname><given-names>RB</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Ngai</surname><given-names>J</given-names></name><name><surname>Yosef</surname><given-names>N</given-names></name><name><surname>Purdom</surname><given-names>E</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics</article-title><source>BMC Genomics</source><volume>19</volume><elocation-id>477</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-018-4772-0</pub-id><pub-id pub-id-type="pmid">29914354</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Meyers</surname><given-names>EN</given-names></name><name><surname>Lewandoski</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo</article-title><source>Genes &amp; Development</source><volume>13</volume><fpage>1834</fpage><lpage>1846</lpage><pub-id pub-id-type="doi">10.1101/gad.13.14.1834</pub-id><pub-id pub-id-type="pmid">10421635</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>R</given-names></name><name><surname>You</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>ERK signaling drives evolutionary expansion of the mammalian cerebral cortex</article-title><source>Neuroscience</source><volume>1</volume><elocation-id>e2393</elocation-id><pub-id pub-id-type="doi">10.1101/2023.08.08.552393</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>FC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Genetic patterning of the mammalian telencephalon by morphogenetic molecules and transcription factors</article-title><source>Birth Defects Research. Part C, Embryo Today</source><volume>78</volume><fpage>256</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1002/bdrc.20077</pub-id><pub-id pub-id-type="pmid">17061260</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>RE</given-names></name><name><surname>Pellicano</surname><given-names>F</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Fibroblast growth factor receptor 3 kinase domain mutation increases cortical progenitor proliferation via mitogen-activated protein kinase activation</article-title><source>Journal of Neurochemistry</source><volume>100</volume><fpage>1565</fpage><lpage>1578</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04285.x</pub-id><pub-id pub-id-type="pmid">17181553</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>RE</given-names></name><name><surname>Kind</surname><given-names>PC</given-names></name><name><surname>Graham</surname><given-names>NA</given-names></name><name><surname>Etherson</surname><given-names>ML</given-names></name><name><surname>Kennedy</surname><given-names>J</given-names></name><name><surname>Fernandes</surname><given-names>AC</given-names></name><name><surname>Marques</surname><given-names>CS</given-names></name><name><surname>Hevner</surname><given-names>RF</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Fgf receptor 3 activation promotes selective growth and expansion of occipitotemporal cortex</article-title><source>Neural Development</source><volume>4</volume><elocation-id>4</elocation-id><pub-id pub-id-type="doi">10.1186/1749-8104-4-4</pub-id><pub-id pub-id-type="pmid">19192266</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tocco</surname><given-names>C</given-names></name><name><surname>Bertacchi</surname><given-names>M</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Structural and functional aspects of the neurodevelopmental gene <italic>NR2F1</italic>: from animal models to human pathology</article-title><source>Frontiers in Molecular Neuroscience</source><volume>14</volume><elocation-id>767965</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2021.767965</pub-id><pub-id pub-id-type="pmid">34975398</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyoda</surname><given-names>R</given-names></name><name><surname>Assimacopoulos</surname><given-names>S</given-names></name><name><surname>Wilcoxon</surname><given-names>J</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Feldman</surname><given-names>P</given-names></name><name><surname>Suzuki-Hirano</surname><given-names>A</given-names></name><name><surname>Shimogori</surname><given-names>T</given-names></name><name><surname>Grove</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>FGF8 acts as a classic diffusible morphogen to pattern the neocortex</article-title><source>Development</source><volume>137</volume><fpage>3439</fpage><lpage>3448</lpage><pub-id pub-id-type="doi">10.1242/dev.055392</pub-id><pub-id pub-id-type="pmid">20843859</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripodi</surname><given-names>M</given-names></name><name><surname>Filosa</surname><given-names>A</given-names></name><name><surname>Armentano</surname><given-names>M</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The COUP-TF nuclear receptors regulate cell migration in the mammalian basal forebrain</article-title><source>Development</source><volume>131</volume><fpage>6119</fpage><lpage>6129</lpage><pub-id pub-id-type="doi">10.1242/dev.01530</pub-id><pub-id pub-id-type="pmid">15548577</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trujillo</surname><given-names>CA</given-names></name><name><surname>Gao</surname><given-names>R</given-names></name><name><surname>Negraes</surname><given-names>PD</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Buchanan</surname><given-names>J</given-names></name><name><surname>Preissl</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Haddad</surname><given-names>GG</given-names></name><name><surname>Chaim</surname><given-names>IA</given-names></name><name><surname>Domissy</surname><given-names>A</given-names></name><name><surname>Vandenberghe</surname><given-names>M</given-names></name><name><surname>Devor</surname><given-names>A</given-names></name><name><surname>Yeo</surname><given-names>GW</given-names></name><name><surname>Voytek</surname><given-names>B</given-names></name><name><surname>Muotri</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Complex oscillatory waves emerging from cortical organoids model early human brain network development</article-title><source>Cell Stem Cell</source><volume>25</volume><fpage>558</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.08.002</pub-id><pub-id pub-id-type="pmid">31474560</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>CA</given-names></name><name><surname>Eren-Koçak</surname><given-names>E</given-names></name><name><surname>Inui</surname><given-names>EG</given-names></name><name><surname>Watson</surname><given-names>SJ</given-names></name><name><surname>Akil</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>53</volume><fpage>136</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2015.10.003</pub-id><pub-id pub-id-type="pmid">26454097</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twigg</surname><given-names>SRF</given-names></name><name><surname>Forecki</surname><given-names>J</given-names></name><name><surname>Goos</surname><given-names>JAC</given-names></name><name><surname>Richardson</surname><given-names>ICA</given-names></name><name><surname>Hoogeboom</surname><given-names>AJM</given-names></name><name><surname>van den Ouweland</surname><given-names>AMW</given-names></name><name><surname>Swagemakers</surname><given-names>SMA</given-names></name><name><surname>Lequin</surname><given-names>MH</given-names></name><name><surname>Van Antwerp</surname><given-names>D</given-names></name><name><surname>McGowan</surname><given-names>SJ</given-names></name><name><surname>Westbury</surname><given-names>I</given-names></name><name><surname>Miller</surname><given-names>KA</given-names></name><name><surname>Wall</surname><given-names>SA</given-names></name><collab>WGS500 Consortium</collab><name><surname>van der Spek</surname><given-names>PJ</given-names></name><name><surname>Mathijssen</surname><given-names>IMJ</given-names></name><name><surname>Pauws</surname><given-names>E</given-names></name><name><surname>Merzdorf</surname><given-names>CS</given-names></name><name><surname>Wilkie</surname><given-names>AOM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gain-of-function mutations in ZIC1 are associated with coronal craniosynostosis and learning disability</article-title><source>American Journal of Human Genetics</source><volume>97</volume><fpage>378</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2015.07.007</pub-id><pub-id pub-id-type="pmid">26340333</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandervore</surname><given-names>LV</given-names></name><name><surname>Schot</surname><given-names>R</given-names></name><name><surname>Hoogeboom</surname><given-names>AJM</given-names></name><name><surname>Lincke</surname><given-names>C</given-names></name><name><surname>de Coo</surname><given-names>IF</given-names></name><name><surname>Lequin</surname><given-names>MH</given-names></name><name><surname>Dremmen</surname><given-names>M</given-names></name><name><surname>van Unen</surname><given-names>LMA</given-names></name><name><surname>Saris</surname><given-names>JJ</given-names></name><name><surname>Jansen</surname><given-names>AC</given-names></name><name><surname>van Slegtenhorst</surname><given-names>MA</given-names></name><name><surname>Wilke</surname><given-names>M</given-names></name><name><surname>Mancini</surname><given-names>GMS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mutated zinc finger protein of the cerebellum 1 leads to microcephaly, cortical malformation, callosal agenesis, cerebellar dysplasia, tethered cord and scoliosis</article-title><source>European Journal of Medical Genetics</source><volume>61</volume><fpage>783</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/j.ejmg.2018.10.018</pub-id><pub-id pub-id-type="pmid">30391508</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velasco</surname><given-names>S</given-names></name><name><surname>Kedaigle</surname><given-names>AJ</given-names></name><name><surname>Simmons</surname><given-names>SK</given-names></name><name><surname>Nash</surname><given-names>A</given-names></name><name><surname>Rocha</surname><given-names>M</given-names></name><name><surname>Quadrato</surname><given-names>G</given-names></name><name><surname>Paulsen</surname><given-names>B</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name><name><surname>Adiconis</surname><given-names>X</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Levin</surname><given-names>JZ</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Individual brain organoids reproducibly form cell diversity of the human cerebral cortex</article-title><source>Nature</source><volume>570</volume><fpage>523</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1289-x</pub-id><pub-id pub-id-type="pmid">31168097</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velasco</surname><given-names>S</given-names></name><name><surname>Paulsen</surname><given-names>B</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>3D brain organoids: studying brain development and disease outside the embryo</article-title><source>Annual Review of Neuroscience</source><volume>43</volume><fpage>375</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-070918-050154</pub-id><pub-id pub-id-type="pmid">32640930</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>X</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Ponce-Arias</surname><given-names>AI</given-names></name><name><surname>O’Laughlin</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>RZ</given-names></name><name><surname>Kobayashi</surname><given-names>N</given-names></name><name><surname>Tshuva</surname><given-names>RY</given-names></name><name><surname>Tsai</surname><given-names>YH</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wong</surname><given-names>FCK</given-names></name><name><surname>Surani</surname><given-names>A</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Ming</surname><given-names>GL</given-names></name><name><surname>Reiner</surname><given-names>O</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>A patterned human neural tube model using microfluidic gradients</article-title><source>Nature</source><volume>628</volume><fpage>391</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1038/s41586-024-07204-7</pub-id><pub-id pub-id-type="pmid">38408487</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>W</given-names></name><name><surname>Shimamura</surname><given-names>K</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name><name><surname>Hynes</surname><given-names>MA</given-names></name><name><surname>Rosenthal</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate</article-title><source>Cell</source><volume>93</volume><fpage>755</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81437-3</pub-id><pub-id pub-id-type="pmid">9630220</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zawerton</surname><given-names>A</given-names></name><name><surname>Mignot</surname><given-names>C</given-names></name><name><surname>Sigafoos</surname><given-names>A</given-names></name><name><surname>Blackburn</surname><given-names>PR</given-names></name><name><surname>Haseeb</surname><given-names>A</given-names></name><name><surname>McWalter</surname><given-names>K</given-names></name><name><surname>Ichikawa</surname><given-names>S</given-names></name><name><surname>Nava</surname><given-names>C</given-names></name><name><surname>Keren</surname><given-names>B</given-names></name><name><surname>Charles</surname><given-names>P</given-names></name><name><surname>Marey</surname><given-names>I</given-names></name><name><surname>Tabet</surname><given-names>AC</given-names></name><name><surname>Levy</surname><given-names>J</given-names></name><name><surname>Perrin</surname><given-names>L</given-names></name><name><surname>Hartmann</surname><given-names>A</given-names></name><name><surname>Lesca</surname><given-names>G</given-names></name><name><surname>Schluth-Bolard</surname><given-names>C</given-names></name><name><surname>Monin</surname><given-names>P</given-names></name><name><surname>Dupuis-Girod</surname><given-names>S</given-names></name><name><surname>Guillen Sacoto</surname><given-names>MJ</given-names></name><name><surname>Schnur</surname><given-names>RE</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Poisson</surname><given-names>A</given-names></name><name><surname>El Chehadeh</surname><given-names>S</given-names></name><name><surname>Alembik</surname><given-names>Y</given-names></name><name><surname>Bruel</surname><given-names>AL</given-names></name><name><surname>Lehalle</surname><given-names>D</given-names></name><name><surname>Nambot</surname><given-names>S</given-names></name><name><surname>Moutton</surname><given-names>S</given-names></name><name><surname>Odent</surname><given-names>S</given-names></name><name><surname>Jaillard</surname><given-names>S</given-names></name><name><surname>Dubourg</surname><given-names>C</given-names></name><name><surname>Hilhorst-Hofstee</surname><given-names>Y</given-names></name><name><surname>Barbaro-Dieber</surname><given-names>T</given-names></name><name><surname>Ortega</surname><given-names>L</given-names></name><name><surname>Bhoj</surname><given-names>EJ</given-names></name><name><surname>Masser-Frye</surname><given-names>D</given-names></name><name><surname>Bird</surname><given-names>LM</given-names></name><name><surname>Lindstrom</surname><given-names>K</given-names></name><name><surname>Ramsey</surname><given-names>KM</given-names></name><name><surname>Narayanan</surname><given-names>V</given-names></name><name><surname>Fassi</surname><given-names>E</given-names></name><name><surname>Willing</surname><given-names>M</given-names></name><name><surname>Cole</surname><given-names>T</given-names></name><name><surname>Salter</surname><given-names>CG</given-names></name><name><surname>Akilapa</surname><given-names>R</given-names></name><name><surname>Vandersteen</surname><given-names>A</given-names></name><name><surname>Canham</surname><given-names>N</given-names></name><name><surname>Rump</surname><given-names>P</given-names></name><name><surname>Gerkes</surname><given-names>EH</given-names></name><name><surname>Klein Wassink-Ruiter</surname><given-names>JS</given-names></name><name><surname>Bijlsma</surname><given-names>E</given-names></name><name><surname>Hoffer</surname><given-names>MJV</given-names></name><name><surname>Vargas</surname><given-names>M</given-names></name><name><surname>Wojcik</surname><given-names>A</given-names></name><name><surname>Cherik</surname><given-names>F</given-names></name><name><surname>Francannet</surname><given-names>C</given-names></name><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><name><surname>Machol</surname><given-names>K</given-names></name><name><surname>Scott</surname><given-names>DA</given-names></name><name><surname>Bacino</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Clark</surname><given-names>GD</given-names></name><name><surname>Bertoli</surname><given-names>M</given-names></name><name><surname>Zwolinski</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>RH</given-names></name><name><surname>Akay</surname><given-names>E</given-names></name><name><surname>Chang</surname><given-names>RC</given-names></name><name><surname>Bressi</surname><given-names>R</given-names></name><name><surname>Sanchez Russo</surname><given-names>R</given-names></name><name><surname>Srour</surname><given-names>M</given-names></name><name><surname>Russell</surname><given-names>L</given-names></name><name><surname>Goyette</surname><given-names>AME</given-names></name><name><surname>Dupuis</surname><given-names>L</given-names></name><name><surname>Mendoza-Londono</surname><given-names>R</given-names></name><name><surname>Karimov</surname><given-names>C</given-names></name><name><surname>Joseph</surname><given-names>M</given-names></name><name><surname>Nizon</surname><given-names>M</given-names></name><name><surname>Cogné</surname><given-names>B</given-names></name><name><surname>Kuechler</surname><given-names>A</given-names></name><name><surname>Piton</surname><given-names>A</given-names></name><name><surname>Klee</surname><given-names>EW</given-names></name><name><surname>Lefebvre</surname><given-names>V</given-names></name><name><surname>Clark</surname><given-names>KJ</given-names></name><name><surname>Depienne</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency</article-title><source>Genetics in Medicine</source><volume>22</volume><fpage>524</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1038/s41436-019-0657-0</pub-id><pub-id pub-id-type="pmid">31578471</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Qiao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A single-cell RNA-seq survey of the developmental landscape of the human prefrontal cortex</article-title><source>Nature</source><volume>555</volume><fpage>524</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1038/nature25980</pub-id><pub-id pub-id-type="pmid">29539641</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>COUP-TFI: an intrinsic factor for early regionalization of the neocortex</article-title><source>Genes &amp; Development</source><volume>15</volume><fpage>2054</fpage><lpage>2059</lpage><pub-id pub-id-type="doi">10.1101/gad.913601</pub-id><pub-id pub-id-type="pmid">11511537</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98096.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Martinez-Barbera</surname><given-names>Juan Pedro</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><p>This study is of interest to neuroscientists interested in brain development, particularly human brain development. Human organoids are excellent models to investigate the relevance of gene and pathways in the context of embryonic development. In this important research paper, the authors present convincing evidence supporting a role of FGF8 in brain development.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98096.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Martinez-Barbera</surname><given-names>Juan Pedro</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98096.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1</p><p>Evidence, reproducibility and clarity: Interesting results from exposing human brain organoids to FGF8 include suggestions that FGF8 contributes to the anterior to posterior patterning of the neocortex, as previously reported in mouse. Good, varied methods with reproducibility described well in the methods section. It would improve the reader's experience however to cite numbers of organoids used in specific experiments/assays in the main text.</p></disp-quote><p>We thank the Reviewer for the positive assessment of our study, and we agree that citing the number of organoids per experimental approach would better allow the readers to appreciate the intrinsic variability of organoid protocols. We have included the number of organoids per experiment in figure legends.</p><disp-quote content-type="editor-comment"><p>Full review:</p><p>Organoids do not develop individual neocortical areas. To approach this issue of area identity, however, the authors compared control and FGF8-treated organoids against an existing dataset of transcriptomes of human fetal brains that separated pre-frontal, motor, somatosensory, and visual areas. This seems a good idea, but results showed both treated and untreated organoids alike expressed genes characteristic of somatosensory and pre-frontal cortical regions (anterior and midlevel areas) apparently suggesting that exogenous FGF8 had little effect. Because the previous dataset was not the authors' work, however, and because a comparison between organoids and actual human tissue is hard to interpret, this whole section is probably only confusing to include.</p></disp-quote><p>We would like to clarify to the reviewer that the effect of FGF8 on antero/posterior area identity is modest in our organoid system, suggesting that different doses or temporal windows of FGF8 treatment may be necessary to achieve a stronger modulation of area identity genes (as stated in Discussion). We agree with the Reviewer that, due to this moderate effect, the transcriptomic comparison with fetal brain areas might be confusing for readers. Therefore, we have moved these types of data to the Supplementary Material (new Figure 7—figure supplement 1). We thank the Reviewer for bringing this to our attention.</p><disp-quote content-type="editor-comment"><p>The authors further stress a dorsal/ventral effect in FGF8-treated organoids. The population of ventral telencephalic interneurons, produced in the lateral ganglionic eminence in mice, expand in the human organoids at the expense of glutamatergic neurons of the dorsal telencephalon. This may be consistent with the loss of ventral telencephalic structures in FGF8-deficient mice. The authors suggest that FGF8 expansion of interneurons is a novel finding not previously seen in animal research and may point to a human-specific characteristic. Readers may believe this part of the paper requires more support, just because multiple studies of FGF8 have not revealed this action. Overall, this paper would benefit from shortening, and by statements that some of the results suggest, but do not guarantee, particular conclusions.</p></disp-quote><p>We agree with the reviewer that before stating that FGF8-induced expansion of interneurons in dorsal telencephalic territories is a human-specific characteristic, more support in mouse studies would need to be performed. However, as stated by reviewer 2 below, there is some evidence that some ventral interneuron markers, such as ASCL1 and DLX2, are expressed in the dorsal telencephalon of the early fetal human cerebral cortex, even if at much lower levels than in ventral telencephalon, and that individual human cortical progenitors can generate both excitatory neurons and cortical interneurons in culture. Thus, FGF8 might promote an intrinsic capacity of dorsal cortical neurons to induce the production of ventral LGE-types of interneurons, which would indeed be a human (or maybe primate)-specific trait. We have better discussed this issue in the revised version of the manuscript, where we now state that “the FGF8-mediated induction of a ventral LGE identity in organoids could reflect a human-specific trait: the inherent ability of human glutamatergic progenitors to generate GABAergic neurons with an LGE-like molecular signature.”.</p><disp-quote content-type="editor-comment"><p>Significance</p><p>The paper is for a fairly specialized audience interested in the development of the cerebral cortex, but also has interest regarding developmental human brain defects</p></disp-quote><p>Although the manuscript sounds upon first reading specific to a specialized audience interested in cortical development, we believe that the strength of our human organoid system is the formation of regionalized organoids including brain regions other than the cortex. Moreover, considering the increasing attention on brain organoids in general, and the lack of information on the action of FGF8 during human cortical development, we are confident that this study will attract a broader audience.</p><disp-quote content-type="editor-comment"><p>Interesting results from exposing human brain organoids to FGF8 include suggestions that FGF8 contributes to the anterior to posterior patterning of the neocortex, as previously reported in mouse. Good, varied methods with reproducibility described well in the methods section. It would improve the reader's experience however to cite numbers of organoids used in specific experiments/assays in the main text.</p></disp-quote><p>We thank again the reviewer for acknowledging the potential of our study. As</p><p>previously mentioned, we agree that providing information about the number of organoids used has further supported the statistical analysis.</p><disp-quote content-type="editor-comment"><p>Reviewer #2</p><p>Evidence, reproducibility and clarity</p><p>……However, organoid technology offers a solution to this and the present study presents an elegant approach to addressing how FGF8 signalling directs both anterior/posterior and dorsal/ventral identity in neural progenitors and their offspring in human development. This has both biological and clinical relevance has the study demonstrates how FGF8 may be a key regulator of expression of susceptibility genes for neurodevelopmental conditions. The methods and approach are described clearly and in great detail and it serves as an exemplar for how studies like this might be pursued in the future. Likewise, the results are presented logically, using excellent figures with clear descriptions of the findings. It is positively entertaining to read and very thought provoking. We don't have any major issues with the conclusions.</p></disp-quote><p>We sincerely appreciate the reviewer’s enthusiastic and thoughtful feedback. The positive remarks on the clarity and detail of our methods and results are very encouraging, and we are pleased that the reviewer found our study both entertaining and thought-provoking.</p><disp-quote content-type="editor-comment"><p>We have some minor issues over presentation and interpretation that we would like the authors to consider.</p><p>Developmental staging. It is stated that the organoids have reached a developmental stage equivalent to 16.5 GW based on expression of key genes such as CRYAB. Firstly, we would prefer an unambiguous way of stating age such as post-conceptional age. It is never clear what gestational weeks exactly means (post-menstrual, post-ovulatory?). Secondly, in several figures, UMAPs generated from the organoids are presented alongside representative mouse brain sections from E13.5 which is equivalent to about 11 post conceptional weeks in human. Although we find the mouse sections helpful, perhaps the potential discrepancy in developmental stage should be pointed out.</p></disp-quote><p>We agree with the reviewer that the staging of human organoids in vitro can be very tricky. We have clarified this issue by using post-conceptional weeks (PCW) instead of gestational weeks in the revised version of the manuscript. It is true, that schematic representations of brain sections of mouse telencephalon of around E13.5 were used in the paper, but the idea was to choose an age where dorsal and ventral territories are clearly separated during embryogenesis to highlight the expression of the different genes. Additionally, many developmental genes show clear gradients only early in development, while they tend to be uniformly expressed later on. For these reasons, we kept the current schematics as we believe they work nice to highlight the dorsoventral or anteroposterior character of key developmental genes next to scRNA-seq data. However, we now clearly state in figure legends that “brain schematics with gene expression patterns are based on embryonic day 13.5 stainings obtained from the Mouse Allen Brain Atlas.”, so that the readers will be aware of possible limitations when comparing gene expression between mouse embryos and human organoid cells.</p><disp-quote content-type="editor-comment"><p>Dorso-ventral patterning. Firstly, we wondered why VGLUT2 was used as a marker for dorsal identity when it is generally regarded as being expressed by subcortical neurons, e.g. thalamus and midbrain, whereas VGLUT1 is the standard marker for cortical neurons :https://doi.org/10.1016/j.tins.2003.11.005? Potentially, VGLUT2 expression may be more an indicator of mid/hindbrain identity than cortical identity. Is there any evidence for VGLUT2 expression by cortical cells in development? Also, MASH1 (more correctly called ASCL1) is not exclusively ventral, having shown to be expressed in a subset of intermediate progenitor cells for glutamatergic neurons in rodent BRITZ doi:10.1093/cercor/bhj168 and particularly human doi: 10.1111/joa.12971 ALZU’BI. We are surprised that the recent evidence that human cortical progenitors do have capacity to generate GABAergic neurons DELGADO 10.1038/s41586-02104230-7; 10.1101/2023.11.06.565899 NAN KIM is not mentioned in this section as perhaps FGF8 doesn't so much ventralise progenitor cells as promote an inherent property. This might explain why MGE-like identity is not observed, whereas LGE/CGE like is, as it has already been shown that MGE-like gene expression by dorsal progenitors is very much less likely than LGE/CGE like expression DELGADO 10.1038/s41586-021-04230-7; ALZU’BI 2017 DOI 10.1007/s00429-016-1343-5</p></disp-quote><p>We fully agree and thank the reviewer for bringing to our attention this interesting discussion and pointing to our confusion between VGLUT1 and VGLUT2 expression profiles. After checking our scRNA-seq data, we realized that the Reviewer is absolutely correct about the issue of using VGLUT2 as a dorsal telencephalic marker, as it is expressed in both dorsal and ventral cells. In contrast, VGLUT1 appears to be more specific for neocortical (dorsal) neurons (see <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>). Moreover, it perfectly fits with our results showing a downregulation of VGLUT1 in dorsal glutamatergic neurons.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98096-sa2-fig1-v2.tif"/></fig><p>To support this point, we have validated the expression profile of VGLUT2 in dorsal cortical neurons, by performing triple VGLUT2/TRB1/CTIP2 and double VGLUT2/SATB2 stainings, that have been added in Supplementary material (see new Figure 4—figure supplement 2G-H’). This has allowed to confirm the use of VGLUT2 as a dorsal marker. We have also performed additional immunostainings involving VGLUT1, juxtaposed with GAD67 to assess dorso-ventral neuronal balance. This new analysis has been quantified using AI and integrated into Figure 4.Notably, these experiments have provided a comprehensive understanding of the expression patterns of VGLUT1 and VGLUT2 in the dorsal or ventral telencephalon and have further elucidated their utility as markers for specific neuronal populations in human brain organoids.</p><p>Furthermore, and importantly, we fully agree with the reviewer that human dorsal cortical progenitors do have the ability to generate GABAergic neurons, even if at lower efficiency than compared to glutamatergic neurons, and that FGF8 might promote this inherent property in human organoids. This new discussion and the new references suggested by the reviewer have significantly contributed to our data interpretation about LGE/MGE development. Again, thank you to the reviewer for these very insightful suggestions.</p><disp-quote content-type="editor-comment"><p>MEA recordings. The presentation of electrophysiological data is quite simple. Detection of spikes is claimed therefore representative traces of the spikes should be included and these can be easily generated with the Maxwell system software. It isn't clear how many times the experiments were repeated and there is no statistical analysis. For example, in the text they state on page 15 'Notably, WNTi+FGF8 organoids showed lower spike frequency (firing rate) and amplitude'. The amplitude difference is 43uV vs 41uV; we doubt this is significantly different. Threshold for detecting burst firing appears to be different between Figure 5C and 5d. Why? Shouldn't it be the same? The axonal tracking analysis in Figure 5E/F needs more explanation. How many axons were tracked? Is there any statistical analysis beyond means and standard deviation?</p></disp-quote><p>We agree with the Reviewer that the presentation of our electrophysiological data needed further improvement. We have repeated key recordings on 4 additional samples coming from 2 different batches, which have allowed us to conduct a comprehensive statistical analysis (see revised Figure 5).</p><p>In detail, we have:</p><p>Extracted representative traces of spikes from the Maxwell software, which have been included as Supplementary material (new Figure 5—figure supplement 1A). Footprints of action potentials have been extracted using the in-built analysis tool available in the software.</p><p>Performed axon tracking analysis on 3 control and 3 FGF8-treated samples coming from 2 distinct batches of organoids. Recordings and analyses have been conducted at different in vitro stages to monitor the growth of axonal tracts, enabling us to perform statistical analysis and observe the temporal evolution of axonal growth (see new Figure 5—figure supplement 1C-G).</p><p>Tested the effects of transient GABA-A receptor inactivation on WNTi+FGF8 organoids via Bicuculline treatment to demonstrate the specific functional effect of increased GABAergic activity upon FGF8 treatment (new Figure 5—figure supplement 2).</p><p>Furthermore, placing the threshold for detecting bursts in the network analysis at different levels in control or treated samples seems to be a routine procedure in this MEA system. Indeed, while the user can set a fixed multiplying factor (that is, of course, the same for both control and treated samples), it is the software that multiplies such factor by the basal average activity of the sample. In this way, bursts can be detected as synchronized activity emerging from the basal one, which, of course, varies in every sample. We have better explained this point in the Materials and methods section, and we thank the reviewer for raising this lack of clarity.</p><disp-quote content-type="editor-comment"><p>Anterior/posterior patterning. Returning to the subject of cortical GABAergic neurons, it has been proposed that the prefrontal cortex contains a relatively higher proportion of GABAergic neurons, although the mechanism for this has not been elucidated (see https://doi.org/10.1111/joa.13055 and references therein). Might higher anterior FGF8 specifying cortical progenitors to produce GABA neurons have a role in this?</p><p>Authors: We thank the reviewer for citing this very interesting review. It is highly possible that FGF8 normally expressed anteriorly might have a role in inducing distinct GABAergic subtypes, such as Calretinin+ interneurons, which have been found to be more abundant in frontal cortices of the developing human fetal brain. Our organoids are too early in terms of the developmental stage to verify whether interneuron subtypes such as CalR+ are more or less represented. We have now added this very interesting point to our revised discussion, stating that the dual role played by FGF8 as an inducer of both ventral and anterior brain identity, opens “intriguing hypotheses about the role of FGF8 in bridging cortical areal identity with the local abundance and type of GABAergic interneurons that, instead of migrating from ventral regions, could be produced locally by FGF8-exposed cortical progenitors.”.</p><p>Nomenclature. As this study principally presents data on mRNA expression levels it might be preferable to use italicised capitals for all gene names (except where referring to mouse genes). Also, common names are used in places and standard gene names in others, e.g. COUPTF1 is referred to NR2F1 but VGLUT1 is not referred to SLC17A7 (also see above re MASH1). It would be good to see everything standardised.</p></disp-quote><p>We appreciate the Reviewer for highlighting these discrepancies. We have now standardized gene names both in the text and figures accordingly.</p><disp-quote content-type="editor-comment"><p>Significance</p><p>This study involves a very imaginative use of organoids combined with a variety of approaches to test if fundamental principles of forebrain development, particularly cell specification and regional patterning, that we have learnt from mouse models are relevant to human brain development. It also has clinical relevance as it explores potential disruptions to development that leader to diseases of higher cognition, such as autism of schizophrenia. It is a very accessible manuscript that should have broad appeal. It makes several incremental additions to the field and points the way to future experiments in this area.</p></disp-quote><p>We sincerely thank the Reviewer's insightful comments and positive assessment of our study.</p><disp-quote content-type="editor-comment"><p>Reviewer #3</p><p>Evidence, reproducibility and clarity:</p><p>In the manuscript &quot;FGF8-mediated gene regulation affects regional identity in human cerebral organoids&quot; the authors used FGF8 to change cellular fate in human brain organoids. The experiments are well-performed and the authors used well-established protocols to generate brain organoids. The results clearly show that FGF8 addition induces an increase of diencephalon/midbrain markers (OTX2, EN2), suggesting that long-term FGF8 treatment can induce also posterior regional identities. These data are reinforced also by scRNAseq highlighting a possible mix of cellular identity.</p></disp-quote><p>We thank the reviewer for this encouraging report about our study highlighting the significance of our findings.</p><disp-quote content-type="editor-comment"><p>Main concern:</p><p>The authors should start using FGF8 at later stages than day 19-21, in trying to maintain the forebrain identity.</p></disp-quote><p>As the reviewer correctly pointed out, the temporal window of FGF8 treatment seems of pivotal importance for the final outcome of regional identity acquisition. Indeed, early treatment with FGF8 at day 5 disrupts FOXG1 expression in organoids, as it was demonstrated in the previous version of Figure 1—figure supplement 1. In accordance with the reviewer’s request, we have treated organoids with FGF8 at later stages (starting at day 20) to test whether forebrain identity is maintained while midbrain induction is reduced when using this temporal window for FGF8 treatment.</p><p>To this purpose, we have treated organoids with the same amount of FGF8 but at different times to be able to compare the different treatments in parallel. In detail, we produced cortical organoids (using XAV-939 as a WNT inhibitor) and added 100 ng/ml FGF8 starting at day5 (early treatment), at day10 (normal treatment) or at day 20 (late treatment). Each condition has used at least n=6 organoids and all samples have been cultured until day 30. By immunostaining, we have measured the intensity of FOXG1 staining as a read-out of telencephalic identity and that of NR2F1 staining to evaluate FGF8 action. Interestingly, we found that adding FGF8 at day20 allowed to preserve high expression of FOXG1, supporting forebrain identity. However, this late FGF8 treatment also resulted in sub-optimal regulation of the major FGF8 target gene NR2F1, indicating that delayed FGF8 treatment could be less efficient in terms of FGF8 signalling modulation. We have incorporated these additional analyses into the Supplementary material (see new Figure 2—figure supplement 1) to provide a more comprehensive characterization of the efficiency time windows of FGF8. We also updated the main text, where we now state that “day20 FGF8 treatment was less efficient in modulating the FGF8-target gene NR2F1” and that day10-11 is “the most appropriate starting time point for FGF8 treatment, able to both preserve FOXG1 expression while efficiently modulating FGF8 target genes.”.</p><p>In conclusion, we thank the reviewer for raising this point. Not only because we think that this experimental setup has allowed us to further detail the effects of distinct temporal windows for FGF8 treatment (new Figure 2—figure supplement 1). But especially because these data have reconfirmed that the temporal window we selected for our study represents the most appropriate choice to effectively modulate FGF8 targets while maintaining high FOXG1 levels in human organoids.</p><disp-quote content-type="editor-comment"><p>To verify the identity of the neurons in the organoids the authors should check their ability to make projections in immunodeficient mice. Human iPSC-derived cortical neurons establish subcortical projections in the mouse brain after transplantation and the location of the different neuronal projections could reveal the rosto-caudal identity of the cortical neurons.</p></disp-quote><p>We agree with the reviewer that conducting in vivo transplants of human organoids would offer an interesting approach to testing the identity of differentiated neurons by tracking their projections. However, we believe that due to the multi-regional character of FGF8-treated organoids (which includes also midbrain-like neurons), their transplant into the neocortex would be of difficult interpretation and would not reveal the precise rostrocaudal identity of transplanted human cortical neurons, as requested by the reviewer. Furthermore, this would almost constitute an entire project on its own, given the technical challenges associated with such experimental approaches. We think that our thorough scRNA sequencing analysis is powerful enough for assessing cell identity, as supported by the majority of organoid studies investigating cell identity through scRNA-seq without resorting to transplantation. In our study, the scRNAseq analysis was subsequently validated by several steps of immunostainings, a simple but fundamental corroborative control approach that is sometimes overlooked in similar studies. Finally, we would like to emphasize that reviewers #1 and 2 found our complementary approaches (molecular, cellular, and functional) appropriate, well-performed, logical and reproducible.</p><disp-quote content-type="editor-comment"><p>Significance:</p><p>The proposed protocol is useful to generate brain organoids with mixed cell populations from different regions of the brain (forebrain, midbrain, hindbrain). However, has limited applications since is not clear whether the proposed structures have some kind of organization.</p></disp-quote><p>We agree with the reviewer that each protocol comes with its own limitations and that a careful characterization of the proportion of different regional domains could definitively improve the significance and applicability of our protocol. To this aim, we are now using artificial intelligence-mediated detection of cortical versus midbrain-like domains in control and FGF8treated organoids, to further improve the characterization of distinct cellular populations and quantify the extent of their domains in multi-regional organoids. These data have been added in a new Figure (Figure 3—figure supplement 3).</p></body></sub-article></article>